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Introduction 
The human oral cavity is inhabited by more than 1010 bacteria that belong at the level of the individual to 
more than 100, and at the population level to at least 500 different species [1]. However, only a few of 
these species may cause disease. One of the largest groups of bacteria found in the oral cavity is the 
streptococci, accounting for 25-50% of the oral microbiota. They are gram-positive facultative anaerobes 
and belong to the order Lactobacillales, which harbours bacteria that produce lactic acid from the 
fermentation of sugars. Based on genetic and phenotypic traits, the streptococci can be subdivided in 
several major groups, of which the anginosus group (S. anginosus, S. constellatus, S. intermedius), the mitis 
group (S. gordonii, S. mitis, S. oralis, S. sanguinis, etc.) and the mutans group (S. mutans, S. sobrinus etc.) 
are particularly prominent in the human oral cavity. Dental caries, one of the most frequent diseases in 
humans, is caused by microorganisms that metabolize dietary sugars into acids [2]. The concomitant 
decrease in pH results in demineralization of the hard tissues of teeth. Mutans streptococci, in particular 
Streptococcus mutans, are considered the principal etiological agents of dental caries [3]. Caries prevention 
strategies should therefore be aimed towards the specific reduction of S. mutans, either by interference with 
colonization, direct or indirect inhibition of growth, or possibly by passive or active immunization. 
In healthy individuals, mitis streptococci make up a large fraction of the total bacterial microbiota of 
the oral cavity. One of the members of the mitis streptococci, Streptococcus gordonii, is among the first 
colonizers of teeth. Compared to S. mutans, S. gordonii has lower cariogenic potential [4], but the organism 
has been implicated in infective endocarditis [5]. This colonization of damaged heart valves can occur 
when S. gordonii or other viridans streptococci (i.e. streptococci form the anginosus, mitis, or mutans 
group) enter the bloodstream after dental procedures. 
Bacteriophages are species-specific bacterial viruses [6]. The life cycle of virulent bacteriophages 
commences with adsorption to receptors located on the surface of the host. After injection of the 
bacteriophage nucleic acid into the host cell, phage proteins are produced, the phage nucleic acid is 
replicated and transcribed and phage particles are assembled within the cytoplasm. Release of mature 
phages requires lysis of the host, which is mediated by phage-encoded holins and lysins. In contrast to 
virulent bacteriophages, temperate bacteriophages can remain in a dormant state within the host by 
integrating their genomic DNA in the host chromosome. When conditions are favourable, this prophage 
state can be left by excision of the phage DNA, after which bacteriophage becomes virulent again and 
multiplication takes place. 
In the 1920s it has been proposed that virulent bacteriophages could be applied to combat specific 
bacterial infections. Apart from use of bacteriophages in the Soviet Union, in no case phage therapy was 
developed to the level of clinical application in the Western world. During the last several years phage 
therapy has regained interest particularly because of the dramatic increase of bacterial resistance to 
conventional antibiotics [7]. In principle, phage therapy could be used to remove S. mutans from dental 
plaque, while leaving beneficial microorganisms unaffected. Unfortunately, only limited information is 
available regarding the existence and the ecological role of bacteriophages in the oral cavity. However, it 
has been estimated that the number of bacteriophages on earth exceeds the number of bacteria by a factor 
of ten [8] and there is no reason to believe that this should not be the case for the oral cavity.  
The present study was initiated with the principal aim to gather more insight into the nature of 
virulent and temperate bacteriophages that infect oral streptococci and their mutual interactions. The data 
should help to provide the rational ground allowing judging the potential of page therapy to prevent 
diseases caused by oral streptococci, in particular dental caries and endocarditis. To achieve this goal, 
various methods from the fields of general microbiology, bacterial molecular genetics, DNA sequencing, 
genetic engineering, and bioinformatics have been combined and exploited. 
 
Results 
Bacteriophage M102 is a virulent bacteriophage specific for S. mutans of serotype c [9]. I determined the 
complete genome of S. mutans bacteriophage M102 and found that it consists of 31,147 base pairs (bp) 
with 41 open reading frames (ORFs). Most of the putative phage structural proteins showed similarity to 
those from bacteriophages of Streptococcus thermophilus, which is a distantly related but rather well 
studied streptococcal species. Bioinformatic analysis indicated that the M102 genome contains an unusual 
lysis cassette, which encodes a holin and two lytic enzymes. These are proteins required for the lysis of the 
host cell during the late stages of the lytic infection cycle. 
Bacteriophage M102 propagates in some serotype c strains of S. mutans, but not in S. mutans of 
serotype e, f or k. In adsorption tests the phage bound to all tested serotype c strains, but not to strains of 
different serotype. The serotype c antigen consists of a of cell-wall linked extracellular rhamnose-glucose 
polysaccharides (RGP). Mutants of serotype c strains that are defective in synthesis of the glucose side 
chain of RGP failed to adsorb phage M102 and thus conferred resistance to infection. These results provide 
evidence that the glucose side chain of RGP acts as the receptor for phage M102 adsorption.  
Resistance to phage infection is in fact suspected to possibly be a main drawback of phage therapy. 
Several mechanisms that could render lactic acid bacteria resistant to phage infection have been described: 
Inhibition of phage adsorption, inhibition of DNA injection, restriction modification of phage DNA, and 
abortive infection [10]. Two years ago, an additional phage resistance mechanism has been reported [11]. 
Focal element of this novel mechanism are so called 'clustered regularly interspaced short palindromic 
repeats' (CRISPR) which consist of highly conserved direct repeats interspersed with variable spacer 
sequences. It was shown that the CRISPR cluster can protect bacteria against invasion of foreign DNA 
elements, such as bacteriophages [12]. Using bioinformatic analysis, I could detect two CRISPR loci, 
designated CRISPR1 and CRISPR2 in the fully sequenced S. mutans strain UA159. The sequences of 
CRISPR1 and CRISPR2 arrays were then determined in a panel of strains from the mutans group isolated 
from different origins. Almost 2/3 of the strains had at least one of the CRISPR regions in their genome. 
More than half of the detected CRISPR1 spacers and about 35% of the CRISPR2 spacers showed sequence 
similarity with the genome sequence of M102, suggesting that the strains acquire immunity to phage 
infection by inserting phage DNA into their CRISPR clusters. Although only few spacers matched 100% 
with the phage sequence, most of the mismatches concerned codon positions that had no effect on the 
amino acid sequences of the encoded protein. Moreover, in mutants of OMZ 381, the lone host strain 
available for phage M102 propagation, that proved resistant to phage M102 infection, additional CRISPR1 
spacers had been inserted, and these spacers had the identical sequence as M102.  
Attempts to isolate temperate S. mutans bacteriophages have failed and it remains unknown whether 
they do exist. But temperate bacteriophages from fresh isolates of mitis streptococci could be readily 
isolated by inducing prophage excision with mitomycin. One such prophage, PH15, was detected in S. 
gordonii strain OMZ 1039 and completely sequenced. The complete genome of PH15 is 39,136 bp in size 
and it contains 61 ORFs. The structural module of the PH15 genome turned out to be most similar to those 
of those of the temperate bacteriophages MM1 and φNIH1.1 of Streptococcus pneumoniae and 
Streptococcus pyogenes, respectively. In strain OMZ 1039, phage PH15 was found to be inserted in the 
cysteinyl-tRNA gene. I purified the PH15 endolysin after expression in E. coli since it is theoretically 
conceivable that an endolysin alone could to be useable for the specific elimination of host bacteria. The 
purified endolysin was found to inhibit growth of S. gordonii and of several different streptococcal species, 
including S. mutans. 
 
Discussion 
This study has provided a first glimpse at the role of bacteriophages in the ecology of the microbiota 
of the oral cavity. Both bacteriophages M102 and PH15 showed similarity to other streptococcal phages. 
The relative ease with which temperate bacteriophages of mitis streptococci could be isolated suggests that 
phages to this group of bacteria are widespread. In contrast, it appears difficult to isolate bacteriophages 
specific for mutans streptococci [12]. This may, at least in part, be caused by resistance (possibly acquired) 
to phage infection since all except one of the serotype c S. mutans strains investigated where resistant to 
phage M102. 
The results from the analysis of CRISPR1 and CRISPR2 arrays suggest that S. mutans is often 
attacked by M102-like bacteriophages, but that the presence of S. mutans phages in the environment goes 
along with the acquisition of novel phage-derived spacer sequences. However, the results from this study 
can not explain why most serotype c strains of S. mutans are resistant to infection by bacteriophage M102. 
But other mechanisms that render bacteria resistant to phage infection may play a role as well. 
Resistance against bacteriophage infection, which occurs frequently in S. mutans, is a possible 
limitation of phage therapy. Another potential problem could be limited access of bacteriophages to the 
inner part of the dental plaque biofilm caused by the extracellular matrix [13]. As alternative to 
bacteriophages, bacteriophage-encoded endolysins might be employed. Bacterial resistance to these 
enzymes is improbable. In addition, due to the smaller size of endolysins compared to bacteriophages, 
limitation of diffusion in biofilms is less likely to occur. Thus, in theory it should be possible to use the 
endolysins encoded by the bacteriophages M102 and PH15 to remove streptococci, in particular S. mutans, 
from biofilms such as dental plaque. 
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Abstract
Bacteriophage M102 is a lytic phage specific for serotype c strains of Streptococcus
mutans, a causative agent of dental caries. In this study, the complete genome
sequence of M102 was determined. The genome is 31 147 bp in size and contains
41 ORFs. Most of the ORFs encoding putative phage structural proteins show
similarity to those from bacteriophages from Streptococcus thermophilus. Bioinfor-
matic analysis indicated that the M102 genome contains an unusual lysis cassette,
which encodes a holin and two lytic enzymes.
Introduction
Dental caries is a frequent disease caused by microorganisms
present on the tooth surface that convert carbohydrates
present in the diet to lactic acid. The acid production results
in demineralization of the tooth enamel and tooth dentin.
Streptococcus mutans, a gram-positive facultative anaerobic
bacterium, has a major role in this demineralization process
(Loesche, 1986).
Prevention of dental caries by reduction of S. mutans
from dental plaque involves nonspecific approaches such as
tooth brushing and the use of antimicrobial agents like
chlorhexidine. Specific approaches include active or passive
immunization and replacement of S. mutans by non-
cariogenic competitor organisms (Samaranayake, 2002),
although none of these concepts has been realized thus far.
In theory, bacteriophages or, preferably, lytic enzymes from
bacteriophages might be used to specifically remove
S. mutans from dental plaque as well. The application of
bacteriophage and bacteriophage-encoded lytic enzymes as
antibacterial agents has recently regained interest (Fischetti,
2001, 2005; Loeffler et al., 2001; Loessner, 2005).
Relatively limited information is available with regard to
the ecological role of bacteriophages in the oral cavity. The
isolation of bacteriophages from human saliva or dental
plaque has had variable success (Tylenda et al., 1985; Armau
et al., 1988; Bachrach et al., 2003; Hitch et al., 2004). Lysis of
and virus release by several strains of S. mutans after
mitomycin treatment or UV exposure has been observed,
indicating that these strains contained prophages (Greer
et al., 1971; Klein & Frank, 1973; Higuchi et al., 1982).
However, none of these phages have been purified and
further characterized. By screening more than 1000 plaque
samples for lytic activity against strains of S. mutans and
Streptococcus sobrinus, Armau et al. (1988) isolated 16 lytic
bacteriophages. Three of these, phages M102, e1 and f2 were
found to be specific for S. mutans of serotype c, e and f,
respectively (Delisle & Rostkowski, 1993). In the present
report, the sequencing and analysis of the genome of phage
M102 is described. In addition, the sequence of the lysis
genes of phage M101, which is similar to phage M102, was
determined.
Materials and methods
Bacterial strains, bacteriophages and growth
conditions
Bacteriophages M101 and M102 and their host strain
S. mutans OMZ381 were acquired from G. Tiraby
FEMS Microbiol Lett 275 (2007) 130–138c 2007 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
(Universite´ Paul Sabatier, Toulouse, France). For phage
propagation, S. mutans OMZ381 was grown in M1D
medium, which consisted of 10 g Bacto tryptone, 5 g Bacto-
peptone, 5 g yeast extract, 5 g NaCl, 2.5 g MOPS (4-mor-
pholinepropanesulfonic acid) and 2 g glucose L1. The pH of
M1D was adjusted to pH of 7.4 with NaOH. Solid media
contained 1.5% agar (for plates) or 0.7% agar (for soft agar).
Phage lysates of M101 and M102 were obtained by infection
of exponentially growing cultures of S. mutansOMZ381 and
subsequent incubation for 16 h at 37 1C. To remove debris,
lysates were centrifuged for 10min at 7000 g and passed
through a 0.4 mm filter.
Electron microscopy
A drop of phage solution (about 109PFUmL1) was applied
for 3min to 400 mesh copper grids coated with Formvar
(Electron Microscopy Sciences) and stabilized with carbon.
The grids were air-dried and subsequently a drop of 1%
phosphotungstic acid (PTA) pH 4.4 was applied for 45 s.
The PTA solution was removed with filter paper, the grids
air dried, and examined with a Philips EM 400T TEM at
80 kV.
Isolation of phage DNA, DNA manipulations and
sequencing
Phage DNA was isolated using the Lambdaprep kit
(Promega, Wallisellen, CH). A shotgun library of phage
M102 genomic DNA was prepared by GATC Biotech (Kon-
stanz, Germany) as follows. Genomic DNA from phage
M102 was sheared by nebulization, blunted with T4 DNA
polymerase and Klenow polymerase, and then cloned into
pCR4Blunt-Topo (Invitrogen). Plasmids from resulting
clones were isolated and sequenced with the T7 and T3
primer. Sequencing was performed using dye terminator
technology on a model 3100 sequencer (Applied Biosys-
tems). Sequences were assembled with the program Seqman
of the Lasergene package (GATC Biotech). Gaps were closed
using PCR and by direct sequencing of the resulting
products. A total of 320 sequencing reactions were per-
formed to obtain the complete sequence of M102 with an
average coverage of 8.15. Digestion of phage DNA with
several different restriction enzymes (PstI, SalI, XhoI, Hin-
dIII, EcoRV) yielded fragments whose sizes were in accor-
dance with the genome sequence.
Partial sequences of phage M101 were obtained by direct
sequencing of PCR products, obtained with primers derived
from the M102 sequence.
Sequence analysis
The assembled sequence of M102 was analyzed for the
presence of ORFs using the program GENEMARK.HMM (Luka-
shin & Borodovsky, 1998), which uses a cutoff of 42
nucleotides for the minimal coding region. Further
sequence analysis used the programs from the GCG package
(Accelrys, Cambridge, UK). Blast sequence similarity
searches were carried out at http://nbc3.biologie.uni-kl.de/.
For multiple sequence alignments, CLUSTALW was used
(http://www.ebi.ac.uk/clustalw/).
Phylogenetic distances between phage proteomes were
essentially calculated as described (Rohwer & Edwards,
2002). In brief, ORFs from M102 were compared pariwise
with all the ORFs of 17 selected Streptococcal or Lactococcal
phages by BLAST analysis (cutoff 0.1). Similar proteins were
then aligned using CLUSTALW (gap opening penalty of 10.00
and gap extension penalty of 0.2). The output (in PHYLIP
format) was used to determine the phylogenetic distance
between each ORF from phage M102 and the corresponding
ORF from the other phages with the program PROTDIST
(http://artedi.ebc.uu.se/programs/protdist.html). In case of
no matching ORF, a penalty of 10 was used. For each phage
compared withM102, the sum of the PROTDIST values divided
by the number of ORFs used in the comparison was
calculated. Calculations were carried out independently for
the complete M102 proteome, for Orf1 to Orf18 (structural
module) and for Orf19 to Orf41 (lysis and replication
module).
Results and discussion
Morphology of bacteriophage M102
Electron microscopic analysis (Fig. 1) showed that M102
had a tail with a length of 269 33 nm (n= 69) and a width
of 9.5 1.2 nm (n= 32). The uniformity of tail lengths
indicates that it is noncontractile. The icosahedral phage
head had a diameter of 63 3 nm (n= 50). These values
differ somewhat from those reported previously (Delisle &
Rostkowski, 1993). The tail was segmented and consisted of
Fig. 1. Electron microscopy images of phage M102.
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segments of 4.0 0.2 nm (n= 56). These results indicate
that phage M102 belongs to the family of Siphoviridae with
morphotype B1.
Genome sequence of M102
The genome of bacteriophage M102 was 31 147 bp in size,
which is slightly smaller than the size that was determined
previously by restriction enzyme analysis (Delisle & Rost-
kowski, 1993). The GC content was 39.21%, close to the
previously reported value (Delisle & Rostkowski, 1993), but
somewhat higher than the value of 36.82% for the genome
of S. mutans UA159 (Ajdic et al., 2002). Analysis of the
genome sequence revealed the presence of 41 ORFs, all
transcribed in the same direction (Fig. 2). Most of the ORFs
had an ATG startcodon, but there were three ORFs with
a GTG start codon and three with a TTG start codon
(Table 1). The sequences of the ORFs were compared with
sequences from protein databases using protein–protein
BLAST. Based on these comparisons, most of the ORFs could
be assigned to the different functional groups (Fig. 2). The
ORFs from the same functional groups clustered together on
the genome.
Structural module of M102
The first ORF located downstream of the M102 cos site, a
probable HNH endonuclease, is similar to Orf45 from
Streptococcus thermophilus bacteriophage DT1 (Tremblay &
Moineau, 1999) (Accession number NC_002072). But in
DT1, and also in other Streptococcal and Lactococcal phages,
e.g. phages Sfi21 (NC_000872), SM1 (NC_004996) and
BK5-T (NC_002796), this ORF is located upstream of the
cos site. Orf2 through Orf15 constitute the DNA packaging
and morphogenesis module. In general, the ORFs from this
module showed high similarity to those of phages from
related organisms, e.g. Streptococci, Lactococci and Staphylo-
cocci. Most of the structural proteins showed similarity to
structural proteins from S. thermophilus phage DT1 (Fig. 2)
Lysis module
The packaging and morphogenesis module is followed by
the lysis module. Orf18 showed weak similarity to a putative
holin from Streptococcus suis (Table 1). Orf19 contained two
glycohydrolase domains, which indicates that this protein
could act as endolysin and cleave the glycosidic N-acetyl-
muramoyl-(b1,4)-N-acetylglucosamine bond of the sugar
backbone of peptidoglycan. This is supported by the simi-
larity over the first c. 200 amino acids to muramidases
encoded by bacteriophages from low GC gram-positive
organisms (Fig. 3), including the lytic enzyme from Strepto-
coccus pneumoniae bacteriophage Cp-1, whose structure has
been solved (Hermoso et al., 2003). The acidic residues of
Cpl-1 thought to function in catalysis were conserved in
Orf19. In general, the C-terminal domains of endolysins
specify binding to the cell wall (Loessner, 2005). The
C-terminal part of Orf19 showed no similarity to other
proteins, except for the C-terminal part of a putative
endolysin from Streptococcus pyogenes MGAS10394 (acces-
sion number YP_060444).
The stop codon of Orf19 overlapped with the startcodon
of Orf20, which was similar to putative endolysins that
appear to be encoded predominantly in bacteriophages
from pyogenes Streptococci and Staphylococci (Fig. 4). Orf20
contains a CHAP (cysteine, histidine-dependent amidohy-
drolases/peptidases) domain, which is present in a variety of
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Fig. 2. Organization of Streptococcus mutans phage M102 genome and comparison with the genome from Streptococcus thermophilus phage DT1
(Accession number NC_002072). For clarity, Orf45 from DT1 is shown at the left site. Putative promoters are indicated with horizontal arrows, cos sites
by vertical arrows. Putative terminators are depicted by OOrfs with similarity are connected by shading and the similarity (in % amino acid identity) is
indicated.
FEMS Microbiol Lett 275 (2007) 130–138c 2007 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
132 J.R. van der Ploeg
Table 1. Characteristics of Orfs encoded by bacteriophage M102
ORF Start
Start
codon Stop
Size
(aa) pI
% identity
(over aa) e-value With [organism] (Genbank accession number) Putative function (conserved domain)
1 181 ATG 549 122 9.61 36 (95) 3e-12 Restriction endonuclease [Pediococcus pentosaceus ATCC
25745] (ABJ68063)
Endonuclease (HNHc)
2 571 ATG 909 112 5.29 27 (96) 0.046 Putative small subunit terminase [S. thermophilus bacteriophage
Sfi19] (AAD44055)
Small subunit terminase
3 896 ATG 2770 624 5.17 40 (614) 1e-133 ORF22 [S. thermophilus bacteriophage 7201] (AAF43515) Large subunit terminase
(terminase_1)
4 2840 ATG 3784 314 5.44 37 (295) 1e-48 Putative portal protein [S. thermophilus bacteriophage DT1]
(AAD21882)
PORTAL protein (Phage_portal)
5 3781 TTG 4677 298 4.09 31 (195) 6e-19 Predicted Clp-protease [S. thermophilus bacteriophage Sfi21]
(AAD41032)
CLP protease (CLP_protease)
6 4697 ATG 5833 378 4.82 24 (368) 2e-15 Major structural protein [Lactococcus phage BK5-T] (AAK56807) Phage capsid (phage capsid)
7 5876 GTG 6187 103 4.15 33 (93) 5e-04 DNA packaging, phage associated [Bacteriophage Sal2]
(YP_535183)
DNA packaging protein
8 6184 ATG 6528 114 9.35 27 (62) 0.06 ORF28 [S. thermophilus bacteriophage 7201] (AAF43521) Unknown
9 6521 ATG 6913 130 6.10 32 (115) 2e-09 ORF29 [S. thermophilus bacteriophage 7201] (AAF43522) Unknown
10 6897 ATG 7253 118 4.30 30 (92) 3e-05 Probable tail component protein 123 [S. thermophilus phage
Sfi19] (T09268)
Probable tail component
11 7271 ATG 7954 227 5.52 38 (194) 3e-34 MPS-7201 [S. thermophilus bacteriophage 7201] (AAB71820) Probable major tail protein (phage tail)
12 8127 ATG 13328 1733 10.13 43 (1754) 0 Putative tail component protein [S. thermophilus bacteriophage
DT1] (AAD21891)
Tail protein (CHAP; pfam05257) (LT-
GEWL; pfam1464) (Phage-related tail
protein)
13 13 328 ATG 14854 508 5.55 28 (512) 4e-59 Putative tail component protein [S. thermophilus bacteriophage
Sfi21] (AAC39282)
Probable tail component
14 14 851 ATG 17007 718 4.81 29 (570)
39 (215)
4e-58
1e-34
Host specificity protein [S. thermophilus bacteriophage DT1]
(AAD21894)
Host specificity protein
15 17 008 ATG 18765 585 4.94 27 (577) 8e-50 Structural protein [Streptococcus phage 2972] (AAW27943) Minor structural protein
16 18 786 ATG 19289 167 7.48 – – – Unknown
17 19 306 TTG 19578 90 9.43 27 (83) 0.001 Hypothetical protein EJ-1p68 [Bacteriophage EJ-1] (NP_945307) Unknown
18 19 575 ATG 20042 155 7.60 30 (107) 0.003 Phage holin, LL-H [S. suis 89/1591] (EAP40817) Holin
19 20 058 ATG 20879 273 4.65 59 (220) 8e-70 Peptidoglycan endolysin [S. agalactiae bacteriophage B30]
(AAN28166)
Cell wall hydrolase (Glyco_25)
20 20 879 ATG 21394 171 5.90 45 (140) 2e-20 Phage-associated cell wall hydrolase [S. pyogenes MGAS10394]
(AAT87679)
Cell wall hydrolase (CHAP)
21 21 720 ATG 22538 272 9.60 54 (266) 8e-70 Hypothetical protein PEPE_1019 [Pediococcus pentosaceus
ATCC 25745] (YP_804517)
Unknown
22 22 571 ATG 22753 60 9.42 – – – Unknown
23 22 973 ATG 23731 252 9.17 49 (259) 2e-63 ORF5 [S. thermophilus bacteriophage 7201] (AAF26604) DnaC homolog (DnaC; COG1484.1)
24 23 731 ATG 23934 67 10.43 55 (49) 1e-07 Hypothetical protein lmo2272 [Listeria monocytogenes EGD]
(CAD00350)
Unknown
25 23 931 ATG 24101 56 9.81 – – – Unknown
26 24 094 ATG 24342 82 3.96 32 (83) 5e-04 Hypothetical protein [Temperate phage PhiNIH1.1] (NP_438123) Unknown
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peptidoglycan cleaving enzymes with L-muramoyl-L-alanine
amidases or D-alanyl-glycyl endopeptidase activity (Bate-
man & Rawlings, 2003).
Phage M102 therefore might encode two endolysins of
different substrate specificity, a muramidase and an amidase
or endopeptidase. The presence of two separate endolysins is
rather unusual, although in many phages different specifi-
cities are combined in one polypeptide. A further peculiarity
is the presence of a possible N-terminal signal sequence
in Orf20, as predicted by the program SIGNALP (http://
www.cbs.dtu.dk/services/SignalP/) (Fig. 4). The genes en-
coding Orf19 and Orf20 could be expressed in Esherichia
coli, but both proteins accumulated in the insoluble fraction,
which precluded confirmation of their role in host cell lysis
(results not shown).
Replication module
The region downstream from the lysis module most
probably constitutes the replication module. Five putative
promoters with high similarity to the  35 and  10
regions of the E. coli s70 consensus promoter were identified
(Fig. 2). The putative promoters were located in the inter-
genic regions of the module that encodes proteins required
for DNA replication. The sequences of four of these promo-
ters were highly conserved among each other. The DNA
replication module also contained three putative Rho-
independent termination signals. They were located down-
stream of ORFs 20, 29 and 38 (Fig. 2). About half of
the ORFs from the replication module had no homologs in
the database. The ORFs showed no sequence similarity to
ORFs from DT1, but some were similar to other Streptococ-
cal bacteriophage ORFs that are implicated in replication
(Table 1).
Proteome comparison
The deduced amino-acid sequences of the ORFs encoded by
M102 were compared with deduced amino-acid sequences
from a collection of Streptococcal and Lactococcal phages
(Table 2). Over the complete proteome, bacteriophage
M102 was most closely related to bacteriophages 7201,
Sfi21, Sfi19 and DT1 from S. thermophilus, which indicates
that M102 belongs to the Sfi21-like siphophage group
(Rohwer & Edwards, 2002). However, the similarity was
largely confined to the similarity between the structural
proteins (ORFs 1–18). For the remaining ORFs, phage
M102 was more similar to S. pneumoniae phages MM1 and
Ej-1 and to S. pyogenes phage PhiNIH1.1.
Determination of the cos site
The cos site of phage M102 was estimated by comparison
of the restriction enzyme pattern of heat-treated andTa
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nonheat-treated phage DNA. Digestion of nonheat-treated
phage DNA with PstI gave one fragment of 6.6 kb, which
resolved in two fragments of 1.4 and 5.2 kb upon heating.
Digestion with XhoI gave a fragment of 4.0 kb, which
became 0.7 kb smaller upon heating. Using a computer-
generated restriction map of the sequence, the cos site
could be mapped within a region of about 1 kb in size. For
a more precise determination, heat-treated phage DNA and
ligated phage DNA were directly sequenced using primers
that were expected to hybridize closely to and in the
direction of the expected cos site. Whereas the ligated phage
DNA showed a contiguous sequence, the sequences of
heat-treated phage DNA terminated, leaving a gap of 11
nucleotides (Fig. 5). The cos site of M102 thus has a 30
overhang of 11 nucleotides (50-ccgcgtgaata-30). The stretch
of the nine first nucleotides of this sequence is 89% identical
to the last nine nucleotides from the cos site of Streptococcus
mitis prophage SM1 (50-gtgacggcgtgaa-30) (Siboo et al.,
2003).
Comparison of bacteriophages M102 and M101
Bacteriophage M101 has the same host strain as M102, but
the restriction pattern of M101 genomic DNA is different
from that of M102 (results not shown). The lysis cassette
and the cos site of M101 were amplified by PCR using
primers derived from the M102 sequence sequenced and
compared with M102. The lysA nucleotide sequence was
85.2% identical, whereas that of lysB was 82.6% identical.
The LysA protein was 91.9% identical whereas the LysB
protein was 91.8% identical. The cos sequence of M101 was
identical to that of M102 (results not shown).
   *
Orf19 :        MTSLKKGDYFIDVSGYQPADLHGVFSASGTNKTI : 34
Lysadh :       MTQTIENRAYGVDVSSFNNANVT-EYTNAGANFVL : 34
Lysmv1 :      MTKTYGVDVAVYQPIDLA-AYHKAGASFAI : 29
LysB30 : VKIPYSATYPTAFRPKSFKNAVTVTDNTGLNKGDYFIDVSAYQQADLTTTCQQAGTTKTI : 180
Cpl-1 :    MVKKNDLFVDVSSHNGYDITGILEQMGTTNTI : 32
Lys44 :    MTRKKLNTILITISALSAFAITSPVFAAKGDQGVDLSHYQ--TSTAEFGQASDKFAI : 55
Orf19 : IKLT---ESTGYYNTSAPSQVATSD----CIGFYHFARFGGSVAQAQTEANFFLSTLAKT : 87
Lysadh : VKVS---EGLDYRNPKAKAQVDSTKQNNVVPMGYHYAHFGADSNRAVQEGNYAISSAKLA : 91
Lysmv1 : VKLT---EGVDYVNRRGPSRWTAPGLTTSTLMPTISRSFGSSVSRAKKEAAYFLKEAKKQ : 86
LysB30 : IKVS---ESIAWLSDRHQQQANTSD----PIGYYHFGRFGGDSALAQREADLFLSNLPSK : 233
Cpl-1 : IKIS---ESTTYLNPCLSAQVEQSN----PIGFYHFARFGGDVAEAEREAQFFLDNVP-M : 84
Lys44 : IQLGGYYDGYFSPQSTYATQVASTIAQGKRAHTYIYSQFSSN-AQADQMLNYYLPKVQTP : 114
* *
Orf19 : DIKY---LVCDYEDSA----SGDKQANTNAVLAFMDVIASAGYKPIYYSYRPFTLENIYH : 140
Lysadh : GVVVGSFLACDYEQGSGNETRGDREANTTAILAFLDTIVSAGYKPLLYSGAYLMKNKINT : 151
Lysmv1 : DISKKRMLWLDWEAGSGNVVTGSKSSNTAAILDFMDAIKAAGWRPGLYSGASLMRTAIDT : 146
LysB30 : KVSY---LVIDYEDSA----SADKQANTNAVIAFMDKIASAGYKPIYYSYKPFTLNNIDY : 286
Cpl-1 : QVKY---LVLDYEDDP----SGDAQANTNACLRFMQMIADAGYKPIYYSYKPFTHDNVDY : 137
Lys44 : KGSI---VALDVESGN---------PNTASVEYALAKIKAAGYTPVLYGYKSFLTAHLDL : 162
*    
Orf19 : DQLNAKYPNSTWIAAYPNYAVTPDP--VWSIFPSIDGARWWQFTSTAIASGLDKNVVLLD : 198
Lysadh : SRILAKYPDCLWVAAYPLGNGVSANVPNFEYFPSMDGVAIWQFTDNWKGMNVDSNIAVKS : 211
Lysmv1 : KQVVKKYGTCLWVASYPTMAAVST--ADFGYFR------------QWTGSPSGS------ : 186
LysB30 : QKIIAKYPNSIWIAGYPDYEVRTEP--LWEFFPSMDGVRWWQFTSVGVAGGLDKNIVLLA : 344
Cpl-1 : QQILAQFPNSLWIAGYGLNDGTAN----FEYFPSMDGIRWWQYSS----NPFDKNIVLLD : 189
Lys44 : ASIAKTYP--LWLAEYPNYNVTTSP--NYNYFPSYDNIGIFQFTSTYKAGGLDGDIDLTG : 218
Fig. 3. CLUSTALW sequence alignment of Orf19 with bacteriophage lytic enzymes. The amino acid sequence of Orf19 from Streptococcus mutans phage
M102 was compared with: Lys44, endolysin from Oenococcus oeni bacteriophage fOg44 (AAD10705.2) (Sao-Jose et al., 2000); Cpl-1, endolysin from
Streptococcus pneumoniae phage Cp-1 (NP_044837.1) (Hermoso et al., 2003); LysB30, endolysin from Streptococcus agalactiae bacteriophage B30
(AAN28166.2) (Baker et al., 2006); Lysmv1, endolysin from Lactobacillus bulgaricus bacteriophage mv1 (P33486) (Boizet et al., 1990); Lysadh, lysin from
Lactobacillus acidophilus bacteriophage ADH (NP_050170.1)(Henrich et al., 1995). Identical residues in all sequences are in white on a black
background. The acidic residues of Cpl-1 proposed to function in catalysis (Hermoso et al., 2003) are indicated. Note that only partial sequences are
shown.
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Conclusions
In conclusion, the genome sequence of M102, which is the
first from a bacteriophage that has S. mutans as host, shows
high similarity to bacteriophages from S. thermophilus in the
morphogenesis module, but less so or not in the lysis and
replication modules. The lysis cassette of M102 is unusual in
that it contains two lytic enzymes, one of which has
probably an N-terminal signal sequence.
Table 2. Proteomic comparison of M102 with Streptococcal and Lactococcal phages
Phage Host Accession number
Mean of protdist values
1–41 1–18 19–41
7201 S. thermophilus NC_002185 4.92 3.14 7.37
Sfi21 S. thermophilus NC_000872 6.02 3.54 9.45
Sif19 S. thermophilus NC_000871 6.05 4.05 8.82
DT1 S. thermophilus NC_002072 6.24 3.52 10.00
BK5-T L. lactis cremoris NC_002796 6.36 5.39 7.70
MM1 S. pneumoniae NC_003050 6.90 7.25 6.41
Lc-Nu L. lactis cremoris NC_007501 7.67 6.92 8.69
EJ-1 S. pneumoniae NC_005294 8.41 9.17 7.37
315.1 S. pyogenes NC_004584 8.77 8.80 8.73
O1205 S. thermophilus NC_004303 8.85 8.87 8.83
PhiNIH1.1 S. pyogenes NC_003157 8.85 10.00 7.26
Sfi11 S. thermophilus NC_002214 8.99 8.72 9.37
2972 S. thermophilus NC_007019 9.02 8.31 10.00
Tuc2009 L. lactis cremoris NC_002703 9.15 10.00 7.97
SM1 S. mitis NC_004996 9.45 9.55 9.32
bIL170 L. lactis lactis NC_001909 9.47 9.09 10.00
Cp-1 S. pneumoniae NC_001825 9.71 10.00 9.30
The sum of all Protdist values was divided by the number of proteins used for the analysis. 1–41: all Orfs; 1–18: Orf1–Orf18; 19–41: Orf19–Orf41.
Orf20 :    MLKKTLAILGLSASLLFVSAHANAHTSRLTLDQTNELYTRLAAEGRGVDTDQVYGMQ : 57
Skl   :      MSKKQEMIQFFIDKANAGDGVDNDGAYGFQ : 30
PlyTW :        MKTLKQAESYIKSKVNTGTDFDGLYGYQ : 28
LysWMY :        MKTKAQAKSWINSKIGKGIDWDGMYGYQ : 28
Ply187 :       MALPKTGKPTAKQVVDWAINLIGSGVDVDGYYGRQ : 35
  *
Orf20 : CVDIDTDLTNNYVG--IPISGNAIDLLDSARRAGYEIVPANK--PPRAGDLFVMDTNALY : 113
Skl   : CADVPCYGLRHWYG--VTLWGNAYDLLESARSQGLKVVYDAD--YPKAGWFFVKSYVAGD : 86
PlyTW : CMDLAVDYIYHVTDGKIRMWGNAKDAINNSFGGTATVYKNYPAFRPKYGDVVVWTTGNFA : 88
LysWMY : CMDEAVDYIHHVTDGKVTMWGNAIDAPKNNFQGLCTVYTNTPEFRPAYGDVIVWSYGTFA : 88
Ply187 : CWDLPNYIFNRYWN--FKTPGNARDMAWYRYPEGFKVFRNTSDFVPKPGDIAVWTGGNYN : 93
 *   
Orf20 : GHPFGHTGYVYK-VNPDGSFETVEQNVG-DDSNFYTGTVAKFMHRTRDYMLGYIRLAYRK : 171
Skl   : GVNYGHTGLVYE-DSDGYTIKTIEQNIDGNWDYLEVGGPCRYNERSVDEIVGYIVPPEEV : 145
PlyTW : T--YGHIAIVTNPDPYGDLQYVTVLEQNWNGNGIYKTELATIRTHDYTGITHFIRPNFAT : 146
LysWMY : T--YGHIAIVVNPDPYGDLQYITVLEQNWNGNGIYKTEFATIRTHDYTGVSHFIRPKFAD : 146
Ply187 : WNTWGHTGIVVG---PSTKSYFYSVDQNWNNSNSYVGSPAAKIKHSYFGVTHFVRPAYKA : 150
Fig. 4. CLUSTALW sequence alignment of Orf20 with bacteriophage lytic enzymes. Orf20 from Streptococcus mutans phage M102 was compared
with: Skl, N-acetylmuramoyl-L-alanine amidase from Streptococcus mitis phage SK137 (CAJ13672) (Llull et al., 2006); PlyTW, N-acetylmuramoyl-L-
alanine amidase from Staphylococcus aureus phage Twort (CAA69021) (Loessner et al., 1998); LysWMY, lysin from Staphylococcus warneri M phage
fWMY (BAD83402) (Yokoi et al., 2005); Ply187, cell wall hydrolase Ply187 from S. aureus bacteriophage 187 CAA69022 (Loessner et al., 1999).
Identical residues in all sequences are in white on a black background, conserved cysteine and histidine residues are indicated by an asterisk. The
putative signal sequence in Orf20 is underlined. The complete sequence of Orf20 fromM102 is shown, but partial sequences are shown from the other
proteins.
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Streptococcus gordonii OMZ1039, isolated from supragingival dental plaque, was found to
harbour a prophage, PH15, whose excision could be induced by mitomycin treatment. Phage
PH15 belongs to the Siphoviridae. The complete genome sequence of PH15 was determined.
The genome was 39136 bp in size and contained 61 ORFs. The genome of PH15 was most
similar in the structural module to the temperate bacteriophages MM1 and wNIH1.1 from
Streptococcus pneumoniae and Streptococcus pyogenes, respectively. In strain OMZ1039,
PH15 was found to reside as a prophage in the cysteinyl-tRNA gene. A plasmid, harbouring the
attP site and the integrase gene downstream of a constitutive promoter, was capable of site-
specific integration into the genomes of different oral streptococcal species. The phage endolysin
was purified after expression in Escherichia coli and found to inhibit growth of all S. gordonii
strains tested and several different streptococcal species, including the pathogens Streptococcus
mutans, S. pyogenes and Streptococcus agalactiae.
INTRODUCTION
In healthy individuals, mitis streptococci make up a large
fraction of the total bacterial microbiota of the oral cavity.
One of the members of the mitis streptococci, Streptococcus
gordonii, is among the first colonizers of teeth. Compared
to Streptococcus mutans, the principal aetiological agent of
dental caries, S. gordonii has low cariogenic potential
(Tanzer et al., 2008). On the contrary, it has been suggested
that S. gordonii can modulate the virulence properties of S.
mutans by interfering with the comCDE quorum-sensing
system, which regulates biofilm formation, bacteriocin
production and genetic competence (Wang & Kuramitsu,
2005). Because of its pioneer colonizing properties and
because of its potential to elicit immune responses in
infants and children, it has been proposed to use
engineered strains of S. gordonii for live vaccine delivery
after mucosal colonization (Fischetti et al., 1996; Lee,
2003). Ideally, such antigens would be exported or
displayed on the cell surface of S. gordonii (Lee, 2003).
Although S. gordonii belongs to the GRAS (generally
regarded as safe) organisms, it has been implicated in
causing infective endocarditis (Douglas et al., 1993). This
colonization of damaged heart valves can occur when S.
gordonii or other viridans streptococci enter the blood-
stream after dental procedures.
It is becoming increasingly apparent that temperate
bacteriophages play an important role in bacterial genome
diversification, in particular in the dissemination of
virulence factors. The availability of bacterial genome
sequences has contributed considerably to this understand-
ing. Prophages have been detected in the majority of the
sequenced genomes (Canchaya et al., 2003). Some
Streptococcus pyogenes and Streptococcus agalactiae strains
have been found to contain multiple prophages or
prophage remnants (Canchaya et al., 2003). It has been
suggested that epidemic outbreaks caused by S. pyogenes
are related to the acquisition of prophages, and hence
phage-encoded virulence factors (Banks et al., 2002). The
function of prophages in contributing to the virulence of
Streptococcus pneumoniae is less evident, but it has recently
been reported that adherence of S. pneumoniae to inert
surfaces and pharyngeal cells is increased after lysogeniza-
tion with phage MM1 (Loeffler & Fischetti, 2006).
Abbreviation: CRISPR, clustered regularly interspaced palindromic
repeats.
The GenBank/EMBL/DDBJ accession number for the complete
genome sequence of Streptococcus gordonii prophage PH15 is
FM163528.
Two supplementary tables, showing the oligonucleotides used in this
study and the ORFs encoded by S. gordonii prophage PH15, and three
supplementary figures, showing phylogenetic analysis of part of sodA
from strains OMZ1038, OMZ1039 and OMZ1081, electron microscopy
of phage PH15 adsorption to S. gordonii and S. oralis, and a comparison
of PH15 ORFs with proteins encoded by streptococcal phages, are
available with the online version of this paper.
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Although the role played by oral streptococci in the ecology
of the oral cavity has been studied to some extent
(Kuramitsu et al., 2007), little is known about the presence
and impact of bacteriophages from these organisms. The
genome sequence of the virulent phage M102, which
infects S. mutans, has recently been published (van der
Ploeg, 2007). The sequenced genomes of three oral
streptococcal strains, including S. gordonii CH1, do not
appear to contain prophages (Ajdic´ et al., 2002; Tanzer et
al., 2008; Vickerman et al., 2007; Xu et al., 2007).
Temperate phages from Streptococcus mitis, an abundant
inhabitant of the oral cavity, have been described (Romero
et al., 2004a; Siboo et al., 2003). S. mitis phage SM1 has
been found to encode two proteins, PblA and PblB, which
mediate binding to platelets and affect virulence in a rat
model of infective endocarditis (Mitchell et al., 2007; Siboo
et al., 2003).
Here, the isolation and the genome sequence of what is
believed to be the first temperate bacteriophage from a
fresh isolate of S. gordonii and the functional analysis
of the phage-encoded endolysin and integrase are
reported.
METHODS
Bacterial strains and growth conditions. Streptococcus, Lactococcus
lactis and Enterococcus faecalis strains are listed in Table 1 and were
routinely grown without agitation in Todd–Hewitt broth supple-
mented with 0.3% (w/v) yeast extract (THY) at 37 uC under aerobic
conditions or in a mixture of 10% CO2 and 90% air. When required,
antibiotics were used at the following final concentrations: erythro-
mycin, 15 mg ml21; kanamycin, 750 mg ml21. Streptococci from
human supragingival plaque were isolated on mitis salivarius agar
(Difco). Escherichia coli strains JM109 and BL21(DE3) were used for
routine plasmid propagation and protein production, respectively,
and grown in Luria–Bertani (LB) medium. When required,
antibiotics were added at the following final concentrations:
erythromycin, 200 mg ml21; kanamycin, 50 mg ml21.
DNAmanipulations.Oligonucleotides used in this study are listed in
Supplementary Table S1. Plasmid purification from E. coli, restriction
enzyme digestion, agarose gel electrophoresis, DNA ligation and
transformation of E. coli were carried out using standard methods
(Ausubel et al., 1987). Chromosomal DNA was isolated by using the
GenElute Bacterial Genomic DNA kit (Sigma). DNA sequencing
employed dye terminators and was performed on an ABI 3730xl DNA
analyser (Applied Biosystems).
For strain identification, part of the 16S rRNA gene was amplified by
using PCR with the universal primers 27f and 1492r. The PCR
product was sequenced using primer 519r. For sequencing of sodA,
PCR was performed with primers sodAf and sodAr, and the product
was sequenced with both primers.
Transformation of streptococci was done as follows. An overnight
culture of the strain of interest was diluted 40-fold in fresh THY
medium and incubated for 3–4 h at 37 uC. In some cases, heat-
inactivated horse serum was added to a final concentration of 5% (v/v).
A suitable amount of plasmid (0.1–1.0 mg) was added to 0.5 ml of the
culture, which was further incubated for 1 h at 37 uC. Appropriate
dilutions were plated on THY medium containing erythromycin. Plates
were incubated for 48 h in 10% CO2/90% air at 37 uC.
Phage propagation, isolation of phage DNA and sequencing
strategy. For isolation of phage DNA from OMZ1039, an overnight
culture was diluted 100-fold in fresh THY medium. After 3 h of
incubation at 37 uC, mitomycin was added to a final concentration of
0.1 mg ml21. The culture was incubated for another 20 h at 37 uC. To
remove debris, the lysate (designated as phage lysate below) was
centrifuged for 10 min at 7000 g and passed through a 0.4 mm pore-
size filter. Phage DNA was isolated from the lysate by using the
Lambdaprep kit (Promega). Digestion of phage DNA with EcoRV
yielded 11 fragments with a total size of about 38 kb. Nine of these
EcoRV restriction fragments (with a total size of about 28 kb) were
cloned in the vector pSMART-Lc-Kan (Lucigen). The inserts of the
resulting plasmids were completely sequenced by using a primer-
walking strategy. In addition, a shotgun library was prepared by
cloning fragments of ~1.5 kb, obtained by hydro-shearing of phage
DNA, in pGEM-T-Easy (MWG-Biotech). These plasmids were end-
sequenced. Sequences were assembled with the program CAP3
(Huang & Madan, 1999). Direct sequencing of PCR fragments
obtained with custom primers was utilized to confirm junction
sequences across the ends of cloned fragments and to fill gaps.
Sequence analysis. The assembled sequence of PH15 was analysed
for the presence of ORFs with the program Genemark.hmm
(Lukashin & Borodovsky, 1998), with the codon usage of S.
pneumoniae strain R6 and a minimum size of 42 bases. Further
sequence analysis used the programs from the GCG package
(Accelrys). BLAST sequence similarity searches were done at http://
www.ncbi.nlm.nih.gov/blast/. For multiple sequence alignments,
CLUSTAL W (http://www.ebi.ac.uk/clustalw/) was used. Analysis of
CRISPR (clustered regularly interspaced palindromic repeats)
sequences in the genome of S. gordonii was done at http://crispr.u-
psud.fr/. Phylogenetic analysis of sodA sequences was performed at
http://www.phylogeny.fr/, using the one-click mode (Dereeper et al.,
2008).
Construction of streptococcal integration vector. The integrase
gene and attP from PH15 were amplified by PCR using primers
PH15-int1 and PH15-int2. The product was digested with SacI and
EcoRI and cloned into plasmid pNE1 (Bartilson et al., 2001) to give
pPH15int. A fragment harbouring a constitutive promoter (cp32)
(Jensen & Hammer, 1998) was generated by annealing of two
complementary primers (cp32f and cp32r) and cloned upstream of
the int gene in the BamHI/SmaI sites of pPH15int to give pcPH15int.
Subsequently, the BamHI/EcoRI fragments from pPH15int and
pcPH15int were cloned into similarly digested plasmid pVA891
(Macrina et al., 1983) to make plasmids pOMZ292 and pOMZ291,
respectively. A plasmid with a truncated integrase gene was
constructed by digestion of pOMZ291 with BglII, filling in the ends
with Klenow polymerase and religation, resulting in plasmid
pOMZ308.
Cloning, expression and activity of the lytic enzyme of PH15.
The lysA gene from PH15 was amplified by PCR using primers
PH15lysf and PH15lysr and DNA from strain OMZ1039 as
template. The product was digested with NdeI and XhoI and cloned
into similarly digested pET28b (Novagen) to give plasmid
pOMZ276. For expression of lysA, a culture of E. coli BL21(DE3)
(Novagen) harbouring plasmid pOMZ276 was grown at 37 uC to
OD600 0.8, upon which IPTG was added to 0.1 mM. Incubation of
the culture at 37 uC was continued for 5 h. Cells were harvested,
resuspended in 16 Bugbuster (Novagen) and incubated with
shaking for 1 h at room temperature. The extract was centrifuged
for 5 min at 16 000 g and the supernatant purified by Ni-NTA
agarose affinity chromatography as recommended by the manufac-
turer (Qiagen), using 250 mM imidazole to elute the protein. The
elution buffer was exchanged with 20 mM sodium phosphate
buffer, pH 7.1, by using an Amicon Ultra-4 centrifugal filter device
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(cut-off 10 000 Da). Cell wall lytic activity of the purified protein
with different bacterial strains was evaluated as follows. One
hundred microlitres of an overnight culture was mixed with 4 ml
THY soft agar and poured on a THY plate. After the soft agar had
hardened, 5 ml enzyme was spotted on the plate. The plate was
incubated for 16 h at 37 uC in 10% CO2 and 90% air and examined
for clear zones indicative of growth inhibition.
Electron microscopy. Grids were prepared by applying drops of
phage lysates (prepared as described above) to Formvar-coated,
carbon-reinforced copper grids for about 45 s, then excess solution
was removed with filter paper. Subsequently, a drop of 1%
phosphotungstic acid (PTA), pH 4.2, was applied for ~15 s and
similarly removed with filter paper. The grids were allowed to dry and
were examined under a Philips EM 400T electron microscope at
Table 1. Micro-organisms used in this study and their lysis by purified endolysin from PH15
Organism Strain number Alternative name, characteristics Source or reference Lysis
S. gordonii OMZ1039 Harbours prophage PH15 This study +
S. gordonii OMZ504 ATCC 12396 (SK6) Kilian et al. (1989) +
S. gordonii OMZ505 ATCC 10558T (SK3) Kilian et al. (1989) +
S. gordonii OMZ606 NCTC 3165 (SK51) Kilian et al. (1989) +
S. gordonii OMZ938 Challis DL1* H. JenkinsonD +
S. oralis OMZ8 ATCC 9811 2
S. oralis OMZ507 SK2 (NCTC 7864) Kilian et al. (1989) 2
S. oralis OMZ607 SK248 M. Kiliand 2
S. oralis OMZ1038 Harbours prophage PH10 This study 2
S. oralis OMZ1081 Harbours prophage PH5 This study ND§
S. mitis OMZ508 SK24 (NCTC 8029) Kilian et al. (1989) 2
S. mitis OMZ991 DSMZ12643 (NCTC 12261) DSMZ 2
S. mitis OMZ1043 BMS H. Busscher|| 2
S. mitis OMZ1049 BA H. Busscher|| 2
S. pneumoniae OMZ810 Wu2 B. Diamond 2
S. sanguinis OMZ499 ATCC 10556 Kilian et al. (1989) +
S. sanguinis OMZ500 SK36 Kilian et al. (1989) +
S. mutans OMZ381 P42 G. Tiraby# +
S. mutans OMZ918 UA159 (ATCC 700610) ATCC ND§
S. mutans OMZ1001 Derivative of UA159 van der Ploeg (2005) +
S. mutans OMZ62 AHT +
S. mutans OMZ125 LM7 +
S. mutans OMZ175 +
Streptococcus cricetus OMZ165 HS6 +
Streptococcus sobrinus OMZ176 2
Streptococcus anginosus OMZ510 NCTC 10713 Kilian et al. (1989) +
S. agalactiae OMZ1092 R. Zbinden** +
S. pyogenes OMZ1091 R. Zbinden** +
Streptococcus constellatus OMZ511 ATCC 27823 Kilian et al. (1989) 2
Streptococcus intermedius OMZ512 ATCC 27335 Kilian et al. (1989) +
Streptococcus salivarius OMZ513 NCTC 8618 Kilian et al. (1989) +
S. thermophilus OMZ1082 DSM 20617 M. LoessnerDD +
Ent. faecalis OMZ940 GC110 D. Clewelldd +
L. lactis OMZ1041 DSM 20729 DSMZ 2
L. lactis OMZ1045 NZ9800 M. Kleerebezem§§ 2
*S. gordonii Challis DL1 originates from the same ancestor as strain CH1, whose genome has been sequenced, but the strains have apparently
diverged during maintenance in different laboratories (Howard Jenkinson, personal communication).
DUniversity of Bristol.
dA˚rhus University.
§ND, Not done.
||University of Groningen.
Albert Einstein College of Medicine of Yeshiva University, New York.
#Universite´ Paul Sabatier, Toulouse.
**University of Zurich.
DDSwiss Federal Institute of Technology Zurich.
ddUniversity of Michigan.
§§NIZO Food Research.
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60 kV. Images were taken at magnifications of633 000,642 000 and
654 500.
To visualize phages adhering to bacteria, 5 ml of exponentially grown
cultures of S. gordonii OMZ1039 and Streptococcus oralis OMZ607
were incubated with 5 ml of phage lysate PH15 for 30 min at 37 uC.
Glutaraldehyde was added to a final concentration of 2.5% for
30 min at room temperature. Fixed cells were harvested by
centrifugation, washed three times with distilled water and resus-
pended to a final volume of 1 ml. Electron microscopy was as
described above.
RESULTS AND DISCUSSION
Presence of temperate phages in fresh
streptococcal supragingival plaque isolates
It was investigated whether cultures of fresh isolates from
human supragingival plaque harboured prophages. Out of
15 isolates tested, 10 lysed following addition of mitomy-
cin. The lysates from these 10 isolates were examined for
the presence of bacteriophages by electron microscopy. In
five lysates, bacteriophages were found to be present,
suggesting that these isolates harboured a prophage.
Analysis of the sequence of the 16S rRNA gene showed
that four isolates belonged to the mitis group of
streptococci; the fifth isolate was identified as
Staphylococcus epidermidis. Two of the sequences were
identical and might represent the same isolate. Therefore,
investigations were continued with the three streptococcal
isolates, which were designated OMZ1038, OMZ1039 and
OMZ1081. Since identification of mitis streptococci on the
basis of 16S rRNA sequences at the species level is not
reliable (Kawamura et al., 1999), part of the sodA gene was
sequenced (Poyart et al., 1998). Strains OMZ1038 and
OMZ1081 were both assigned as S. oralis, whereas
OMZ1039 was identified as S. gordonii (Supplementary
Fig. S1). In this study, the temperate phage (designated
PH15) from OMZ1039 was characterized.
Phage PH15 did not form plaques with S. gordonii strains
OMZ505 and OMZ938, which suggests either that the host
range is narrow or that the phage is defective. Electron
microscopic analysis of PH15 showed that it belongs to the
Siphoviridae, having a long, presumably non-contractile tail
of 231±39 nm and an icosahedral head with a diameter of
59.7±5.4 nm (Fig. 1). Incubation of PH15 with bacteria
indicated that the phage adhered to OMZ1039
(Supplementary Fig. S2a), but not to S. oralis strain
OMZ607 (Supplementary Fig. S2b), which suggests that
phage adherence is specific.
Genome sequence of PH15
The complete genome sequence of PH15 was determined
to be 39 136 bp in size, with a GC percentage of 40.51%,
which is identical to the GC percentage of the genome
sequence of S. gordonii Challis CH1 (accession no.
CP000725).
A total of 61 ORFs were encoded on the phage genome.
They are listed in Supplementary Table S2, and a sequence
comparison of the ORFs from PH15 with proteins from
other streptococcal phages is summarized in
Supplementary Fig. S3. Three of the ORFs had a GTG
start codon, five a TTG start codon and the rest an ATG
start codon. The transcription of most ORFs was directed
to the right, but six ORFs, all located near attL (Fig. 2),
were oriented in the opposite direction. There were four
sequences with 100% identity to the E. coli consensus
promoter (ttgaca-n17-tataat). These were located just
upstream of ORF5, ORF9, ORF56 and ORF59.
According to their putative functions and assuming a
genetic organization similar to that in other bacteriophages
from low-GC-content Gram-positive organisms (Canchaya
et al., 2003), the ORFs were assigned to different functional
groups, i.e. lysogeny, replication and regulation, packaging,
morphogenesis and host lysis (Fig. 2).
The lysogeny module is located on the most leftward part
of the genome. The module consists of ORFs, the order of
which follows the conserved pattern found in Siphoviridae
from low-GC-content Gram-positive bacteria (Lucchini et
al., 1999). ORF1 showed similarity to numerous putative
integrases from low-GC-content Gram-positive strep-
tococci, lactococci, lactobacilli and bacilli. The highest
similarity (78% identity) was found with the putative
integrase from bacteriophage LambdaSa2, which has been
identified as a prophage in S. agalactiae strain 2603 V/R by
genome sequencing (Tettelin et al., 2002). One of the few
similar proteins with demonstrated activity is the integrase
Fig. 1. Electron microscopic analysis of phage PH15, showing
the long, presumably non-contractile tail and icosahedral head.
Two different micrographs are shown to give a better impression of
the head and tail of the phage.
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from L. lactis phage TPW22 (Petersen et al., 1999). ORF1
appears to be preceded by its own promoter and separated
from ORF2 by an inverted repeat (free energy of 14.6 kcal
mol21; 61.1 kJ mol21). This suggests that ORF1 is
transcribed independently of the genes upstream.
ORF2 and ORF3 did not show sequence similarity to genes of
known function. ORF4 was similar to cI-like repressors from
lactococcal phages LC3 (Blatny et al., 2003) and Tuc2009
(Kenny et al., 2006). As in most streptococcal and lactococcal
phage genomes, the genetic switch for lysogeny/lysis is most
likely located upstream of the gene encoding the cI-like
repressor. This region contained two putative operators for
the cI-like repressor which overlap with the two putative
promoters for cI and ORF5. ORF5 was preceded by an E. coli
s70 promoter sequence with an extended 210 region. The
imperfect inverted repeat ccacgaaacgtgt, which overlaps with
this promoter, might serve as a binding site for the cI-like
repressor. The gene encoding the latter protein was also
preceded by a putative operator sequence (ccacgaaaggaaa).
The sequences of the operators resemble those of the
operator from lactococcal phage Tuc2009 (Kenny et al.,
2006). An additional copy of the operator (ccacgaaacgtgg)
with perfect dyad symmetry was present in the 39 region of
ORF8, encoding a putative Cro-like repressor. Such an
additional copy of the operator has also been found in the
Cro-like repressor of lactococcal phages LC3 and Tuc2009
(Blatny et al., 2003; Kenny et al., 2006). In contrast to most
other streptococcal and lactococcal phages (Lucchini et al.,
1999), the Cro-like repressor was separated from the cI
repressor by three ORFs. Of these, ORF5 was very small and
without similarity to other genes, whereas ORF6 and ORF7
showed similarity to ORFs from S. mitis phage SM1 (Siboo et
al., 2003).
In the module that putatively encodes proteins involved in
regulation and transcription, only a few of the ORFs could
be assigned a function based on sequence similarity with
known proteins or on the presence of conserved motifs.
The packaging module consists of ORF33 and ORF34,
which most likely encode the small and large subunits,
respectively, of a terminase. The structural module of PH15
encodes the structural proteins of the phage in the order
capsid and tail, which corresponds to the usual order in
streptococcal and lactococcal phages. Overall, the ORFs
from the structural module showed a similar synteny and
sequence similarity to the structural proteins from S.
pyogenes wNIH1.1 (Ikebe et al., 2002) and S. pneumoniae
MM1 (Obrego´n et al., 2003).
The lysis modules of Siphoviridae generally consist of two
genes, which encode a holin and an endolysin. This appears
to be also the case for PH15. ORF54 is predicted to contain
two transmembrane helices and was most similar to the
holins from S. mitis phage Sk137 (Llull et al., 2006) and S.
pneumoniae phage EJ-1 (Dı´az et al., 1996). ORF55 has an
amidase-5 domain, suggesting that it cleaves the peptido-
glycan at the amide bond between N-acetylmuramic acid
and L-alanine of the stem peptide. ORF55 was similar to a
number of putative endolysins from Streptococcus thermo-
philus bacteriophages (Sheehan et al., 1999). In about half
Fig. 2. Organization of the S. gordonii phage PH15 genome and comparison with the genome from S. pneumoniae phage
MM1. ORFs with similarity to proteins encoded by bacteriophage MM1 (NC_003050; Obrego´n et al., 2003) are indicated by
blocks. The percentage amino acid identity is represented by the colour of each block (light yellow, 20–39% identity; dark
yellow, 40–59% identity; brown, 60–79% identity). The colour code for the different modules was adopted from Obrego´n et al.
(2003). Lysogeny and lysogenic conversion modules are shown enlarged. Putative promoters are indicated by hooked arrows,
putative transcriptional terminators by V. The upper and lower scale bars indicate the size in bp.
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of these S. thermophilus bacteriophages, an intron has been
found to be present in the endolysin gene (Foley et al.,
2000), but there was no indication that this is the case for
the endolysin gene of PH15 (see below). Following ORF55,
a putative termination signal was present with a free energy
of 213.5 kcal mol21 (56.5 kJ mol21).
The region downstream of the lysis module and flanking
the attR site frequently encodes lysogenic conversion genes,
whose expression changes the phenotype of the host strain
(Canchaya et al., 2003). In PH15, this region contains six
ORFs (ORF56–ORF61), whose amino acid sequences did
not show sequence similarity to those of proteins of known
function. However, some of the ORFs (ORF56, ORF57 and
ORF60) showed similarity to ORFs encoded in the
lysogenic conversion region of Streptococcus dysgalactiae
phage 3396 (Davies et al., 2007). ORF56 and ORF59 were
preceded by a consensus s70 E. coli promoter sequence,
suggesting that these genes are expressed in the lysogenic
state.
Presence of CRISPR in S. gordonii Challis
It has recently been shown that one of the defence
mechanisms against bacteriophage infection involves the
CRISPR system (Barrangou et al., 2007). CRISPR arrays
consist of identical repeats that are separated by spacer
sequences. Bacteria can acquire resistance to bacteriophage
infection by the incorporation of short phage-derived
sequences between the repeats (Barrangou et al., 2007). The
precise mechanism of phage resistance mediated by
CRISPR is unknown, but is thought to be the counterpart
of RNA interference in eukaryotes. The genome from S.
gordonii Challis CH1 (accession no. CP000725; Vickerman
et al., 2007) contains a CRISPR array with repeats of 36 bp
and a total of 26 spacers of 30 bp in size. The sequences of
the repeats were identical to the repeats of CRISPR1 from
different S. thermophilus strains (Barrangou et al., 2007).
Analysis of the spacer sequences indicated that none of
these spacers matched with the genome sequence of phage
PH15. Interestingly, however, the first spacer matched with
the genome sequence of the inducible S. pneumoniae
prophage EJ-1 (Romero et al., 2004b), apart from one
mismatch. This suggests that S. gordonii Challis encoun-
tered a phage very similar to EJ-1.
Characterization of the phage attachment site in
S. gordonii OMZ1039
To determine the phage and bacterial attachment sites attP
and attB, genomic DNA from OMZ1039 was directly
sequenced. The choice of primers was based on the
assumption that the attachment sequences are in proximity
to the putative phage integrase at the 59 end and of the
putative lysin at the 39 end. Thus, one primer (15a5-1) was
located in the integrase gene (ORF1), the other (15g7-7)
was located in ORF61. The genomic sequencing resulted in
distinct sequence traces, up to a point where overlapping
peaks were observed, probably due to a mixture of phage
and bacterial sequences. By subtracting the known phage
sequence from the mixed sequence, the bacterial sequence
was deduced. Subsequently, the bacterial sequence that
bordered the phage sequence was confirmed by PCR,
combining primers located in the phage sequence and the
bacterial sequence. The PCR products had the expected
sizes and sequencing confirmed the correctness of the
attachment sites.
The attP site could be deduced from these sequences and
was 18 bp with the sequence 59-TAAGGCGGTAGAC
GGATT-39. The attB site was found in the genome of S.
gordonii Challis NCTC 7868. Further analysis showed that
the first 16 bp of the attP site were identical to the last
16 bp of the cysteinyl-tRNA, indicating that in OMZ1039
phage PH15 has integrated just downstream of this gene
(Fig. 3a). By PCR amplification of chromosomal DNA with
primers 15att2 and 15att3, it was determined whether other
S. gordonii strains possess the same attB sequence.
Template DNA from S. gordonii strains OMZ504,
OMZ505 and OMZ606 gave a PCR product of the
expected size, whereas template DNA from OMZ938 did
not yield a product. Sequencing of the products from
OMZ504 and OMZ505 confirmed that the attB site was
identical to that in OMZ1039.
The att sequence from PH15 was similar at the 59 end to
the attP sequence from L. lactis phage TPW22. This phage
has been shown to integrate in L. lactis at the identical
position of the cysteinyl-tRNA (Petersen et al., 1999;
Williams, 2002). Due to sequence differences in the
cysteinyl-tRNA gene, the attachment sites are also different.
The integrase from TPW22 has 49% identity to the
integrase of PH15. It thus appears that the integrase has
coevolved with the cysteinyl-tRNA gene. As described
above, the putative integrase from S. agalactiae phage
LambdaSa2 shows very high sequence similarity to the
PH15 integrase. Analysis of the sequence downstream of
the LambdaSa2 integrase gene indicated the presence of an
identical attachment site (not shown).
BLAST searches showed that, apart from S. gordonii, the
PH15 attB sequence was fully conserved in S. agalactiae.
Allowing for one mismatch at the last base pair, the attB
sequence was also found in all other streptococci whose
genome has been sequenced up to now: Streptococcus suis,
S. mutans, S. pneumoniae, Streptococcus sanguinis, S.
pyogenes and S. thermophilus.
Construction of an integration vector for (oral)
streptococci
To confirm the functionality of the putative integrase, the
int gene (ORF1) and attP were cloned into vector pVA891
(Macrina et al., 1983), which cannot replicate in strep-
tococci. In plasmid pOMZ292, the int gene is preceded by
the putative promoter present in PH15. Plasmid pOMZ291
contains an additional synthetic promoter (cp32) upstream
Prophage PH15 from Streptococcus gordonii
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of this putative promoter (Fig. 3b). It was examined
whether the plasmids could be integrated into the genome
of S. gordonii OMZ938 after introduction by transforma-
tion of naturally competent cells. Plasmid pOMZ291 gave
rise to transformants (46103 c.f.u. mg21), whereas
transformation with plasmids pVA891 or pOMZ292 did
not yield colonies. This confirms the functionality of both
integrase and attP. It also suggests that successful
integration requires the presence of the synthetic promoter.
The putative promoter located upstream of the integrase
may not be functional in plasmid pOMZ292, since a
phage-encoded transcription factor might be lacking. In
addition, a plasmid with a C-terminal-truncated integrase
gene (pOMZ308) could not be introduced into S. gordonii
OMZ938, which shows that the integrase is absolutely
required for integration. PCR and sequence analysis
confirmed that pOMZ291 had inserted at attB (not
shown). The stability of the integrated plasmid was
evaluated by cultivation in THY medium without anti-
biotic selection and counting the number of antibiotic-
sensitive colonies after plating. After about 50 generations
in non-selective medium, all colonies were antibiotic-
resistant. After about 100 generations, six out of 50
colonies had lost antibiotic resistance.
The conservation of the attB sequence in streptococci should
in principle allow for integration of pOMZ291 in the
genomes of a wide variety of oral streptococcal species.
Indeed, transformation of S. mutans strains OMZ381 and
OMZ918, S. sanguinis strain OMZ500 and S. mitis strain
OMZ991 with plasmid pOMZ291, but not with pVA891,
yielded erythromycin-resistant colonies. Combining PCR
and sequence analysis of the product, it was confirmed that
integration occurred at the expected position in the genome
of S. mutans OMZ918. Since the attB sequence is present in
all sequenced streptococcal genomes, it is expected that
plasmid pOMZ291 will integrate in most streptococcal
genomes, provided that the organism can be transformed.
It may thus be a valuable tool for delivery of foreign genes in
single copy. The systemmay also be used to introduce single-
copy transcriptional fusions at an ectopic site.
Production of active endolysin from the lysA gene
of PH15
Phage endolysins are potentially useful as antibacterial
agents to treat infections because of their specificity and
high activity. To explore the specificity of the PH15
endolysin, the lysA gene (ORF55) was cloned into the E.
coli expression vector pET28b, expressed as a fusion to a C-
terminal His-tag. Upon induction with IPTG, a 31 kDa
protein was produced, which is somewhat smaller than the
calculated size of 32.4 kDa. Addition of the protein to a
Fig. 3. (a) Integration site of PH15. The gene organization around the attachment site of the S. gordonii CH1 genome
(accession no. CP000725; Vickerman et al., 2007) is shown. (b) Map of the streptococcal integration vector pOMZ291.
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culture of S. gordonii OMZ1039 led to a more than
threefold decrease in optical density within 5 min (Fig. 4).
The protein also showed weak activity towards Ent. faecalis
OMZ940, but not towards L. lactis OMZ1041 (Fig. 4). The
protein retained activity for 6 months when stored at 4 uC
or at 220 uC in 44% glycerol. The activity of the purified
protein towards different bacterial species was evaluated by
spot assays (Table 1). The protein inhibited growth of all
tested strains of S. gordonii, S. mutans and S. sanguinis. The
protein was also active with the pathogenic streptococci S.
pyogenes and S. agalactiae. However, S. mitis and S. oralis
strains and one S. pneumoniae strain were not inhibited.
This could be caused by a difference in murein structure,
since S. mitis and S. oralis contain a direct link between the
stem peptides (Lys-direct type peptidoglycan), whereas S.
gordonii, S. mutans and S. sanguinis contain a Lys-Ala1-3 or
Lys-Ala2-3 type peptidoglycan (Schleifer & Kilpper-Ba¨lz,
1987). The requirement for a Lys-Ala1-3 type peptidoglycan
could indicate that the enzyme acts as an endopeptidase,
cleaving a bond within the peptide cross-link. Growth of S.
thermophilus OMZ1082 was also inhibited by LysA, which
is not surprising, since the protein was most similar in
sequence to endolysins from S. thermophilus bacterio-
phages. The enzymes from S. thermophilus have not been
characterized in detail, but the enzyme from bacteriophage
O1205 has also been reported to be active towards S.
mutans (Sheehan et al., 1999).
In summary, phage PH15, which is believed to be the first
S. gordonii bacteriophage to be identified, appears struc-
turally related to S. pyogenes phage wNIH1.1 and S.
pneumoniae phage MM1. The phage was found to harbour
a putative lysogenic conversion region, which may encode
virulence factors. The phage endolysin was active towards a
broad range of oral streptococci, including pathogenic
streptococci. Finally, the conserved nature of the phage
attachment site may be exploited for the construction of
streptococcal integration vectors.
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Characterization of Streptococcus gordonii prophage PH15: complete genome 
sequence and functional analysis of phage-encoded integrase and endolysin 
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Supplementary Table S1. Oligonucleotides used in this study 
Primer 
name 
Sequence Purpose 
27f GAGTTTGATCMTGGCTCAG Sequencing of 16S rRNA 
1492r GGYTACCTTGTTACGACTT Sequencing of 16S rRNA 
519r GWATTACCGCGGCKGCTG Sequencing of 16S rRNA 
sodAf TRCAYCATGAYAARCACCAT Sequencing of sodA 
sodAr ARRTARTAMGCRTGYTCCCARACRTC Sequencing of sodA 
cp32f GATCCAGTTTATTCTTGACATATTGCCGGTGTGTTG
GTATAATAACTTGAT 
Construction of cp32 promoter 
cp32r ATCAAGTTATTATACCAACACACCGGCAATATGTC
AAGAATAAACTG 
Construction of cp32 promoter 
PH15-int1 GATCGAGCTCCACACTTCTCATCGCCAAAC Construction of integration vector 
PH15-int2 GATCGAATTCATCGCCCCAAATTTGCC Construction of integration vector 
PH15lysf CCATGCATATGGCAGATATTGCAAGC Cloning of lysA in expression vector 
PH15lysr GATCCTCGAGTTTTAGTTGTAGTAATTTACTAGA Cloning of lysA in expression vector 
15g7-7 AGAGAGTGGAAGCGGCGGGATA Determination of att site 
15a5-1 CACAGTCTAAGGCATACATACG Determination of att site 
15att1 CTTTTCTAAATACAGGGACCA Determination of att site 
15att2 GTGTATTGACGAAAGTCCTTT Determination of att site 
15att3 TATCTCAGCCTCTTTTTGAA Determination of att site 
smuattB-r AACATCAACGGTTCTGTCAC Sequencing of integration site of 
pOMZ291 in S. mutans 
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Supplementary Table S2. ORFs encoded by S. gordonii prophage PH15 
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
1 1142 75 355 41421.0 9.61 78 (356) Prophage LambdaSa2, site-specific recombinase, 
phage integrase family [S. agalactiae 2603V/R] 
AAN00747 
Integrase 
2 1799 1263 178 20069.8 4.94 -   
3 2056 1853 67 7890.4 6.33 90 (66) Hypothetical protein CGSSp14BS69_13048 [S. 
pneumoniae SP14-BS69] ZP_01828431 
 
4 2807 2058 249 28546.0 4.50 70 (230) Phage transcriptional repressor [S. pneumoniae 
SP14-BS69] ZP_01828430 
cI-like repressor 
5 2952 3023 23 2698.5 4.79 -   
6 3098 3310 70 8188.7 6.34 88 (70) gp6 [Streptococcus mitis phage SM1] 
AAP81888 
 
7 3966 3286 226 26014.9 6.33 85 (226) gp7 [Streptococcus mitis phage SM1] 
AAP81889 
 
8 4024 4236 70 8066.6 9.54 53 (60) Prophage L54a, Cro-related protein 
[Staphylococcus aureus subsp.] AAW37529 
Cro-like repressor 
9 4591 4367 74 8400.6 5.01 78 (73) Hypothetical protein CGSSp14BS69_07036  
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
[Streptococcus pneumoniae SP14-BS69] 
ZP_01829261 
10 4756 4944 62 7088.7 10.03 59 (61) Helix–turn–helix motif [Streptococcus suis 
89/1591] EAP40412 
 
11 5042 5575 177 20201.3 10.14 60 (176) Prophage LambdaSa2, HNH endonuclease 
family protein [Streptococcus agalactiae 
2603V/R] AAN00738 
Homing 
endonuclease 
12 5575 5859 94 11257.2 9.28 81 (94) Hypothetical protein SAG1875 [S. agalactiae 
2603V/R] AAN00737 
 
13 5872 6180 102 12058.0 5.65 -   
14 6191 6313 40 4822.0 9.96 -   
15 6310 6420 36 4436.2 3.71 59 (27) Hypothetical protein CGSSp14BS69_06602 [S. 
pneumoniae SP14-BS69] EDK64614 
 
16 6417 6704 95 11185.8 4.95 38 (89) Phage protein [Bacteriophage 9429.1] 
ABF31734 
 
17 6685 7170 161 18337.9 4.88 78 (161) Hypothetical protein CGSSp9BS68_09297 [S. 
pneumoniae SP9-BS68] EDK79004 
 
18 7193 8320 375 43368.5 8.75 90 (374) Hypothetical protein CGSSp6BS73_08219 [S. 
pneumoniae SP6-BS73] EDK75550 
 
19 8334 9146 270 30506.9 7.28 87 (273) Phage NTP-binding protein [S. pneumoniae SP6-
BS73]. EDK75552 
 
 
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
20 9167 9673 168 18931.1 4.27 73 (169) Hypothetical protein CGSSp6BS73_08234 [S. 
pneumoniae SP6-BS73] EDK75553 
 
21 9692 10513 273 30857.8 6.27 89 (273) Phage protein [S. pneumoniae SP23-BS72] 
EDK80841 
Primase 
22 10510 11859 449 52174.0 5.54 89 (446) Prophage ps2 protein 15 [S. pneumoniae SP9-
BS68] EDK79011 
Helicase 
23 12160 12543 127 15362.0 10.23 -   
24 12545 13033 162 18489.7 6.17 41 (172) Predicted pyrophosphatase [Haemophilus 
influenzae R2866] EDK10823 
 
25 13030 13293 87 10229.0 5.77 74 (71) Hypothetical protein CGSSp14BS69_07176 [S. 
pneumoniae SP14-BS69] EDK64687 
 
26 13290 13823 177 20399.5 4.65 38 (186) Hypothetical protein CGSSp9BS68_09352 [S. 
pneumoniae SP9-BS68] EDK79015 
 
27 13823 13960 45 5217.4 3.99 -   
28 13978 14151 57 6524.6 4.50 -   
29 14138 14356 72 8247.8 5.82 53 (43) Conserved hypothetical protein [S. suis 89/1591] 
YP_950578 
 
30 14358 14600 80 9237.9 6.59 -   
31 14587 14772 61 7316.8 8.01 -   
32 14754 15194 146 17284.0 8.71 58 (137) ORF24 [S. thermophilus temperate  
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
bacteriophage O1205] AAC79540 
33 15799 16284 161 18289.9 4.89 78 (144) Phage terminase, small subunit [S. pneumoniae 
SP6-BS73] EDK75565 
Terminase small 
subunit 
34 16274 17581 435 50851.6 7.90 66 (434) Putative terminase large subunit [S. pneumoniae 
bacteriophage MM1 1998] AAZ82443 
Terminase large 
subunit 
35 17646 19103 485 54768.2 4.64 66 (486) Putative minor capsid protein [S. pyogenes 
MGAS8232] AAL98299 
Minor capsid 
protein 
36 19108 20253 381 43431.9 6.43 60 (377) Putative minor capsid protein [S. pyogenes 
MGAS8232] AAL98298 
Minor capsid 
protein 
37 20395 20967 190 20786.0 4.45 45 (166) Phage protein [S. pyogenes MGAS6180] 
AAX72355 
Scaffolding 
38 20982 21854 290 32631.6 5.80 54 (301) Lj928 prophage protein [Lactobacillus johnsonii 
NCC 533] AAS09201 
 
39 21868 22110 80 8859.3 4.26 55 (36) ORF041 [Staphylococcus phage 29] YP_240537  
40 22103 22291 62 7161.3 4.43 -   
41 22295 22702 135 15210.1 5.87 44 (132) Hypothetical protein, phage associated [S. 
pyogenes M1 GAS] AAK33647 
 
42 22692 23042 116 13402.4 5.15 43 (116) Putative minor capsid protein - phage-associated 
[S. pyogenes MGAS315] AAM79830 
Minor capsid 
protein 
43 23042 23404 120 13271.7 10.62 48 (117) Putative minor capsid protein [S. pneumoniae Minor capsid 
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
bacteriophage MM1 1998] AAZ82452 protein 
44 23401 23814 137 15538.8 4.36 56 (126) Hypothetical phage protein [S. pyogenes str. 
Manfredo] CAM29856 
Minor capsid 
protein 
45 23818 24267 149 16479.5 4.88 63 (148) Major tail shaft protein [S. pyogenes 
MGAS10394] AAT87489 
Tail protein 
46 24324 24788 154 17897.5 9.13 46 (146) Unknown phage protein [S. pneumoniae SP18-
BS74] EDK67458 
 
47 24801 25367 188 21988.9 4.29 51 (188) Phage protein [S. pneumoniae SP18-BS74] 
EDK67459 
 
48 25371 29270 1299 135676.7 5.65 37 (1027) Putative minor tail protein, tape measure protein 
[S. pneumoniae bacteriophage MM1 1998] 
AAZ82457 
Tape measure 
protein 
49 29272 29985 237 26623.4 9.67 49 (236) Hypothetical phage protein [S. pyogenes str. 
Manfredo] CAM29861 
 
50 29982 33791 1269 141825.9 5.61 33 (723) PblB [S. mitis phage SM1] AAG18640 Anti-receptor 
51 33806 34006 66 7441.7 4.79 -   
52 34003 34572 189 21158.0 4.77 42 (117) Hypothetical protein [Bacteriophage EJ-1] 
CAE82149 
 
53 34585 34863 92 10730.6 5.78 72 (88) Hypothetical protein [Bacteriophage EJ-1] 
CAE82150 
 
 
ORF From bp To bp aa Molecular 
mass (Da) 
pI Identity (%) 
over (aa) 
With [organism] accession number Putative function 
or motif 
54 34886 35149 87 9770.8 9.37 52 (84) Holin [Bacteriophage Sk137] CAJ13671 Holin 
55 35170 36021 283 31331.4 4.14 70 (280) ORF288 gp [S. thermophilus bacteriophage 
Sfi21] AAC39288 
Endolysin 
56 36208 36522 104 11697.5 4.59 58 (97) Hypothetical protein phi3396_63 [Streptococcus 
phage phi3396] ABN10836 
 
57 36537 36824 95 11147.7 4.23 41 (97) Hypothetical protein phi3396_60 [Streptococcus 
phage phi3396] ABN10833 
 
58 36840 37151 103 12274.0 4.54 39 (43) Hypothetical protein CLOL250_01083 
[Clostridium sp. L2-50] EDO58357 
 
59 37342 37449 35 4212.5 10.74 -   
60 37611 37979 122 13999.2 4.58 52 (59) Hypothetical protein phi3396_61 [Streptococcus 
phage phi3396] ABN10834 
 
61 38766 39041 91 10895.0 8.63 54 (77) Hypothetical protein CGSSp14BS69_13850 [S. 
pneumoniae SP14-BS69] EDK64655 
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Supplementary Fig. S1. Phylogenetic analysis of part of sodA from strains 
OMZ1038, OMZ1039 and OMZ1081 (shown in red and boxed). Type strains are 
underlined. The marker represents a 0.07% difference in nucleotide sequence. 
Supplementary Fig. S2. Electron microscopy of phage PH15 adsorption to (a) S. 
gordonii OMZ1039 and (b) S. oralis OMZ607. 
Supplementary Fig. S3. Comparison of PH15 ORFs with proteins encoded by 
streptococcal phages. The amino acid sequence of each ORF from PH15 was 
compared with those of the proteins encoded by S. pneumoniae phage MM1 
(accession no. NC_003050), S. mitis phage SM1 (NC_004996), S. pyogenes 
INIH1.1 (NC_003157), S. agalactiae phage LambdaSa2 (NC_004116), S. 
pneumoniae phage EJ-1 (NC_005294) and S. disgalactiae phage 3396 
(NC_009018). The percentage amino acid identity is represented by the colour of 
each box (white, no identity; light yellow, 20–39% identity; dark yellow, 40–59% 
identity; orange, 60–79% identity; red, >80% identity). 
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Abstract
Bacteriophage M102 is a virulent siphophage that propagates in some serotype c
Streptococcus mutans strains, but not in S. mutans of serotype e, f or k. The serotype
of S. mutans is determined by the glucose side chain of rhamnose–glucose
polysaccharide (RGP). Because the first step in the bacteriophage infection process
is adsorption of the phage, it was investigated whether the serotype specificity of
phage M102 was determined by adsorption. M102 adsorbed to all tested serotype c
strains, but not to strains of different serotypes. Streptococcus mutans serotype c
mutants defective in the synthesis of the glucose side chain of RGP failed to adsorb
phage M102. These results suggest that the glucose side chain of RGP acts as a
receptor for phage M102.
Introduction
Mutans streptococci are thought to play an important
role in caries development in humans and in some
animals (Loesche, 1986). The group of mutans streptococci
consists of seven different species: Streptococcus mutans,
Streptococcus rattus, Streptococcus sobrinus, Streptococcus
cricetus, Streptococcus ferus, Streptococcus macacae and
Streptococcus downei. Streptococcus mutans and S. sobrinus
are frequently found in the human oral cavity (Loesche,
1986). Apart from the classification at the species level,
mutans streptococci have also been classified into nine
different serotypes, based on differences in their cell wall
polysaccharides. Streptococcus mutans is divided into four
different serotypes: c, e, f and k. They produce cell wall
rhamnose–glucose polysaccharides (RGPs) consisting of a
backbone structure of a1,2- and a1,3-linked rhamnosyl
units with glucose side chains linked to alternate molecules
on the cell wall (Pritchard et al., 1986). Each serotype RGP
has unique linkages of its glucose side chains (Fig. 1;
Pritchard et al., 1986).
RGP synthesis in S. mutans is initiated by transfer of N-
acetylglucosamine-1-phosphate to a lipid carrier, most likely
undecaprenyl phosphate (Yamashita et al., 1999). Synthesis
of the rhamnan backbone requires dTDP-L-rhamnose,
which is produced from D-glucose-1-phosphate by the
products of the rmlABCD genes (Tsukioka et al., 1997a, b).
The activated rhamnose units are linked to N-acetylgluco-
samine-lipid through RgpA, RgpB and RgpF to form the
rhamnan backbone (Yamashita et al., 1998a; Shibata et al.,
2002). Glucose side chain formation requires gluA, encoding
glucose-1-phosphate uridyltransferase, for the synthesis of
UDP-D-glucose (Yamashita et al., 1998b). This precursor is
attached to the rhamnan backbone by RgpE, RgpH and
RgpI (Ozaki et al., 2002). RgpE and RgpH are glucosyl-
transferases required for glucose side chain formation of
RGP, and RgpI regulates the branching frequency of glucose
side chain on RGP in serotype c strain Xc (Yamashita et al.,
1998a; Ozaki et al., 2002). The differences in the glucose side
chain formation of RGP among serotype c, e and f strains
were found to depend on a serotype determinant locus
downstream from rgpF (Fig. 2) (Shibata et al., 2003). In
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variants of serotype c, named serotype k, the glucose side
chain of RGP is lacking, probably because rgpE is not
expressed (Nomura et al., 2005).
Bacteriophage M102 is a virulent siphophage specific
for S. mutans of serotype c (Delisle & Rostkowski, 1993;
van der Ploeg, 2007). M102 produces clear plaques on
only some of the serotype c strains of S. mutans, but
cannot infect serotype e and f strains (Delisle & Rostkowski,
1993). Because the first step in the bacteriophage in-
fection process is the adsorption of the phage, the specifi-
city of phage M102 for serotype c strains might be
determined by the receptor. Here, we investigated whether
serotype-specific RGP functions as a receptor of bacterioph-
age M102.
Materials and methods
Strains and growth conditions
Mutans streptococci (Table 1) were routinely grown in
Todd–Hewitt broth (THY, Becton-Dickinson) with 0.3%
yeast extract (Oxoid), at 37 1C in an environment of 10%
CO2 and 90% air. Streptococcus mutans OMZ 381S is a
spontaneous streptomycin-resistant mutant of OMZ 381
(van der Ploeg, 2007). THY plates contained 1.5% agar.
THY soft agar contained 0.7% agar. Bacteriophage M102
and its propagation have been described before (van der
Ploeg, 2007). The antibiotics used for selection of S. mutans
were spectinomycin (1000mgmL1), erythromycin
(15 mgmL1) and streptomycin (1000mgmL1).
Construction of mutants
For the construction of plasmids pSTN and pSTC, a DNA
fragment containing the genes from rgpF to ORF12 (Fig. 2)
from S. mutans strain Xc was inserted into the multicloning
site of pBluescript SK II (1) to yield plasmid pST. For
pSTN, the region containing ORF7 through ORF11 was
replaced with a spectinomycin resistance gene. For construc-
tion of pSTC, the region containing ORF7 in pST was first
replaced with the erythromycin resistance gene; subse-
quently, the region harbouring ORF10 was deleted.
Strain OMZ 381SN was constructed by transformation of
OMZ 381S with BssHII-digested plasmid pSTN to specti-
nomycin resistance. OMZ 381SC was generated by transfor-
mation of OMZ 381SN with BssHII-digested plasmid pSTC
to erythromycin resistance.
Replacement of serotype f-specific genes in strain OMZ
175 was as described previously (Shibata et al., 2003).
Serotype f
Serotype c
Serotype e
α1,3 α 1,2 α 1,3 α 1,2
Glc
α 1,2
Glc
α 1,2
α 1,3 α 1,2 α 1,3 α 1,2
Glc
β 1,2
Glc
β 1,2
α 1,3 α 1,2 α 1,3 α 1,2
Glc
α 1,3
Glc
α 1,3
RhaRhaRhaRha
RhaRhaRhaRha
RhaRhaRhaRha
Fig. 1. Structure of cell wall-linked RGPs in Streptococcus mutans
serotypes c, e and f.
ORF12
ORF7 rgpH rgpI ORF10 ORF11
ORF1e ORF2e ORF3e ORF4e
ORF1f ORF2f ORF3f
Serotype c
Serotype e
Serotype f
1 kb
S. mutans
Xc81
OMZ 381SN
Spectinomycin resistance gene
rgpA rgpB rgpC rgpD rgpE rgpF
Fig. 2. Organization of the rgp loci in Strepto-
coccus mutans serotype c, e and f strains. The
lower part of the diagram indicates the regions
responsible for glucose side chain formation
during RGP synthesis. Genes with a high
sequence similarity are indicated by identical
shading. The rgpA through rgpF genes and
ORF12 are common to the three serotypes.
In strains Xc81 and OMZ 381SN, the
serotype-specific genes were replaced by a
spectinomycin resistance gene.
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Briefly, OMZ 175 was first transformed with BssHII-di-
gested plasmid pSTN to spectinomycin resistance. The
resulting strain was then transformed with BssHII-digested
plasmid pSTC to erythromycin resistance.
Streptococcus mutans strains Xc41, Xc42 and Xc52 have
been described previously (Yamashita et al., 1998a, 1999).
rgpE and rgpHmutations in strain OMZ 381S were obtained
by transformation with genomic DNA from S. mutans
strains Xc45 (Yamashita et al., 1998a) and Xc48 (Ozaki
et al., 2002), respectively, with selection for erythromycin
resistance. Correct gene replacement was verified by PCR
analysis.
Adsorption assays
Adsorption of phage M102 to mutans streptococci was
investigated as follows: 100 mL of phage M102 (c. 104PFU)
was mixed with 100 mL of an exponentially growing culture
(OD550 nm of about 0.4) of the strain and incubated for
30min at 37 1C. Phages adsorbed to bacteria were pelleted
by centrifugation for 5min at 16 000 g. The amount of
nonadsorbed phages remaining in the supernatant was then
determined by a standard plaque assay. For this, 100mL of an
appropriate dilution was mixed with 100 mL of an overnight
grown culture of OMZ 381S and incubated for 30min at
37 1C. After addition of 4mL of molten THY soft agar (THY
with 0.7% agar), the mixture was poured over an THY agar
plate, which was incubated overnight at 37 1C in 10% CO2
and 90% air. The number of plaques was counted.
Results
It was first examined whether the serotype specificity of
phage infection was determined by adsorption (Fig. 3).
M102 adsorbed to all seven serotype c strains tested, whereas
it did not adsorb to strains of different serotypes. On the
other hand, whereas M102 adsorbed to all tested serotype c
S. mutans strains, these strains were not infected. Because S.
Table 1. Strains used in this study
Strains Serotypes
Original
designation/characteristics Sources or references
S. mutans OMZ 381 c P42, host strain for M102 van der Ploeg (2007)
S. cricetus OMZ 62 a AHT Laboratory collection
S. cricetus OMZ 165 a HS6 Laboratory collection
S. mutans OMZ 7 c NCTC 10449 Laboratory collection
S. rattus OMZ 63 b FA1 Laboratory collection
S. mutans OMZ 64 c IB1600 Laboratory collection
S. mutans OMZ 67 c GS5 Laboratory collection
S. mutans OMZ 918 c UA159 ATCC
S. mutans OMZ 1040 c PK1 Laboratory collection
S. mutans Xc c Laboratory collection
S. sobrinus OMZ 176 d Laboratory collection
S. mutans LM7 e Laboratory collection
S. mutans MT4653 e Laboratory collection
S. mutans OMZ 175 f Laboratory collection
S. mutans MT6219 f Laboratory collection
S. sobrinus 6715 g Laboratory collection
S. downei MFe28 h Laboratory collection
S. mutans OM98x k Yutaka Sato, Tokyo Dental College
S. mutans OMZ 381S c Spontaneous streptomycin-resistant mutant of OMZ 381 This study
S. mutans OMZ 381SN None OMZ 381S, but serotype-specific genes replaced with
spectinomycin resistance gene
This study
S. mutans OMZ 381SC c OMZ 381SN, but harbouring rgpH, rgpI and ORF11 This study
S. mutans Xc81 None Xc, but serotype-specific genes replaced with
spectinomycin resistance gene
Shibata et al. (2003)
S. mutans LM7-81C c LM7, but serotype exchanged from e to c Shibata et al. (2003)
S. mutans OMZ 175C c OMZ 175, but serotype exchanged from f to c This study
S. mutans MT6219-81C c MT6219, but serotype exchanged from f to c Shibata et al. (2003)
S. mutans Xc41 None Xc, but rgpA<erm Yamashita et al. (1998a)
S. mutans Xc42 None Xc, but rgpB<erm Yamashita et al. (1998a)
S. mutans Xc52 None Xc, but rgpG<erm Yamashita et al. (1999)
S. mutans OMZ 381S-45 None OMZ 381S, but rgpE<erm This study
S. mutans OMZ 381S-48 None OMZ 381S, but rgpH<erm This study
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mutans serotype c, e, f and k strains have a different RGP
structure, but are very similar otherwise, further investiga-
tions focused on these serotypes.
Three mutants of rgpA (Xc41), rgpB (Xc42) or rgpG
(Xc52), which did not produce a rhamnan backbone and
hence no RGP at all (Yamashita et al., 1998a, 1999; Shibata
et al., 2002), were examined for adsorption by phage M102.
M102 did not adsorb to these mutants (Fig. 4), which
suggests that RGPs function as the phage receptor. We then
constructed strains from which the serotype-specific genes
had been removed or exchanged, and determined their
ability to adsorb M102 (Fig. 4). The phage adsorbed to
serotype c wild-type strains OMZ 381S and Xc, but not to
the respective strains OMZ 381SN and Xc81, in which the
locus downstream from rgpF and upstream from ORF12
had been deleted (Fig. 2).
As mentioned above, phage M102 did not adsorb to
serotype e strain LM7 or serotype f strains MT6219 and
OMZ 175, but replacing the serotype-specific loci of these
strains by the serotype c-specific locus from strain Xc led to
recombinant strains showing drastically increased adsorp-
tion of M102 (Fig. 4). Nevertheless, M102 could not infect
these mutants.
The results demonstrate that the presence of the serotype
c-specific locus involved in the glucose side chain formation
of RGP is essential for the adsorption of M102, thus strongly
suggesting that the serotype-specific glucose side-chain acts
as the receptor for M102. To confirm our hypothesis, it was
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investigated whether bacteriophage M102 could be propa-
gated in OMZ 381S mutants impaired in the formation of
the glucose side chain of RGP. Strains OMZ 381SN, OMZ
381S-45 and OMZ 381S-48 did not adsorb bacteriophage
M102 (Fig. 5) and were resistant to infection (relative
efficiency of plating o 1 109). The serotype-specific
rgpH, rgpI and ORF11 (Fig. 2) from strain Xc were then
introduced into OMZ 381SN as described in Materials and
methods. The resulting strain, OMZ 381SC, adsorbed phage
M102 (Fig. 5) and was sensitive to infection (relative
efficiency of plating 0.14), which demonstrates that the
serotype-specific genes from strain Xc are sufficient for
phage infection.
Discussion
Bacteriophage infection requires irreversible adsorption to a
specific receptor. Bacteriophages infecting gram-positive
bacteria first encounter the cell wall, which is decorated with
polysaccharides and teichoic acids, either linked to the
cytoplasmic membrane or linked to the peptidoglycan. Not
surprisingly, these structures have previously been shown to
function as a bacteriophage receptor (Vinga et al., 2006).
Here, we have demonstrated that the glucose side chain of
RGP is indispensable for adsorption and infection of S.
mutans bacteriophage M102.
Cell wall carbohydrates frequently serve as a phage
receptor in lactococci or thermophilic streptococci, but the
exact molecular nature of the receptor has not yet been
elucidated for any of the bacteriophages investigated. Stu-
dies to identify the receptor of Lactococcus lactis bacterio-
phages bIL170 and f645 by random mutagenesis revealed a
gene cluster likely involved in the synthesis of rhamnose-
containing cell wall polysaccharides (Dupont et al., 2004).
Interestingly, one of the genes identified showed similarity
to S. mutans rgpE, which exists in all serotypes of S. mutans
and whose gene product acts as a glucosyltransferase
(Fig. 2).
The requirement for glucose substitution of a phage
receptor is not unprecedented. Glycosylation of cell wall-
linked teichoic acid was found to be essential for phage
adsorption and susceptibility of Listeria monocytogenes
(Cheng et al., 2008). Cell wall-bound teichoic acid consist-
ing of glycosylated poly(glycerol-phosphate) is the primary
receptor for Bacillus subtilis bacteriophage SPP1. In this
case, reversible adsorption of phage to teichoic acid accel-
erates binding to the membrane receptor YueB, which is
irreversible (Baptista et al., 2008). Finally, Lactobacillus
delbrueckii phage LL-H adsorption to lipoteichoic acid
depends on a-glucose substitution (Ra¨isa¨nen et al., 2007).
Although M102 adsorbed to all tested serotype c S.
mutans strains, only strain OMZ 381S was sensitive to phage
infection. The mutants that were converted from serotype e
or f to serotype c showed drastically increased phage
adsorption, but were not infected by M102. Thus, adsorp-
tion to the host is an essential, but not the sole determinant
for successful phage infection. Several different mechanisms
of phage resistance have been described (Forde & Fitzgerald,
1999; Barrangou et al., 2007), but at present it is unknown
what mechanism causes resistance to M102 in serotype c
strains.
The potential use of bacteriophage to remove cariogenic
mutans streptococci from dental plaque is thus limited by
serotype specifity, but also by other, unknown, factors. For
these reasons, it might be better to use phage-encoded
endolysins for selective elimination of S. mutans from dental
plaque.
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Summary 
Clustered regularly interspaced short palindromic repeats (CRISPR) consist of highly 
conserved direct repeats interspersed with variable spacer sequences. They can 
protect bacteria against invasion by foreign DNA elements. The genome sequence of 
Streptococcus mutans strain UA159 contains two CRISPR loci, designated CRISPR1 
and CRISPR2. The aims of this study were to analyze the organization of CRISPR in 
further S. mutans strains and to investigate the importance of CRISPR in acquired 
immunity to M102-like phages. The sequences of CRISPR1 and CRISPR2 arrays 
were determined for 29 S. mutans strains from different persons. More than half of 
the CRISPR1 spacers and about 35% of the CRISPR2 spacers showed sequence 
similarity with the genome sequence of M102, a virulent siphophage specific for S. 
mutans. Although only few spacers matched the phage sequence completely, most 
of the mismatches had no effect on the amino acid sequences of the phage-encoded 
proteins. The results suggest that S. mutans is often attacked by M102-like 
bacteriophages, and that its acquisition of novel-phage derived CRISPR sequences 
goes along with the presence of S. mutans phages in the environment. Analysis of 
CRISPR1 of M102-resistant mutants of S. mutans OMZ 381 showed that some of 
them had acquired novel spacers and the sequences of all but one of these matched 
the phage M102 genome sequence. This suggests that the acquisition of the spacers 
contributed to the resistance against phage infection. However, since not all resistant 
mutants had new spacers, and since the removal of the CRISPR1 array in one of the 
mutants and in wild-type strains did not lead to loss of resistance to infection by 
M102, the acquisition of resistance must be based on further elements as well.  
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Introduction 
The human oral cavity is inhabited by more than 500 different bacterial 
species (Paster et al., 2001), of which only a few cause disease. Dental caries, one 
of the most frequent diseases in humans, is caused by microorganisms that 
metabolize dietary sugars into acids. The concomitant decrease in pH results in 
demineralization of the hard tissues of teeth. Mutans streptococci, in particular 
Streptococcus mutans, are considered the principal etiological agents of dental 
caries. Most efforts to develop strategies for prevention of this disease are therefore 
aimed towards reduction of S. mutans by interference with colonization or by passive 
or active immunization while leaving beneficial microorganisms untouched. Phage 
therapy, the application of bacteriophages to combat bacterial infections, has 
regained interest during the last several years due to the increase of bacterial 
resistance to conventional antibiotics. In principle, phage therapy could be used to 
specifically remove S. mutans from dental plaque. 
Relatively little is known about S. mutans bacteriophages and about the role 
they play in the ecology of S. mutans in the oral cavity. It is difficult to isolate 
bacteriophages specific for mutans streptococci (Bachrach et al., 2003; J. R. van der 
Ploeg, unpublished results). Armau et al. (1988) isolated 16 lytic bacteriophages 
specific for strains of S. mutans and Streptococcus sobrinus by screening more than 
1000 plaque samples. Three of these, phages M102, e1 and f2, appeared similar, as 
suggested by comparable virion sizes, GC content, DNA-DNA hybridization, and 
restriction fragment analysis, although the phages showed different serotype 
specificity (Delisle & Rostkowski, 1993). The genome sequence of M102, which is 
specific for S. mutans serotype c strains, has been determined (van der Ploeg, 
2007). Another serotype c specific bacteriophage, M101, appears closely related to 
M102 (van der Ploeg, 2007).  
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One of the weaknesses of phage therapy is the eventual development of 
resistance against bacteriophage infection. S. mutans strain OMZ 381 is one of only 
few strains supporting propagation of M102 (Delisle & Rostkowski, 1993; J. R. van 
der Ploeg, unpublished results). The causes for this limited host range are not 
known. Several mechanisms that render lactic acid bacteria resistant to phage 
infection have been described: Inhibition of phage adsorption, inhibition of DNA 
injection, restriction modification of phage DNA, and abortive infection (Forde & 
Fitzgerald, 1999). In the case of S. mutans nothing is known about the latter three 
mechanisms, but it has been shown that M102 does adsorb also to S. mutans 
serotype c strains that do not support propagation (Shibata et al., 2009). This 
suggests that factors different from phage adsorption must determine resistance of S. 
mutans serotype c strains to infection by M102.  
Recently, a novel phage resistance mechanism, which relies on Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR) and a set of CRISPR-
associated genes (cas), has been discovered (Barrangou et al., 2007). CRISPR 
clusters consist of direct repeats of 24-47 bp, which are separated by unique spacers 
of 25-72 bp (Makarova et al., 2006; Sorek et al., 2007). Several CRISPR subtypes 
exist and each subtype has its own particular set of cas genes (Kunin et al., 2007). 
CRISPRs are found in about 40% of sequenced bacterial genomes and in about 90% 
of sequenced archaeal genomes (Sorek et al., 2007). Frequently, a high number of 
the CRISPR spacer sequences show homology to bacteriophage or plasmid 
sequences. It was shown that Streptococcus thermophilus mutants with acquired 
resistance to phage infection had incorporated an additional CRISPR spacer, whose 
sequence matched 100 % with part of the phage genome (Barrangou et al., 2007). 
Removal of this spacer sequence led to sensitivity to phage infection (Barrangou et 
al., 2007). Apart from providing resistance to bacteriophages, CRISPR interference 
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was also shown to block plasmid DNA conjugation and transformation (Marraffini & 
Sontheimer, 2008). 
In the present study, the incidence and the composition of CRISPR in S. 
mutans and other mutans streptococci was examined and the role of CRISPR in 
protection against bacteriophage infection was investigated. 
 
 
Materials and Methods 
 
Strains, plasmids and phages and growth conditions 
S. mutans strains used are listed in Table 1. Unless specified otherwise, they were 
routinely grown at 37 °C under anaerobic conditions or in an atmosphere of 10 % 
CO2 and 90 % air in THY medium, which consists of Todd-Hewitt (Beckton-
Dickinson) with 0.3 % yeast extract (Oxoid). Solid medium contained 1.5 % agar. 
Bacteriophages M102 and M101 were propagated in S. mutans strain OMZ 381 as 
described (van der Ploeg, 2007). When required, erythromycin was added to a final 
concentration of 10 ȝg ml-1. Escherichia coli JM109 was used as host for propagation 
of plasmids and grown in LB medium at 37 °C with aeration. When required, 
erythromycin was added to a final concentration of 200 ȝg ml-1. 
 
PCR amplification and DNA sequencing 
Chromosomal DNA was isolated with a GenElute bacterial genomic DNA kit (Sigma). 
CRISPR1 arrays were amplified by PCR with primers CRu and CRd or Cru2 and 
Crd2 (Supplementary Table S1). For amplification of CRISPR2 arrays, primers Cau 
and Cad, or Cau2 and Cad2 were used. Taq DNA polymerase (New England 
Biolabs) or Jumpstart Taq polymerase (Sigma) were employed. The PCR program 
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consisted of an initial denaturation for 3 min at 95 °C, followed by 30 cycles of 
annealing for 30 s at 55 °C, extension for 3 min at 72 °C and denaturation for 30 s at 
95 °C. PCR products were purified with a Jetquick PCR purification kit (Genomed) 
and directly sequenced using dye-terminator technology (Microsynth) with one of the 
primers used for amplification. When required, a primer walking strategy was 
employed for the sequencing of large CRISPR arrays. 
The serotype of S. mutans strains OMZ 380, OMZ 382, OMZ 737, and 
OM1079 was determined by PCR analysis (Shibata et al., 2003). In addition, spaP, 
atlA, SMU.1757c, or SMU.1762c from some strains were amplified by PCR with 
primers listed in the Supplementary Table S1 and sequenced with one of the primers 
used for amplification. Specific fragments of bacteriophage M101 were amplified and 
sequenced using primers specified in Supplementary Table S1.  
 
Bioinformatic analyses 
CRISPR spacers were identified by using the CRISPR finder tool (available at 
http://crispr.u-psud.fr/; Grissa et al., 2007) combined with visual inspection of the 
sequence. Similarity of spacers to M102 was analyzed by tblastx (using 0.1 as e-
value cut off). Similarity between spacer and database sequences was searched for 
by blast analysis. Weblogo (Crooks et al., 2004) was used to visualize sequence 
consensus motifs. 
 
Isolation of mutants resistant to infection by phage M102 
S. mutans strain OMZ 381 is one of a few strains which support propagation of 
bacteriophage M102 (Delisle & Rostkowski, 1993; Shibata et al., 2009). Strain OMZ 
381 was therefore chosen to isolate phage-resistant mutants. For this, 100 ȝl of serial 
dilutions of an exponentially growing OMZ 381 culture were mixed with about 3x108 
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pfu of phage M102. After incubation at 37 °C for 30 min, 4 ml of M1D soft agar (van 
der Ploeg, 2007) were added, immediately poured on a M1D plate and incubated for 
48 h at 37 °C. Colonies that appeared were recloned on M1D agar and tested for 
resistance to phage infection. 
One further M102-resistant mutant was isolated in the course of an animal 
experiment. In brief, in a study approved by the “Veterinäramt des Kantons Zürich” 
and conformed to the Swiss laws on animal protection, ten specific-pathogen-free, 
caries-susceptible Osborne-Mendel rats (Institute of Oral Biology, University of 
Zurich, Zurich, Switzerland) were associated orally with S. mutans OMZ 381 as 
described (Thurnheer et al., 2008). Thereafter, phage M102 (105 pfu, 0.1 ml) was 
applied in the oral cavity of the rats (twice daily on days 23, 24, 25 and 26). Oral 
swabs were taken from all rats on days 29, 34 and 43, suspended in 0.9 % NaCl and 
various dilutions were plated on S. mutans selective medium. Three S. mutans 
colonies from each rat were tested for resistance to phage M102. Only two mutants 
were obtained, both from day 43, of which one, OMZ 432, was used for further 
investigation. 
 
Construction of mutations in CRISPR1 and SMU.1405c  
For construction of mutants with a deletion in CRISPR1, a double-crossover 
replacement strategy was employed. The region 5’ to CRISPR1 was amplified by 
PCR with primers CR1 and CR2, using genomic DNA from S. mutans OMZ 1001 as 
template (OMZ 1001 is a derivative of UA159 with high transformation frequency). 
The product was digested with BamHI and HindIII and cloned into plasmid pFW15 
(Podbielski et al., 1996) to create plasmid pOMZ357. Subsequently, the region 3’ to 
CRISPR1 was amplified with primers CR3 and CR4, digested with EcoRI and NcoI, 
and cloned into pOMZ357 to create pOMZ358. Plasmid pOMZ358 was linearized by 
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digestion with BamHI and introduced into S. mutans strains by transformation of 
naturally competent cells (Perry & Kuramitsu, 1981). Selection for chromosomal 
integration was done on THY agar plates containing erythromycin. Correct integration 
was confirmed by PCR analysis. 
A similar strategy was used for the construction of SMU.1405c knock-out 
mutants. An approximately 500 bp fragment internal to SMU.1405c was amplified by 
PCR with primers 1405c1 and 1405c2. The fragment was digested with BamHI and 
HindIII and cloned into pFW15 to give plasmid pOMZ417. A second fragment 
harbouring the 3’ end of SMU.1405c was amplified with primers 1405c3 and 1405c4, 
digested with PstI and EcoRI and cloned into pOMZ417 to yield plasmid pOMZ418. 
The EcoRI linearized plasmid pOMZ418 was introduced into different strains of S. 
mutans by transformation. Selection for and confirmation of plasmid integration was 
done as described above. 
 
 
Results  
 
Bioinformatic analysis of CRISPR arrays and cas genes in S. mutans UA159 
The annotated genome of S. mutans UA159 (Ajdiü et al., 2002) was found to 
harbour two CRISPR loci, designated CRISPR1 and CRISPR2. Two S. mutans 
CRISPR types have also been identified recently by others (Haft et al., 2005; Horvath 
et al., 2008a). As outlined in Fig. 1A, CRISPR1 is located between open reading 
frames (ORF) SMU.1400 and SMU.1398 and contains six identical copies of a 
partially palindromic sequence of 36 bp (5’-
GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC-3’). A seventh degenerated 
repeat with 67% identity (5’-GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT-
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3’) is located proximal to SMU.1398. All repeats are interspersed by spacers of 30 bp 
in size. The CRISPR1 array is preceded by four open reading frames (SMU.1405c, 
SMU.1404c, SMU.1403c and SMU.1402c) whose amino acid sequences show 
similarity to those of cas genes of the Nmeni subtype (Haft et al., 2005). This subtype 
is usually associated with the CRISPR repeat cluster 10 (Kunin et al., 2007), to which 
the S. mutans CRISPR1 repeat also belongs. An additional partially homologous 
repeat (5’-TTTAACTTGCTGTGTTGTTTCGAATGATTCCAACAC-3’) is present 
upstream of SMU.1405c (Fig. 1), which is a common feature of this CAS/CRISPR 
subtype (Haft et al., 2005). Another annotated ORF, SMU.1399, overlaps with the 
CRISPR1 array (not shown). Its deduced amino acid sequence shows no similarity to 
proteins of known function.  
The CRISPR2 locus of UA159 is located between SMU.1753c and 
SMU.1752c and consists of two 32 bp partially homologous repeats (5’- 
GTCGCACCCTTCACGGGTGCGTGGATTGAAAT-3’ and 5’- 
GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT-3’), separated by a 34 bp spacer 
(Fig. 1B). The first repeat is identical to a CRISPR repeat present in the genome of 
Streptococcus pyogenes M49 (McShan et al., 2008). It is a member of repeat cluster 
3 (Kunin et al., 2007), associated with subtype Dvulg cas genes (Haft et al., 2005). 
The black labelled genes from SMU.1764c to SMU.1753c located upstream of the 
first repeat (Fig. 1) belong to this subtype. However, two of these appear to be 
truncated through a frame shift mutation genes (csd1 and cas1) and a premature 
stop codon (cas1). 
 
Distribution of CRISPR1 and CRISPR2 in mutans streptococci 
The distribution of CRISPR1 and CRISPR2 in 29 isolates of S. mutans (Table 
1) was investigated by PCR analysis and sequencing, using primers derived from the 
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sequences bordering the CRISPRs of S. mutans UA159. Since it turned out that 
strains OMZ 186, OMZ 949 and OMZ 961 contained identical CRISPRS (see below), 
OMZ 949 and OMZ 961 were omitted from the analysis. CRISPR1 was detected 
more frequently (in 19 out of 27 strains) than CRISPR2 (9 out of 27). In only 4 strains 
(OMZ 7, UA159, OMZ 67 and OM98x), both CRISPR clusters were present. Three 
serotype c strains yielded neither a CRISPR1 nor a CRISPR2 PCR product. Most 
positive strains displayed many more repeats and spacers in both CRISPR1 and 
CRISPR2 than S. mutans UA159 (Fig. 2A and 2B). 
A total of 305 CRISPR1 spacers were found in the 19 strains that yielded a 
PCR product, the mean number was 16.0 (range 3-38; Supplementary Table S2). 
Within CRISPR2 155 spacers were found in 9 positive strains with a mean number 
17.2 spacers per strain (range 1-50).  
 
Sequence analysis of CRISPR1 and CRISPR2 spacers and repeats 
Spacers: 
More than 90% of the CRISPR1 spacer sequences were 30 bp in size, the 
remaining spacers consisted of 28, 29 or 31 bp (Supplementary Table S2). Most 
were unique, only the terminal spacer (preceding the terminal degenerated repeat) 
showed some conservation. A total of six different terminal spacers was found, of 
which one occurred in eight different strains. Apart from the conservation of the last 
spacer, there were only eight identical CRISPR1 spacer pairs and these pairs were 
always located close to each other within a single strain. A peculiarity was CRISPR1 
from OM98x with a block of three spacers in repeat. These duplications may have 
been selected in response to phage predation as they could lead to an increased 
efficiency of inhibition of the target nucleic acid. Alternatively, identical spacers could 
have been generated by errors of the CRISPR machinery.  
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With respect to CRISPR2 spacers, sequences of 34 bp occurred most 
frequently, followed by 35, 33 and 36 bp (Supplementary Table S3). As for CRISPR1, 
identical spacers were detected only occasionally. An exception was again the 
terminal spacer sequence, which occurred in three variants.  
Repeats: 
 The sequences of the CRISPR1 and CRISPR2 repeats are summarized in 
Supplementary Tables S4 and S5, respectively. In contrast to spacer diversity, no 
sequence variation was found in the CRISPR repeats, except for the terminal repeat 
which was found in three variants. In all strains, except for MT4963, the last residue 
of the terminal repeat was either C or T. Regular CRISPR2 repeats occurred in two 
variants, with only one base pair being affected. The terminal repeat was different 
from the regular repeats and also occurred in two variants.  
 
Inactive CRISPR2 in UA159 due to mutations 
As described above, cas1 and csd1, which are associated with CRISPR2, appeared 
to be truncated in UA159. Since this strain contains only one CRISPR2 spacer, it has 
been postulated that the mutations in cas1 and csd1 render the CRISPR2 system 
inactive (Horvath et al., 2008a). To find evidence for this hypothesis, part of the cas1 
gene (861 bp) from strains OMZ 960 and OM98x were sequenced. The data show 
that these strains contain 13 and 33 CRISPR2 spacers respectively, which suggests 
an active CRISPR2 system. Compared with the sequence of UA159, two base pairs 
(GT) are inserted in both OMZ 960 and OM98x (Supplementary Figure S1). In 
addition, the stop codon present in the UA159 sequence is absent in OMZ 960 and 
OM98x.  
Likewise, part of the sequence of csd1 (660 bp) from OMZ 960 was 
determined. Comparison with UA159 revealed two differences: an A-G transition, 
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which has no influence on the amino acid sequence of the encoded protein and an 
insertion of one bp within a homopolymeric dA tract in the UA159 sequence, which 
results in a frame shift (data not shown). Together, these results suggest that both 
cas1 and csd1 are non-functional in UA159, probably implying that UA159 has lost 
the ability to incorporate novel CRISPR2 spacers.  
 
Identical CRISPR1 sequences in OMZ 186 and OMZ 961 
The CRISPR1 sequences of OMZ 961 (NG8, obtained from G. Spatafora) and OMZ 
186 (KSPK2 or JC-2) were identical. This appeared rather unlikely, since the strains 
had been isolated in New Guinea and Sweden respectively (R. Russell, personal 
communication). Hence, the CRISPR1 sequence of OMZ 949 (NG8, obtained from 
D. Cvitkovitch) was determined as well and found to be identical to CRISPR1 from 
OMZ 961 and OMZ 186. To investigate this further, a part of the sequence of the 
spaP gene of these three strains was determined, since it had been reported that 
spaP is different in KSKP2 and NG8 (Demuth et al., 1990; Paula Crowley, personal 
communication). However, in the present study the spaP sequences obtained from 
OMZ 961 and OMZ 186 were identical to KSPK2 (data not shown), which strongly 
suggests that some laboratories hold the same strain under different names. 
 
Similarity of CRISPR spacers to bacteriophage M102  
Of the 305 CRISPR1 spacer sequences determined, only five matched the 
bacteriophage M102 genome sequence exactly. However, 164 CRISPR1 spacers 
showed sequence similarity to M102 (more than 17 identical residues; Fig. 2A). The 
majority of them contained mismatches at degenerate positions, and the encoded 
amino acid sequence remained unchanged compared to M102. From 201 
mismatches investigated, 161 concerned the third position of the codon of the 
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targeted M102 ORF, and mostly were silent (n=152). The remaining 49 mismatches 
resulted in 30 amino acid changes.  
Of the 156 CRISPR2 spacers, 55 (35 %) showed sequence similarity  to M102 
(more than 22 identical residues; Fig. 2B), but none matched perfectly. Again, the 
majority of the mismatches were positioned at the third base of the codon (69 out of 
93 mismatches investigated). In total, only 18 amino acid changes resulted from 
these mismatches. 
 It had been shown previously that within a CRISPR repeat family 
bacteriophage derived sequences located adjacent to the proto-spacers, the region 
in the phage genome correspoding with the spacer, exhibit conservation (Bolotin et 
al., 2005; Deveau et al., 2008; Horvath et al., 2008b). In this study, comparison of the 
sequences adjacent to CRISPR1 proto-spacers showed conservation within the 
three-bases-stretch at the 3’ end (5’-WRR; Fig. 3A). Two sub-motifs were recognized 
in different strains. In OMZ 64, OMZ 382, OMZ 1040, OMZ 1079, OMZ 381 and 
MT4863 a 5’-WAAR-3’ motif is present (Fig. 3B), whereas the remaining strains show 
a 5’-WGG-3’ motif (Fig. 3C). In contrast, no conservation was observed next to the 5’ 
end of the proto-spacers (not shown).  
With regard to CRISPR2 the sequences 3’ to the CRISPR2 proto-spacers 
showed no conservation, whereas the three bases located at the 5’ site exhibited 
commonly the motif 5’-TTC-3’ (Fig. 3D).  
 
Similarity of CRISPR spacers to other sequences 
Apart from the evident sequence similarity to bacteriophage M102, some CRISPR1 
and CRISPR2 spacers showed similarity to other invading mobile elements, namely 
bacteriophages from other streptococci, plasmids and transposons (Supplementary 
Table S6). Three CRISPR1 and CRISPR2 spacer sequences showed similarity to a 
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48 kb plasmid present in three copies in the genome of Streptococcus agalactiae 
pNEM316-1 (Glaser et al., 2002). Some CRISPR2 spacers from OMZ 26, OMZ 27 
and OMZ 960 match the sequence of the genomic island Tnsmu1, which 
encompasses SMU.191c to SMU.221c and is present in UA159 and other S. mutans 
strains (Waterhouse et al., 2007). The clustering of spacers in OMZ 27 hints at 
repeated attacks of Tn1smu or at simultaneous incorporation of multiple spacers 
from the Tn1smu genome. Two CRISPR1 spacers matched the ORFs SMU.1705 
and SMU.820 of S. mutans UA159. 
 
Analysis of CRISPR1 in M102-resistant mutants 
Spontaneous mutants of OMZ 381 resistant to infection by M102 could easily be 
isolated. PCR analysis showed that in 14 of 57 analyzed mutants the size of the 
CRISPR array had increased by approximately the size of one spacer and one 
repeat (Table 2). The acquisition of a novel spacer and repeat in these mutants was 
confirmed by DNA sequencing. In OMZ 432, a strain isolated from a rat whose oral 
cavity had been inoculated with the wild-type strain (OMZ 381) and then challenged 
with phage M102, two additional CRISPR1 spacers were detected (Table 2) 
With one exception (OMZ 381-M5) all newly acquired spacers and repeats 
became inserted proximal to the CRISPR1 leader. This corroborates results from 
previous studies with phage resistant S. thermophilus mutants (Barrangou et al., 
2007; Deveau et al., 2008). In all but one case (OMZ 381-M71), the novel spacer 
sequences matched the genome sequence of M102 perfectly. In OMZ 381-M71 one 
mismatch at the ultimate 5’ base of the proto-spacer is present. In some mutants, 
nearly identical spacers are incorporated (Table 2).  
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In mutants M3, M60 and M71 the spacer matched the same phage sequence, 
but the length of the spacer differed. This was also found for two other mutants (OMZ 
432 and M56). The region 3’ to the proto-spacer sequence exhibited a conserved 
motif (YAAAWY), which is similar to the CRISPR1 motif described above (Fig. 3B). 
Bacteriophage M101 is related to phage M102 (van der Ploeg, 2007). It was 
therefore investigated whether the M102-resistant mutants were also resistant 
against phage M101. The results showed that only mutants M60 and M71 were 
sensitive to M101 infection (Table 2). In these mutants, the acquired CRISPR1 
spacer is homologous to a sequence of M102. However, this sequence is also 
present in the CRISPR1 spacer in mutant M3, which was resistant to infection by 
M101. To determine whether the differences in sensitivity to phage infection were 
related to differences in the proto-spacers, their sequences were determined. Some 
of the proto-spacer sequences in M101 were identical to those in M102 (M3, M60 
and M62), whereas others were different. In fact the proto-spacer in M101 differed 
from the novel spacer in mutant M5 by as many as 7 nucleotides. Although M5 is 
resistant to infection by M101, it is hard to conceive that the acquired spacer in this 
mutant could provide protection. It has previously been reported that mutation of only 
one nucleotide in the phage proto-spacer rendered S. thermophilus bacteriophage 
2972 unaffected to CRISPR-mediated resistance (Deveau et al., 2008). 
 
Inactivation of SMU.1405c or CRISPR1 is insufficient to render sensitivity for 
infection by the bacteriophage 
In order to try to confirm that resistance to phage M102 is conferred by the CRISPR1 
system, mutants in the cas5 gene SMU.1405c were constructed in OMZ 67, OMZ 
961, OMZ 1001, OMZ 381-M3, and OMZ 381-M46. However, all resulting mutants 
remained resistant to infection by phage M102 (data not shown). Next, the CRISPR1 
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clusters of OMZ 7, OMZ 67, OMZ 1001, OMZ 381-M3 and OMZ 381-HS were 
deleted and replaced by an erythromycin resistance cassette. These mutants 
remained also resistant to infection by phage M102 (not shown). 
 
 
Discussion 
The results of this study show that mutants of strain OMZ 381, which have 
become resistant to bacteriophage M102, have acquired novel CRISPR1 spacers 
that are most likely derived from the phage genomic DNA since their sequence 
matches the genome sequence of M102. This finding is in agreement with studies 
with phage resistant mutants of S. thermophilus (Barrangou et al., 2007; Horvath et 
al., 2008b). However, just as remarkable is the fact that in the majority of the M102 
resistant OMZ 381 mutants no change in the CRISPR1 cluster had occurred. Thus, it 
is evident that in S. mutans there must exist other CRISPR1/2 independent and not 
yet identified mechanism(s) for acquired immunity to phage infection. In line with this 
conclusion are two further observations: 1st, inactivation of the CRISPR1 cluster in 
several different S. mutans strains and in a phage-resistant mutant of OMZ 381 with 
an acquired supplementary CRISPR1 spacer, did not re-establish sensitivity to M102 
infection; 2nd, some of the novel M102-resistant mutants were also resistant to 
infection by M101, although there was only partial homology between the novel 
spacer sequence and the proto-spacer of M101. One possible explanation is that 
many S. mutans strains (other than UA159), may carry further, still unknown CRISPR 
cluster(s) with CRISPR-associated genes. In fact, some S. thermophilus strains 
possess three different CRISPR arrays (Horvath et al., 2008b). Whole genomic 
sequencing of other S. mutans strains may reveal whether one or more additional 
CRISPR clusters exist. 
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This study demonstrates that the prevalence, the composition and the 
sequence of CRISPR1 and CRISPR2 in S. mutans are highly variable. The 
polymorphic nature of CRISPR makes the two clusters useful markers for 
epidemiologic studies. CRISPR1 was found to occur more frequently than CRISPR2. 
Although the choice of primers and or PCR conditions might have an influence on the 
results, the distribution frequency is congruent with results from a comparative 
genomic hybridization study (Waterhouse et al., 2007). In that study, it was shown 
that a complete set of CRISPR1-associated genes (SMU.1405 to SMU.1400) was 
present in seven of nine strains investigated. Of these nine strains, seven were also 
part of the present work (GS5, At10, L18, LML5, LML7, MT4863 and MT4653) and in 
all but LML5 a CRISPR1 array was found. LML5 has been reported previously to lack 
CRISPR1-associated genes (Waterhouse et al., 2007) and indeed, no CRISPR1 
array could be detected. With respect to CRISPR2, however, a complete set of 
CRISPR2-associated genes (SMU.1764 to SMU.1753) and a CRISPR2 array were 
only present in a single strain, GS5 (OMZ 67). These results agree with previous 
observations that particular CRISPR repeat clusters are functionally coupled with 
particular CAS subtypes (Horvath et al., 2008b; Kunin et al., 2007).  
My comparison of the sequences of cas1 and csd1 from strain UA159 with 
those from other strains and species suggests that both genes are non-functional in 
UA159. It has been speculated that Cas1 functions to integrate novel spacers into 
CRISPR2 (Makarova et al., 2006). Hence, UA159 should have lost the ability to do 
so, and this would fit with the here described observation that UA159 contains only a 
single CRISPR2 spacer. This hypothesis is also consistent with the observation that 
in E. coli the Cas1 protein was found dispensable for resistance to infection by 
phageO (Brouns et al., 2008). 
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About half of the CRISPR1 and CRISPR2 spacers exhibited similarity to the 
genome of phage M102. It has previously been shown for S. thermophilus that a 
correlation exists between resistance to phage infection and the number of spacers 
with sequence similarity to phage sequences (Bolotin et al., 2005). In the present 
study, only one pair consisting of an infecting phage (M102) and a receptive strain 
(OMZ 381) was available for investigation. This limited material does not allow 
drawing conclusions about the relationship between CRISPR content and phage 
resistance. But the high prevalence of M102 homologous spacer sequences among 
S. mutans strains suggests that S. mutans is frequently exposed to M102-like 
phages. Interestingly, most mismatches between homologous spacers and the M102 
phage sequence affected the third base of the codon. This indicates that many 
different variants of M102 may exist and possibly evade CRISPR-mediated 
resistance through silent or conservative mutations without affecting the function of 
phage-encoded proteins. Such a mechanism has been proposed for S. thermophilus, 
where a single base pair change in the phage genome was sufficient for escaping 
resistance caused by the CRISPR machinery (Barrangou et al., 2007; Deveau et al., 
2008). This could represent a major driving force for the evolution of bacteriophage 
mutants. 
Plasmids occur in about 5 % of all S. mutans strains (Caufield et al., 1988). 
However, none of the CRISPR1 or CRISPR2 spacers showed sequence similarity to 
the previously identified S. mutans plasmids pLM7 and pUA140 (Zhou et al., 2001). 
This is surprising, since spacers with similarity to a plasmid from S. agalactiae were 
present in some strains. Equally unexpected, though not unprecedented, was the 
finding that two CRISPR1 spacers matched ORFs present in the S. mutans UA159 
genome. There are no indications that these ORFs are located on genomic islands or 
are part of prophage sequences. It is hence not clear why spacers derived from 
 
18
these ORFs were incorporated. Speculatively, one could postulate that the CRISPR 
machinery occasionally confounds host DNA or host mRNA with invading nucleic 
acids and erroneously attacks the former. Alternatively, uptake of homologous 
chromosomal DNA of lysed S. mutans cells during natural competence might 
provoke capture of novel spacers.  
In summary, this study demonstrates high degree of variability in the 
sequences of CRISPR1 and CRISPR2 in S. mutans. A large fraction of CRISPR1 
and CRISPR2 spacers have homology to M102, suggesting that the organism often 
encounters M102-like phages. Although the presented data indicate that acquired 
resistance to M102 infection cannot be explained by the function of the two identified 
CRISPR clusters alone, the emergence of phage resistant mutants following 
exposure to M102, as observed experimentally in vivo in a rat model, seems to be a 
rather frequent event. 
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 Table 1:  Strains of S. mutans used in this study 1 
Strain 
Original 
designation 
Sero- 
type 
presence of 
CRISPR1* 
presence of 
CRISPR2* Origin  
Reference or source 
OMZ  7 NCTC 10449† c 3 7 UK (Edwardsson, 1968) 
OMZ  20 MT118 c 33 -‡ Japan (Hamada & Ooshima, 1975) 
OMZ  25 MT142 c 18 - Japan (Hamada & Ooshima, 1975) 
OMZ 26 C67-1 c - 6 The Netherlands (de Stoppelaar et al., 1971) 
OMZ 27 C67-25 c - 50 The Netherlands (de Stoppelaar et al., 1971) 
OMZ 30 MT12 c - 42 Japan (Hamada & Ooshima, 1975) 
OMZ 64 IB1600 c 12 - Sweden (Krasse, 1966) 
OMZ 67 GS-5 c 22 2 USA (Gibbons et al., 1966) 
OMZ 70 ATCC 33535 § c - - Switzerland (Guggenheim, 1968) 
OMZ 186 KPSK2 = JC2 c 5 - Sweden (Carlsson, 1967) 
OMZ 380 P34 c 8 - France G. Tiraby, Toulouse 
OMZ 381 P42 c 6 - France G. Tiraby, Toulouse 
OMZ 382 S61 c 31 - France G. Tiraby, Toulouse 
 
26 
OMZ 737 R9 c - - UK D. J. Bradshaw, Salisbury 
OMZ 918 UA159 c 6 1 USA ATCC 
OMZ 949 “NG8” c 5 -  D. Cvitkovitch, Toronto 
OMZ 960 UA130 c - 13 USA G. Spatafora, Middlebury 
OMZ 961 “NG8” c 5 -  G. Spatafora, Middlebury 
OMZ 1040 PK1 c 20 - USA (Gibbons et al., 1966) 
OMZ 1079  c 38 - Switzerland J. R. van der Ploeg, unpublished results 
At10  c 6 - Sweden (Edwardsson, 1968) 
L18  c 15 - Finland (Grönroos & Alaluusua, 2000) 
LML5  c - - UK (Waterhouse & Russell, 2006) 
LML7  c 9 - UK (Waterhouse & Russell, 2006) 
MT4863  c 6 - Japan (Hamada et al., 1980) 
OMZ 125 LM7 e 26 - USA  (Gibbons et al., 1966) 
MT4653  e 16 - Japan (Hamada et al., 1980) 
OMZ 175  f - 1 Switzerland (Guggenheim, 1968) 
OM98x  k 25 33 Japan T. Sato, Tokyo 
 
27 
 28 
1 
2 
3 
4 
* the number of spacers is shown 
† NCTC, National Collection of Type Cultures 
‡ -, None detected 
§ ATCC, American Type Culture Collection 
Table 2: M102-resistant mutants of OMZ 381 
 
mutant novel spacer sequence size 
(bp)
M102 
coordinates * 
5' seq† 3' seq‡ sensitivity 
to  M101§ 
M101 proto-spacer¶ 
OMZ432 AGGAAATCTCCTTACACGCTTAGCAAGTGT 30 21421-21450 AACAGAAAAG TAAATGCTAG - AGGAAATCTCCTTACACGCTTAGCAAGCAT 
OMZ432 AAGATGGCTGAAGAGACCGGGGTTAACGCC 30 12228-12198 (r) TACCATTTCC TAAATTAGCA - AAGATGGCTGAAGAGACCGGGGTTAACGCC 
OMZ 381-HS TGACAGCAATTTTTACACTGGCACAGTAGC 30 21301-21330 ATGTAGGTGA TAAATTTATG - TGATAGCAACCTCTACACCGGAACAGTAGC 
OMZ 381-M3 ATATGTAATAGGTCATAATGATGATGGCAC 30 17268-17297 TTGCCCGTGA TAAAACAATT - ATATGTAATAGGTCATAATGATGATGGCAC 
OMZ 381-M5 GCAGTCAGTAGCGCAACAAGAGCTACAGGC 30 16560-16579 TTGCAGACGC TAAAGCAAGT - ACAATCAGTCGCACAACAAGAACTGCAAGC 
OMZ 381-M19 TATGCGTTGGATTGTTTTTGCTCTGTCTA 29 21869-21841 (r) TAGCACCGAT TAAAGCCTTC - TGTGCGTTGAATTGTCTTTGCTCTGTCTA 
OMZ 381-M46 TCATTTCTCCTGCATTTTATTAGTAACTAG 30 21687-21658 (r) ACCTCTATTT TAAATTATGC - TCCTTTCTCCTGCATTTTATTAGGCGCTAG 
OMZ 381-M51 TAGCAAACGGAGCTTTGCTGTATAGAGCCCTT 32 1463-1432 (r) TTAGCAACTT AAAGTTGAAG - TAGCAAACGGAGCTTTGCTGTATAGAACCCTT 
OMZ 381-M54 GATAATGCTTTTGCCAAAGCACAGCTAATC 30 4621-4650 CGACGTTATC CAAAACGCTT - GATAATGTTTTTGCTAAAGCGCAGTTAATC 
OMZ 381-M56 CAAGATGGCTGAAGAGACCGGGGTTAACGCC  31 12228-12198 (r) TTACCATTTC TAAATTAGCT - CAAGATGGCTGAAGAGACCGGGGTTAACGCC 
OMZ 381-M60 AATATGTAATAGGTCATAATGATGATGGCAC  31 17267-17297 TTTGCCCGTG TAAAACAATT + AATATGTAATAGGTCATAATGATGATGGCAC 
OMZ 381-M62 TAAGAATTTGTTTTCTTTGGCATTCAGCCA  30 1993-1964 (r) CTTTCAATTC CAAATTCAAG - TAAGAATTTGTTTTCTTTGGCATTCAGCCA  
OMZ 381-M63 GTGGCAAAAGTGATAGCTAGGAACATGCCT  30 9798-9827 AATCGAAGAT CAAATCATCA - nd# 
OMZ 381-M69 AAAGAGGAATACAAAGACCCGAATACTTGGA 31 1808-1838 CAAGATGATA TAAAGTCTAA - AAAGAGGAATACAAAGACCCGAATACTTGGA 
OMZ 381-M71 CATATGTAATAGGTCATAATGATGATGGCAC  31 17267-17297 TTTGCCCGTG TAAAACAATT + AATATGTAATAGGTCATAATGATGATGGCAC  
 
*  coordinates of M102 proto-spacer. (r), reverse strand. 
† sequence 5’ to the M102 proto-spacer 
‡ sequence 3’ to the M102 proto-spacer 
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 30 
§ +, sensitive; -, resistant to infection by phage M101 
¶ Proto-spacer sequence of M101. Underlined residues are different from the corresponding proto-spacer of M102 
# nd, not determined 
Legend to figures 
 
Fig. 1:  
Organization of CRISPR1 (A) and CRISPR2 (B) arrays and associated genes in 
S. mutans UA159. Lines below the Orf numbers show the size the gene would have 
when frame shift or stop codons (see text) would be removed. CRISPR spacers are 
shown by boxes (black, conserved; white, degenerated). Repeats are shown by 
diamonds. 
 
Fig. 2:  
Analysis of CRISPR1 (A) and CRISPR2 (B) in S. mutans. Repeats are shown as 
lines; the last non-conserved repeat is shown as dashed line. Spacers are 
represented by diamonds; shading indicates similarity to known sequences. Spacers 
that are encircled have identical sequences; spacers that are surrounded by a 
rectangle show similarity to sequences different from the genome of phage M102.   
 
Fig. 3:  
Weblogo motifs of sequences 5’ and 3’ to proto-spacers.  A, Sequences located 
3’ to CRISPR1 proto-spacers; B, sequences 3’ to CRISPR1 proto-spacers targeted 
by spacers from strains OMZ 64, OMZ 382, OMZ 1040, OMZ 1079 and OMZ 381;  C, 
sequences 3’ to CRISPR1 proto-spacers targeted by spacers from strains OMZ 20, 
OMZ 25, OMZ 67, OMZ 186, OMZ 380, OMZ 382, UA159, AT10, L18, LML7, 
Mt4863, OMZ 125, Mt4653 and OM98x;  D, sequences 5’ to CRISPR2 proto-
spacers. 
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Legend to supplementary figures 
 
Supplementary figure S1: Comparison of part of the cas1 gene from S. mutans 
strains UA159, OMZ 960 and OM98x, Streptococcus equi subsp. zooepidemicus 
strain MGCS10565 and S. pyogenes strain MGAS2096. Identical bases in all five 
sequences are indicated with an asterisk. Differences between S. mutans strains are 
indicated by arrows.  
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Supplementary Table S1: Oligonucleotides used in this study 
 
Name Sequence (5’-3’) Used for 
Cru CATGATTCAAGCTGATCCTA Amplification and sequencing of CRISPR1 
Crd CGACTCATCTCATTAAATCC Amplification and sequencing of CRISPR1 
Cru2 GAGATGAATGGCGCGATTAC Amplification and sequencing of CRISPR1 
Crd2 CGGAACGGTCATTACCTA Amplification and sequencing of CRISPR1 
Cau AATCTGGGTTGCACATCAAA Amplification and sequencing of CRISPR2 
Cad TATAAGCTGATGGCGTTAAG Amplification and sequencing of CRISPR2 
Cau2 TCACAAACGGTGCAACTAC Amplification and sequencing of CRISPR2 
Cad2 GTTGCTTTCATGGACGAACTC Amplification and sequencing of CRISPR2 
CR1 GATCGGATCCTAGCGATAAACAATGGA Generation of mutant in CRISPR1 
CR2 GATCAAGCTTTCGCTAGAAATCAATCT Generation of mutant in CRISPR1 
CR3 GATCCATGGTGAAGCAATAATTCAAGT Generation of mutant in CRISPR1 
CR4 GATCGAATTCAAAGTTGCTGACAAATC Generation of mutant in CRISPR1 
CR5 CCTTGCTGAAGTTGGTTCAC Verification of mutant in CRISPR1 
atlA1 AGCATTGACCCTATTTATGG Amplification and sequencing of atlA 
atlA2 TAACAGCATTCCTTGTCTCT Amplification and sequencing of atlA 
spaP1 TCATGAGGCAGAAGTTGCTA Amplification and sequencing of spaP 
spaP2 TCGGCGGTGTGGGTTTATTT Amplification and sequencing of spaP 
1405c1 GATCGGATCCATGGCGTATTTAAGGTT construction of mutants in SMU.1405c 
1405c2 GATCAAGCTTTGTGCCTTAGCAATCTC construction of mutants in SMU.1405c 
1405c3 GATCCTGCAGAAGGCTATTGGCAAGTG construction of mutants in SMU.1405c 
1405c4 GATCGAATTCCGTGACGCGCATAGTAA construction of mutants in SMU.1405c 
1405c5 CAATGGCTCTATTCCACATC verification of mutants in SMU.1405c 
erm GTGTTCGGTGAATATCCAAG verification of mutants in SMU.1405c 
1757cf GCGAGATAATATTGTTATCA Amplification and sequencing of SMU.1757c 
1757cr AGCTGAGCTTGTACATAAGG Amplification and sequencing of SMU.1757c 
1762cf CAGAAGAAATTGGCCTGGTT Amplification and sequencing of SMU.1762c 
1762cr AATACACCTTTCGGTTTACG Amplification and sequencing of SMU.1762c 
M101-
1A 
GACACAAACGCGCTTTA Amplification and sequencing of M101 
M102-36 CTTGCTCATACTTGTGCC Amplification and sequencing of M101 
M101-3 GGTCTCAGCTCTCAAGATTTC Amplification and sequencing of M101 
M101-4 CTGCTGTTCCCAGGGGATAAA Amplification and sequencing of M101 
M101-5 AAACGTTATCTAGGCACTTA Amplification and sequencing of M101 
M101-6 TTATCAGGACGTGGAATATC Amplification and sequencing of M101 
M102-19 GTAAGACAGTTGGCAAGG Amplification and sequencing of M101 
M101-8 ATAGACTGCGACCGTTCC Amplification and sequencing of M101 
M101-9 ACGACGAGCAAGACGAAAA Amplification and sequencing of M101 
M101-10  AGCTTGACAACGTCTTTA Amplification and sequencing of M101 
 
 
Supplementary Table S2
spacer sequence bp M102 seq id* s^ from bp to bp 5' to spacer 3' to spacer
>UA159-1 AAAAGGAAACGCCATTAATTAATATGGTGA 30
>UA159-2 GATTGAACCAGCTAGCGCAGTTAGTGCTCT 30 GATTGAACCAGCTAGTGCAGTAAGCGCACT 26 f 5122 5151 GGCATGAAGC TGGTGTAATT
>UA159-3 CGCTAAAAGCTGTTGTGTCATCATAGTTAG 30 CGCTAAAAGCTGTTGTGTCATCATAGTTAG 30 r 13478 13449 CGTTGCCCTT TTGAAATTTC
>UA159-4 TAAATATTTTCAATTAGACAATAGACAAAC 30
>UA159-5 TGCCTATGTATTCGGACATGACTTGCCACA 30
>UA159-6 ATGTGAAAAGAAAGTAACTACTACATTTGA 30
>OMZ 381-1 AAATATTTGAAAATTGTTTTTCACTAGATA 30
>OMZ 381-2 TTATTTGTCATAATTTTCCTTTCTATTATCT 31
>OMZ 381-3 GCTTATCGACTATATCAAGCTCCGCTTGCT 30 GCTTATCGACTATGTCAAGTTTCGCTTGCT 27 r 25167 25138 TCAAAGGCTT TAAAATTCAC
>OMZ 381-4 ACTCATTAGTATAAAAAAAACGTTACAGAG 30
>OMZ 381-5 CTTCAAGAAACCATCAAAGACCCTAACCC 29
>OMZ 381-6 TGGCACATATAATCCGTAAAGGCGGCACAT 30
>OMZ 7-1 GAAAAGCCAGCTCAAGACGATAATCTTGAG 30
>OMZ 7-2 CTGTTAATTCAAACTCATGTAACACAGGCT 30 CCACCAGTTCAAACTCATGTAGAATTGGTT 20 r 17716 17687 GGATTATTTT TTGCACTTGC
>OMZ 7-3 CGGCATATATAATCCGTAAAGGCGGCACAT 30
>OMZ 20-1 AAAATCTATGATGTGCCTTCCGATTTCGTC 30 AAAGTCTATGATGTACCTTCTGATTTTGTC 26 f 3626 3655 ACAGATTGCA GGCGGGCGCG
>OMZ 20-2 ACGAGAACTGCAATATCAGGTTTAACCTCT 30 ACAAGTACTGCAATATCAGGTTTAACTTCT 27 r 7617 7588 TGCACTTTGG TGAAGTTCGT
>OMZ 20-3 GCACTACAAGACGGCTATTGCTGATGAAGT 30 GCATTACAAGACAGCCATTGCTGACGAAGT 26 f 1573 1602 TTGACTCAAA CGGAGAGCTT
>OMZ 20-4 TAAGCCCGTTTTCTAGTTCTTCGCGGCTCT 30 TGAGCCCGCTTTCAAGCTCTTCACGACTCT 24 r 26271 26242 TTAAACTCCT TAGCAATATA
>OMZ 20-5 GAGGTGACTCTTAGAAAGAGGGGATAGAGG 30 TAGGCGACTCTTAGAAAGAGGGGATAGAGG 28 f 5847 5876 AGTCAATTAA TGGCATTAGT
>OMZ 20-6 ATAAGATAGAAGCACTCAAGCATAAGCAAT 30 ACAAAATAGAAGCACTCAAACACAAGCAGT 25 f 8332 8361 AGCGCAGAGA TCAGAAGTCA
>OMZ 20-7 GCGAGCACTAGACAGATTGACTTCTGCTAT 30 GCGAGCATTAGACAGATTAACTTCTGCTAT 28 f 29973 30002 TTAAGCGCAA TTTATAAGTT
>OMZ 20-8 CAATTCGTCAAATTCTCCACCCAAGAGCGC 30 TAATTCGTCAAATTCTCCACCTAGAAGCGC 26 r 30908 30879 GTAAATTTTA TGGATTAGCT
>OMZ 20-9 TCTTCATCGGATGACTCAGGACCAAATGTGG 31
>OMZ 20-10 GTAGAAATATATACTGGTAGCGCCGCTCTT 30
>OMZ 20-11 TAACTAACCCGACAACAATCACTGTTACTG 30 TAACTAATCCAACAACAATCACAGTTGTTG 25 f 15947 15976 GAAAAGAGCA TGGTCAATGT
>OMZ 20-12 AATCTAGCAGACAAGCTTGACCAAGTTATT 30 AATCTAGCAGACAAGCTTGACCAAGTTATT 30 f 13143 13172 AGAAGAAAAC GGACTTCTCG
>OMZ 20-13 TAACTAACCCGACAACAATCACTGTTACTG 30 TAACTAATCCAACAACAATCACAGTTGTTG 25 f 15947 15976 GAAAAGAGCA TGGTCAATGT
>OMZ 20-14 GTGCGTCTTGTCGTTTTCCCAGATATTCAC 30 CTGGGTCTTGTCGTTTTCCCAGATATTTAC 28 r 2876 2905 TAAAATCAAA TGGGTCTTTA
>OMZ 20-15 TAATTAAAGGTATGATTTGATGAAATTTAT 30 TGATTAAGGGTATGATTTGATGAAATACAT 26 f 13309 13338 AGACAAAATT TGGGTTTGAT
>OMZ 20-16 AAACAAAGCGGTCTTCTTCGCTGGCAATTC 30 AAATAAGGCAGTCTTTTTCGCTGGCAATTC 26 f 7639 7668 AGCCAAAGAA TGGCGTAATG
>OMZ 20-17 TGTTGATGTATCAGATACATTTCCAAATGG 30
>OMZ 20-18 CTTTCCAAGCCTGGCTGAAACAATCAAACA 30
>OMZ 20-19 TGGGGCGCACGAACTCAAAGTCTTTATTGG 30 TGGGTCGTACTAACTCAAAGTCTCTCTTAG 25 f 1278 1307 ATCTTGTCTA CTAGCGTGCA
>OMZ 20-20 GCTAATATGAGTACAAGTTTTGATGAAGCC 30 GCTAATATGAGTGCGAGTTTTGACGAGGCT 25 f 18208 18237 CAACTCAGAC AAAAATTACA
>OMZ 20-21 CAGTGACTATGACGGAACTTACTTTTAGATA 31 CAGTGATTATGATGGGACTTACTTTTAGATA 27 f 19262 19292 AAATTTGGGG GGGGATTTAT
>OMZ 20-22 GTCAGTTCTTTAATTATGCTATAAGCTAGA 30 GTCAGCTCTTTAATCACGCTATAAGCTAGA 27 r 23391 23362 ACTGTCTTTT TGACTTTTAC
>OMZ 20-23 CAAGTCTCAAAGCTTTGCACAAAATGATAT 30
>OMZ 20-24 GAGAAATCAGCACAAGAAGAAAATCTTGAA 30
>OMZ 20-25 AGGTAAGGTTAGGTAAGGATAGATTAGGTA 30 AGGTAAGGATAGGTAAGGATAGATTAGAGT 26 f 22105 22134 GTGGACACAC TAGGAAAGAA
>OMZ 20-26 GCAAAACTGATAACGTGAAAGCTGTTGATT 30 GCAAAGCTGACAGCGTGAAAGCCGTCGATT 25 f 25813 25842 GTCGCAAATG TGGAAACAGG
>OMZ 20-27 CAATGAGTTTTGGAGAAGCCTGGAAATTAA 30 CTATGAGTTTTGGAGAAGCTTGGAAATTAA 28 f 27366 27395 ATCGTGTACG AGGCTATGCG
>OMZ 20-28 TGGTTCAATCTATAATGTTAAAGCGAATTA 30
>OMZ 20-29 TTGCAGATATATTATAATATCCGGTTGATT 30 GGGCGCTGGTGTTATAATAACCAGTCGACT 18 r 20202 20173 ACTTGACTAG CAGTCAGTTT
>OMZ 20-30 CCACAGAGCATTTAAAGTGTTAACATCCAT 30
>OMZ 20-31 CTGAATGGTAAAGTTTATTTCTCTCTTTGC 30 CTGAATGGTAAAGTTTATTTCTTTCTTTAC 28 r 229 200 AGCCATCTAG CAGTAAAACT
>OMZ 20-32 ACAAGCTGGAGATTTTAAAGCAGCTGATAT 30
>OMZ 20-33 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>OMZ 67-22 ATGTGAAAAGAAAGTAACTACTACATTTGA 30
>OMZ 25-1 AGAGCGCAACTTTAAAACCATCTTACCAGC 30 AGAACGCAACTTCAAAACCATCTTGCCAGC 27 f 11675 11704 TTGTTCCAAA TGGAACAGAA
>OMZ 25-2 TAAAACAAAAAAAGATGTAATTTAATAACG 30
>OMZ 25-3 AAAGTCTATGATGTGGGCTAAACCATCATA 30
>OMZ 25-4 CTTGTAGCATTAATAAATCTGTATTTGCTA 30
>OMZ 25-5 ATACCAGTTTCTGACTCAAGTGTATAAGCA 30
>OMZ 25-6 ACGTAATTTTGTAACGCCTTATAAGTTTAT 30 ACGCAATTTCGTAACGCCTTATAAATTTAT 27 f 14308 14337 TTAAGAACTC CGGTTCAAAA
>OMZ 25-7 ACTACAGCAACAGACATCGTTTTGATTGTC 30 ACTAACGCAACAGACATTGTTTTAATTGTC 26 f 19605 19634 TAGCTTAATA GGGCTCTTAA
>OMZ 25-8 GCCGAAAAGCGCAGAACTTCGCGGTGGT 28 TCCAAAAAGTGCAACATTGCGCGGGGGA 19 f 24681 24708 GAACCATCGT TGGTGCAAGG
>OMZ 25-9 GTGCCTAAGTCGTCCAAAACTAAGTAGTCT 30 GTCCCTAAGTCGTCCAGAACTAGATAATCT 25 r 23529 23500 GATTTTCTCA ATACTGTTAA
>OMZ 25-10 CTCTTTTGCGTTGAGGACTTCCGCCCCCGC 30 CTCTTTAGCATTAAGAACTTCTGTTCCAGC 22 r 11732 11703 GTTCCGCTGT TGGCAAGATG
>OMZ 25-11 GAAAGTTTTAGAAATGTATAGAAGTTTTAC 30 GAAAGTTTTATAAATGTACAGAAGTTTTAC 28 f 168 197 AAATTAAGTA TGGTAAAGAA
>OMZ 25-12 TACTAAGCAGTTTGCAGATGAAGACCCGC 29 TACTAAGCAGTTTGCAGATGAAGACCCAC 28 f 13079 13107 TCGCCAAGGT GCGGGATTGA
>OMZ 25-13 ACCGCGTTGTTCTAAAAATCTAATTTGTTT 30
>OMZ 25-14 TGGACGCAAGAATATCTATTTAAATGGTTC 30 TGGACGCAAGAACATTTACTTGAACGGTCC 24 f 14104 14133 ACGACCAGTT AGGTCGTGCA
>OMZ 25-15 AAATCCACCAACTGACTCAATTGATCCATT 30 AAAGCCACCAGTTGACTCAATGGATCCATC 25 r 18385 18414 CGTTGAGGTA TGGCAAGCTG
>OMZ 25-16 CCAAAATTTTTAGCTCAAAAATACGGCAAA 30 CCGAAGTTTCTAGCTCAAAAATACGGCCGA 25 f 23615 23644 TAATCTAGAA CGGCTGTACA
>OMZ 25-17 AAAGCTGATTTTTTTATTTTTCCAGCCAGT 30
>OMZ 25-18 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>OMZ 64-1 CAACAAATCAGCGATTTGATTGAGTCTGCGG 31 AAACAAATTAGTGACTTAATTGAGTCTGCCG 25 f 19848 19878 AGTTACAGAT TAAATTCGCT
>OMZ 64-2 GTACACTCAGCAACTAACCCATCTGCGCCT 30 GTACATTCAGCAACCAATCCATCGGCACCT 28 f 7466 7495 CAACATGGTT CAAATCAGCT
>OMZ 64-3 GATTGACTTTGTAGATGTAACCTGTGTGAC 30 GATTAACCTTGTAAACATAGCCAGTGTGAC 23 r 21260 21231 CTGCCATCAG CGAAAGGGTG
>OMZ 64-4 GATTGAAAAAACTATTGTCTATAGAATTTT 30
>OMZ 64-5 AGAGGTGGCATTAGTAACAATAGAAGAGTTT 31 AGAGGTGGCATTAGTAACGACAGAAGAATTT 28 f 5872 5902 AAGAGGGGAT AAAGATTATC
>OMZ 64-6 CAACAGCAACAATCAAATCAAGAGCAATTT 30 TAACAGCAATAACCAAATCAAGAGTAATTT 26 f 11315 11344 ACGCTATTTT CAAGTCTACT
>OMZ 64-7 AATGATAAAGCTTGTTTCTCTCTTTACCAG 30 AATGGTAAAGTTTATTTCTTTCTTTACCAG 26 r 226 197 CATCTAGCTG TAAAACTTCT
>OMZ 64-8 GATTAAAACAATGTCTGTTGCTGTAGTTAC 30 AATTAAAACAATGTCTGTTGCGTTAGTTAT 26 r 19631 19602 AGAGCCCGAC TAAGCTATCA
>OMZ 64-9 ACTTGAAGATGGTCGTGGAGCTACAAGTCA 30
>OMZ 64-10 CTACATTATCAACAATATTAGCTTGGGGAC 30
>OMZ 64-11 TGCAAAATCAGCAACAGGATACATTATCAC 30
>OMZ 64-12 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>OMZ 67-1 GGTCCGCCTGTATAAACTGCAACAGTACC 29 GGTCCGCCTGTATAGACTGCGACCGTTCC 25 r 12313 12285 TGAGCTAACG CGGTTTTGGT
>OMZ 67-2 AACGAAAACCAATTCAACGCCCCTCGCGGT 30 AATGAAAATCAATTCAATGCACCGCGAGGC 23 f 14405 14434 TGACAGAGAT TGGTCTGAAA
>OMZ 67-3 TAATAGCAATCGTGACGGACGTATTGATTT 30 TAATAGCAATCGTGATGGACGTATTGATTT 29 f 18561 18590 GAAGCTGTCT ACTTTGACTT
>OMZ 67-4 TTTTATCAAAGATTTCGTTTTTGTGCTGTT 30
>OMZ 67-5 GTTGAGTGCAACAGCTAGCTAATAGCTTTT 30
>OMZ 67-6 TACGCCCTAAATACGACAGGTCAGGACGAT 30 TACGCTCTAAATACAACAGGACAAGACGAC 25 f 15685 15714 TAAGAATAAA TGGACTAGTT
>OMZ 67-7 CAATCAAGCTGCACGCTCGCCAATAGAGACT 31 TAATCAAGCTGCACGCTAGCTAAGAGAGACT 27 r 1326 1296 AAGAAAATCA TTGAGTTAGT
>OMZ 67-8 ATGGACGGCGCTTGAATGGCTACATAATGA 30 ACGGCCGTCGATTGAATAGTTACATAATGA 24 f 1008 1037 GATACTGTAT AGGCTTCAAT
>OMZ 67-9 TATCAAGGCAGGAACAAAATACAGACCTAA 30 CTTAAAAGCAGGAACGAAATACAGACCTAG 24 f 22286 22315 AGCACTTAAA TGGTGCAAAA
>OMZ 67-10 GAGGCGCGTGTACGGCAAGAAGAGCTGAGA 30
>OMZ 67-11 CTTTTGATGGTAAGCAGGTCATGAGAATGA 30
>OMZ 67-12 AAAATATATTATTGATTTGCCAGAACCTAT 30
>OMZ 67-13 AGTGATTATGATGGAACTTACTTTTAAGGT 30 AGTGATTATGATGGGACTTACTTTTAGATA 25 f 19263 19292 AATTTGGGGC GGGGATTTAT
>OMZ 67-14 CTCTGGCTCTAATGCTTATCTAGAGGATAC 30
>OMZ 67-15 CCGTCGCCTTTTGCGATAGTTAGTCCATCT 30
>OMZ 67-16 AGGCATTTTCTGATTGAGATTTTCGATATT 30 AGGCATTTTCTGATTGAGGTTTTCGATATC 28 r 1183 1154 AGTCAATAAA TGGAAAGATG
>OMZ 67-17 ATTTCTGCTAACGCTTATCACTTGTTTTAC 30
>OMZ 67-18 TATAGCTAATATGTGTATACTGACAGCGCA 30 TATAGCTAATATGTGTATACTGACAGCGCA 30 f 5944 5973 ATCAATCAAA AGAAAGATTG
>OMZ 67-19 TAAAAAGACTACACAAGAATTAATTGATAT 30
>OMZ 67-20 AAGCAGGTTCTAGTGTAGCTATGGGCGCTA 30 AAGCCGGCTCTAGTGTGGCTATGGGCGCCA 26 f 12058 12087 GCTATGGAAG AAGGTGACGA
>OMZ 67-21 GTCACGAGCTACTCTGTCTAAATAGTTTGG 30
>OMZ 1040-8 AAAGCGTTTGGAGCTTTTTGAAGAGCTGGA 30
>OMZ 186-1 AAGCTCCGTCTGTCTTGCTCTTCGCATTCT 30 AGAACGCAAAAAGCAAAACTGATGGAGCGT 23 r 11070 11041 GTTTGCTTAA TGGCAAATGC
>OMZ 186-2 CTTTGTAACTCAATGTTACTAACTGAAGGC 30
>OMZ 186-3 CAATTTTATCGGTTCCACCTAGACAACCAGA 31
>OMZ 186-4 ATCTGAGATTTAACAAAATCATCTTATCAA 30 ATCTAAGATTTAATAAAATCATCTTGTCTA 26 f 1248 1277 AAAGACGATA TGGGTCGTAC
>OMZ 186-5 ACTAGCAACACAGCACCTTTCAGCGCAAGT 30 ACTAGCAATACAGCACCTTTCGTCGCAAGC 26 f 13685 13741 GCCGGAGCTA GGAACGCTTA
OMZ 380-1 TGCTCGTCATCTGATGACTCGACAAGTCGT 30 CGCTTGTCATTTGATGACTTGCTAAGTCGT 24 r 3023 2994 ATCACATTTG TTGATAACTT
OMZ 380-2 CGAGCTTAGCAAACTTCTTTGCGCCAGCAT 30 CGAGCTCAGCGAATTTCTTTGCGCCTGCGT 25 r 6632 6603 TCTTCGGTAG AAGTCATCTT
OMZ 380-3 AAGTTTTGTGTATATTTATCGCGACTCAAA 30 GAGCTTTGTATATATTTATCGAGACTCTAA 25 f 3124 3153 TATATGGCGA AGGTAGGGCA
OMZ 380-4 AGGTCGTGGTGTTGATACTGACCAAAAGTA 30 AGGTCGTGGTGTGGATACTGACCAAGTTTA 26 f 21010 21039 TAGCCGCGGA TGGCATGCAA
OMZ 380-5 CAGGCGAGGGCAAAGTCGGGACTGATAGCA 30
OMZ 380-6 TGATAATCTTTTGTGAAACCACGAAGTCTT 30
OMZ 380-7 AAACAAAGTTATCATCTGCACGAGTCTTAG 30 AAACGAAGTTATCATCTGCACGGGTTTTAG 27 r 7748 7719 TTAGCAGCCC CGGTATTAGT
OMZ 380-8 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>OMZ 382-1 GGACTTAATCTAATCCGCGGTGCGCTTGG 29 GGGCTTAATCTTGTTCGTGGTGCACTTAG 22 f 8955 8993 GTTTACAAAC CAAAATCAAA
>OMZ 382-2 TTTTTAGTGGAACCTTTAAAAATCCTGCTA 30 TTTTTAGTAGAGCCTTTAAAAATTCTGCTG 27 r 23682 23653 GTACACGTCG TACAGCCGTC
>OMZ 382-3 TTTACTTTGATAAAAAGGAGATAACGCGTT 30 TTTACTTTGATAAAAATGAGATAACGCGTT 29 f 1098 1127 GATTACCATT TAACTCGTTT
>OMZ 382-4 TAATCAGACTGCAGAAAGTCTTGCCAAGGC 30 CAATCAAACAGCAGAAAGCCTTGCTAAAGC 24 f 8738 8767 CTAAGCGCGT AAAATCGGCA
>OMZ 382-5 TGTTGTAAAATCTACTGCTGTTGCACCAGC 30 TGTAGTGAAATCCACTGCAGTAGCACCAAC 24 f 19913 19942 CACGCGGTAC CAAGCCAGCA
>OMZ 382-6 TTTTTGCTTCTTTTGTTTTTGTAACTGTCC 30
>OMZ 382-7 AACTACGTCGCTCTGATTATGTATGAGGCT 30
>OMZ 382-8 TCCGTCTTCTCCGCCACTTTCTGGGTCCGC 30 ACCGTCTTCTCCACCTGACTCAGGGTCTGA 21 r 12611 12582 AACCTTGAGG CAAGTGTTCT
>OMZ 382-9 GGACTTAATCTAATCCGCGGTGCGCTTGGT 30 GGGCTTAATCTTGTTCGTGGTGCACTTAGC 22 f 8984 8955 GTTTACAAAC AAAATCAAAG
>OMZ 382-10 ACAATTTGCGCAGGCGCAGAGCCATATTTAA 31 ACGATTTGCGCAGGCGCAGAGCCGTATTTGA 28 r 25560 25530 TTTACTGACT TAAAGTAAAC
>OMZ 382-11 GGCAGATGACGAAGGCTTTATCGACAGAGC 30 GGCAGATGACGAAGGCTTTATAGACAGAGC 29 f 21821 21850 TGTCGATGGG AAAAACAATC
>OMZ 382-12 AGGCAAAGCAATCATAGCGCCGATTATTTT 30 AGGAAGGACAACTAAAGCGCCGATTATTTT 23 r 10487 10458 CAATTTTAAA GAGAGGAGCA
>OMZ 382-13 TTAAAACCTTATTTACAAAGTTATCTGCGT 30
>OMZ 382-14 TCTTTCTGGGTACACTAGCTAAGACAGACG 30 TCTTTCTTAGCACACTAGCTAAGACAGACA 26 f 20293 20322 GAAGCGAACT TTAAATATTT
>OMZ 382-15 GTTTGAACCGTTCTTTATCTGCTATGTCTT 30
>OMZ 382-16 AGCACTAACGTAATCACTAATGCGCTATTG 30
>OMZ 382-17 AGTTAATCTATCTAATACTCGCTTGCGCTT 30 AGTTAATCTGTCTAATGCTCGCTTGCGCTT 28 r 29994 29965 AAATAGCAGA AAAGACTCTG
>OMZ 382-18 ATTTTAGTCACTCTATTCCCTCTTTCTTTT 30
>OMZ 382-19 GAGAGGAAAAAGCAAAATGAAAGTCACAAA 30 GAGAGGAAAAAACAAAATGAAAGTCACAAA 29 f 26461 26490
>OMZ 382-20 TGAAGATTGGAAAGCATTTGCAGAAGAACG 30 TGAAGATTGGAAAGCATTTGCAGAAGAACG 30 f 26713 26742 AATGGAATTT CAAAGCAGAA
>OMZ 382-21 AGAATACAAAGAATTAGCAATACAAAAAGC 30
>OMZ 382-22 TTGCAGTTAAGTAGTTCATAGCGCGCTGAT 30
>OMZ 382-23 GACTGAAGTTTTGCACGAAATAATCTTTAT 30 GACTAAAGTTTTGCACAAAGTAGCCTTTAT 25 r 17779 17750 GCTGTTACCT CGAGCCCGCA
>OMZ 382-24 GCAAACGTGAGATTTTAGTGCCTGTGTCCT 30 GCAATCTGGAAATTTTAGTTCCTGTGTCTT 24 r 15325 15296 GCCACTGTTT CAAAACTAAT
>OMZ 382-25 GATAATGCTACATACAATTACAAGACAATG 30
>OMZ 382-26 AAAGAAGAAGTTATCAAATACAAAGCTATT 30
>OMZ 382-27 ATTGAAAATTAATTTTATTCGCTTCATTGC 30
>OMZ 382-28 TTCATAAGCTAAGCTGTCAAATACTTTTCC 30
>OMZ 382-29 GTATGTAATCGGGCATGATGATGATGGTAC 30 ATATGTAATAGGTCATAATGATGATGGCAC 25 f 17268 17297 TTGCCCGTGA TAAAACAATT
>OMZ 382-30 TAGAATTACAAATTTTCCATAAGCTGAAAA 30
>OMZ 382-31 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>OMZ 1040-1 TCTTAGAGTTGAGACAATAGCACTAAATGT 30 TCTGAGAGTAGAGACTATAGCGCCAAACGT 24 r 6157 6128 CAAATCGAGC TAAATCATTA
>OMZ 1040-2 TTGTGAAAGGACGCAACCTCAATCCGTTTA 30 TTGTGAAAGGACGTAATTTAAACCCTTTCA 23 f 24482 24511 CTTTTAGCGA CGAAAGAAGT
>OMZ 1040-3 CGATTATCGATGGAGAAAAAGCATATATGC 30
>OMZ 1040-4 CGCGGCTTTTTAAAAGAGACCGGGGGGTCT 30 TGCGGCTTTTTAAAAGAGACCGGGGGGTCT 29 r 31143 31114 ACGCGGGTTC CAAAATATTT
>OMZ 1040-5 TTCTTTGGTTATGACTCTTACGGCCTAACC 30 TTTTTTGGCTATGACTCTTACGGCTTAACT 26 f 2366 2395 AAACTTAGCA AAAGTTGTCA
>OMZ 1040-6 CTTATCACTAATTTGCTTGACTAGCTTTCT 30 CTTATCACTGATTTGCTTAATTAATTTCCT 24 r 25298 25269 TTTCTAAACG CAAGTCTGCG
>OMZ 1040-7 CAGAAGTTCAATTACTGATACAATCTCTTG 30 CAGAAGTTCAATTACTGATATAATCTCTTG 29 r 30624 30595 ATCCCATCAG TAAGTCTCTA
>At10-2 TAGTCCAGAAGTCTGTTACTTGTTGAGACC 30
>OMZ 1040-9 TGTTTTACTGGTATAGGATTTGTCATCTTG 30
>OMZ 1040-10 AGATATGTTGTCTATTGTCAACACGTTCCC 30
>OMZ 1040-11 GGCGAGCTGAAGGATAATGAAGGTCTTGGC 30 GGAGAGCTTAAAGACAATGAAGGACTTGGC 25 f 1604 1633 TGACGAAGTC AAAATCAAGT
>OMZ 1040-12 GTTTTCATTCTGCTTACTGTCGCCAAGATT 30 ATTCTCATTCCGCTTACTGTCACCAAGGTT 25 r 9752 9723 GAGTAGCAGC AAATGCTTTG
>OMZ 1040-13 GTCTTCTTTTTGCGCGTGTGTCTTAGCCTCA 31 ATCTTCTTTTTGCGCGTGCGTTTTCGTCTCG 25 r 23269 23239 TTGATAATTT TTGGAATTTG
>OMZ 1040-14 AAATGGTGGTTTGACTGACTCTGGTATTTT 30 GGACGGTGGTTTGACAGACTCAGGGATTTT 24 f 7345 7374 AAACTAAAGC AGAAATTACC
>OMZ 1040-15 ATAAGCACCGATTACATCTTTTGTTTTTGT 30
>OMZ 1040-16 TAATTACAATCAGTTTAAAAGTTGCAATGC 30 TAACTTCTGCTATTTTATAAGTTGCAATGC 22 f 29990 30019 TTAGACAGAT TAAGCCAAAC
>OMZ 1040-17 CCTTAGCGGAGTCAAGAAGTCGACGGACCC 30 TCTTAGCGGAGTCAAGAAGACGACGGATCC 27 f 15519 15548 ATCGTGTCTT AAAATCAAAA
>OMZ 1040-18 CAAACGTTTTTTTATTAGGAAAATCGCTGA 30
>OMZ 1040-19 ACCATTAGTTAGCACAAGTTCGTTATTACA 30
>OMZ 1040-20 TGGCACATATAATCCGTAAAGGCGGCACAT 30
>OMZ 1079-1 AATTCTGCGCTGCTTATCAAAAGTTCGCTG 30
>OMZ 1079-2 TCTTAGAGTAGAGACTATAGCGCCGAATGT 30 TCTGAGAGTAGAGACTATAGCGCCAAACGT 27 r 6157 6128 CAAATCGAGC TAAATCATTA
>OMZ 1079-3 TCCAGCAAAGGTCCCGAGGAAAGAACCTCT 30 TCCTGCAAAGGTTCCGAGAAAGGAACCTTT 25 r 8927 8898 AAATTACGTT CAAAACACTC
>OMZ 1079-4 TCAAAGAGTCTAGCGACCGCTCCAGTGTTT 30 TCAAAGAGTCCAGCGACCGTTCGAGTGTTT 27 f 8866 8895 TCCGATAAAC TGAAAGGTTC
>OMZ 1079-5 TGTTTGAGCAGAATATAAACGCTGTTGTCA 30 CCTTTGAACAGAACATAAACACTGTTGTTA 25 f 25171 25200 GATAAGCAAG AAAAATACAA
>OMZ 1079-6 TAAAAAAGATAATCACTACACAGTAGAGCT 30 CAAAAAAGATAATCACTACACAATAGAACT 27 f 13810 13839 GAACCATCAC AAAGAAAGCG
>OMZ 1079-7 CACGCGCCGGTGACTTGTTTGTCATGGACA 30 CTCGCGCTGGAGATTTGTTTGTTATGGATA 24 f 21174 21203 AATAAACCGC CTAACGCGCT
>OMZ 1079-8 TTCCGCTTCCACTTACCTTGACTTTGGCGT 30 TTCCGCTTCGACATATCTTGATTTTGGCAT 25 f 12431 12640 GACCTATTTC AAAATCAGGA
>OMZ 1079-9 AAGCTAAGAATTACATAATTGAAGCGACTT 30 AGGCTAAAAATTACATAATTGAAGCAACTT 27 f 18233 18262 AGTTTTGACG TAAGCGATAA
>OMZ 1079-10 AGCAGGTAAATAATTATGTCAGATAATATT 30
>OMZ 1079-11 TAATGCAAAAGTGAATGACTCTATCAAATG 30
>OMZ 1079-12 AGACCTGTTCATGCCAATTTATTCGCTTTC 30
>OMZ 1079-13 CTACTCAAGTTAGCGGATTGACTACAGCAC 30 CTATTCAAGTCAGCGGATTAACCACAGCAC 26 f 19006 19035 TTGAGTGCAA AAAGTGAGTT
>OMZ 1079-14 TAGAGTCTCACCTCCTTTCTAATGTTAATA 30
>OMZ 1079-15 ATCAGGAAGCGACGACAAAGATGGCGGAAC 30 ATCAGGAAGCGACGACAAAGACGGCGGAAC 29 f 12464 12493 TTGGCATAAA TAAAGCGGAT
>OMZ 1079-16 TGCTGTTAAGCGTTTAGCAGACTACGTAAA 30 GGCTGTTCAACGTTTAGCAGATTATATTAA 23 f 19787 19816 AAAAGAAATT TAGATCCAAG
>OMZ 1079-17 TGAGGTTTTCAATGTCTGGGAAGATGCTCA 30 TGAGGTTTTCGATATCTGGAAAGATGTCCA 25 r 1169 1140 ATTTTCTGAT TGAAACGAGT
>OMZ 1079-18 GTAATATAATGCAACAATTAACTAACGCTC 30
>OMZ 1079-19 TTCGTATCATTAATGCGGGCATTTTCTCCC 30 TTCGTATCATCAGCGCAGGCATTTTTTGCC 24 r 24823 24794 ATAGCGACTT AGAGATTTTT
>OMZ 1079-20 TTTGAAATTGGTTGATAAGATTGGCTCTGT 30 TTTGAAATTGGTTGATGAGATTGGCCTTGT 27 f 4272 4301 GAGCGCTAGA TAAAGTTAAC
>OMZ 1079-21 CGTCTTTTGTCTCAATCACAATCCCGGCTT 30 CGTCTTTAGTTTCAACAACAATTCCTGCTT 24 r 24649 24620 TCTATAGCAC CAAATCCGTC
>OMZ 1079-22 CAGAAGCACAAGATGAGAAAGAGATTGAAC 30 CAGAAGCACAAGATGCGAAAGAGATTGAAT 28 f 4313 4343 AAAGTTAACG TAAAACCGCA
>OMZ 1079-23 TGACGAAACAAGACATTATGAGTTGCGTTT 30 TGATGAAACAAAGCATTATGAGTTGCGTTT 27 f 7205 7234 TTATCGTGGA AAAAGTGACT
>OMZ 1079-24 ATTAATCGGCGCCTTAGTTGTCTTACCTTT 30 AATAATCGGCGCTTTAGTTGTCCTTCCTTT 26 f 10460 10489 CTCCTCTCAA TAAAATTGCG
>OMZ 1079-25 CACTTTAAAAAAAGAAAGGTAAAAAATGTG 30
>OMZ 1079-26 TAAAAGTAAGTCCCGTCATAATCACTGCCC 30 TAAAAGTAAGTCCCATCATAATCACTGCCC 29 r 19288 19259 ATCCCCTATC CAAATTTGGA
>OMZ 1079-27 TAACAGTAACAATCAAATCAAGAGTAACTT 30 TAACAGCAATAACCAAATCAAGAGTAATTT 26 f 11315 11344 ACGCTATTTT CAAGTCTACT
>OMZ 1079-28 TGAAAAACTTAAAAATCAGCGTGATAATGC 30
>OMZ 1079-29 GACTGTAAAAACAGGTGTTGCTAGTCTCTC 30
>OMZ 1079-30 TTACAATCATTTAGTCGATTTGTTCGCTAG 30
>OMZ 1079-31 AGTCGTGATAATCGTTTTGTCGCGAGCGTT 30 AGTTGTAATAATTGTTTTGTCGCGCGCGTT 26 r 23605 23576 GTTCTAGATT CAAGATGCTG
>OMZ 1079-32 AAAAAGACCGGCGTAATCAGCAAAACGTTA 30 AAAAAAACAGGTGTAATCAGCAAAACACTA 25 f 10407 10436 AGAGTTTAAC CAAGTTGCAT
>OMZ 1079-33 TGAGAACATCCGCAGAGCTTATAGAGAGA 29 CGAAAATATTCGCCGGGCCTACAGAGAAA 19 f 701 730 GTAATGGCAG TTAAATCAGA
>OMZ 1079-34 GATACGTATATGCTATTTTTATCTAGAAAG 30
>OMZ 1079-35 TTGTGTGTTTCAGGGTCCATAATTGCCACA 30 TTGTGTGTTTCTGGGTCCATAATAGCCACG 28 r 7329 7300 AGTTTTTGCT TAAACACGTT
>OMZ 1079-36 ATCAAACAAGACGAAGACAGCGACGCCAAG 30 ATCAAGCAAGACGAAGACAGCGACGCTAAG 28 f 11841 11870 TGGAAAAACC AAGAAAGCCA
>OMZ 1079-37 ACGTTCTATGTTTTTATGGTTTATTCTGAA 30
>OMZ 1079-38 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>At10-1 CATTCTTAGGAATAGCTAGAGTGACATTAT 30
>OMZ 125-18 AGAACTTCAAGCCAAAATCGAAGAGGTATT 30 AGAACTTCAAGCAAAAATAGAAGAGGTGCT 26 f 23895 23924 AAGACTTGGA GAATAAATGA
>At10-3 AACTGAAGAGTACACGAAAATGCAGTCAGA 30 GACTGAAGAGTATACAAAAATGCAGTCGGA 26 f 9398 9427 CTAAGCTGAC AGGCAAAATT
>At10-4 GTATCATCAGCGCTGGCATTTTTTCCCACG 30 GTATCATCAGCGCAGGCATTTTTTGCCAGA 26 r 24820 23791 GCGACTTTTC GATTTTTGCT
>At10-5 CTGACCAAGAGAATTAATTCTAAAGATAAA 30
>AT10-6 GGCACATATAATCCGTAAAGGCGGCACAT 29
>L18-1 AGGCGTTAACCCTGGATTGTTTAGTCACCT 30 AGGCGTTAACCCCGGTCTCTTCAGCCATCT 23 f 12197 12226 TAGCTAATTT TGGAAATGGT
>L18-2 CGCTTTCCAGATTTGGGGGAGTGATTATGA 30 CGCTTTCCAAATTTGGGGCAGTGATTATGA 28 f 19244 19273 ATAACGATGT TGGGACTTAC
>L18-3 CACGGGACAAGATGACTGGACTAGTTATGT 30 AACAGGACAAGACGACTGGACTAGTTATGT 27 f 15699 15728 CTCTAAATAC TGGAACCACT
>L18-4 GAAAGAATAGACATTATTTCTCCAGTCAAT 30
>L18-5 CAGAGAAAAGGTTCAACATGAGTGGGAAGA 30
>L18-6 GCAAACACTGATTTGTCAGTTGCAAGGCCT 30 GCAAATACTGACTTGTCAGTCGCGAGACCT 25 r 13938 13909 ATTACCAATT AGATAACCGT
>L18-7 AATCAAAAGCAGAGAAACAACACTGATTGA 30
>L18-8 GCTTTAATTCGTCAATACAATTCACTGCAA 30
>L18-9 TGTTATTGACTTTAATAAACAAAAGAAAGC 30
>L18-10 CGTGCAGGAGATGATCAACTTTGCTTGATT 30
>L18-11 ATAAAGATGTGGAGAATATCTGTAACTATC 30
>L18-12     TGGAAAATTTGTAATAAATTAGGAAGAATG 30 TGGAAAATTTGTAACAAGTTAGGAAAGATG 26 f 27500 27529 TTATTTCAAT AGGTAAAAAT
>L18-13 TGCAGATGATAACTTTGTTTGGGCTGCTAA 30 TGCAGATGATAACTTCGTTTGGGCTGCTAA 29 f 7729 7758 CTAAAACCCG CGGCAACGAC
>L18-14 GTTTAATTATCGTCTTATTAGTTCCAGAA 29 GTTTGATTATCGTTTTATTAGTGCCAGAA 26 r 20166 20138 GACTCAGTCA GCAGAGAAGA
>L18-15 ACTAGCAACACAGCACCTTTCAGCGCAAGT 30 ACTAGCAATACAGCACCTTTCGTCGCAAGC 26 f 13685 13714 GCCGGAGCTA GGAACGCTTA
>LML7-1 AGTCACTAGTTGAAACTTGACTAGTTGCGC 30 AATCACTAGTTGCAACTTGACTAGGGGCGC 26 r 20226 20197 AATCCAATGC TGGTGTTATA
>LML7-2 AGAAAAGGCTCAAACACTTCTTCAAATTAT 30
>LML7-3 GTATTGATAATGGACAACATGTCTTGTCCT 30 GTATTGATGATGGACAACATGTCTTGCCCT 28 r 9335 9306 TTTAGGAAAT TGCACCTTGC
>LML7-4 CGCTATCAAGGCTAAACGCGGGGACGTCGA 30 TGCCATCAAAGCTAAGCGCGGGGATGTCGA 25 f 6691 6720 ATATGGCAGA CGGTAACAGA
>LML7-5 CTTAATAGCTCTGCGTCTGAACGCTGAAAT 30 CTTAATAGCTCCGCGTCTGAGCGCTGAAAC 27 r 14634 14605 CTTACGGTCA TGTAGCGCCG
>LML7-6 TGAATGTGTTGCTGCACACGTAACACTCAG 30
>LML7-7 TACTATAGCCACTTTACGTATCATTAAGGC 30
>LML7-8 TTTGCCTGATGGGTCCATTGAGTCGACTGG 30 CTTGCCAGATGGATCCATTGAGTCAACTGG 26 f 18378 18407 CTGATAACAG TGGCTTTTAC
>LML7-9 GGCACATATAATCCGTAAAGGCGGCACAT 29
>MT4863-1 TCTTACCATCACCAATTGGCTCAGAAACAT 30
>MT4863-2 AGTGGGTGACTCGATAAAGATGCAACTGCT 30
>MT4863-3 TTGCTTTGCTGACTTTTACAACTTTTTTCC 30 TAGCTTTGCTGACTTTTACTACTTTTTTTC 27 f 19349 19378 AGTGCTCTTG AAAACCGCGT
>MT4863-4 CGTAACATATATTTGATTGCATTCCCCCAA 30
>MT4863-5 ACATTTGCATTGACGACGCGAACGCCAATC 30 ACATTTGCATTGACGACGCGAACGCCAATC 30 f 2921 2950 TTTTACATCA AAAGATGACA
>MT4863-6 TGGCACATATAATCCGTAAAGGCGGCACAT 30
>OMZ 125-1 CCCTTAATAGAAGCACGTTTTAAACGTTC 29 CCGCTGATAGAAGCGCGTTTTAAGCGTTC 24 f 9636 9664 GGTTTCGGAC TGGCAAAAAA
>OMZ 125-2 GCAATTCAGTTTCATCCCATGGGAGCAACA 30 GCAATTCAGTTTTATCCCCTGGGAACAGCA 26 f 2164 2193 TCCATTTGTC GGGCTCTATT
>OMZ 125-3 TCTTGTGCAAAAACAAGCAGAAGCGTCCTC 30 TCTTGTGCAAATACCAGTAGAAGTGTCCTC 26 r 1774 1803 CAGAGCTCCA TGATAAAGAG
>OMZ 125-4 GATAAACTTGACCAAGTAATTGGTCTTCTA 30 GACAAGCTTGACCAAGTTATTGGACTTCTC 25 f 13152 13181 CAATCTAGCA GGCGCAATCT
>OMZ 125-5 GTGAATTTAAGATTGGCAGTCAGACACCAG 30
>OMZ 125-6 AGTCTATGATGTGCCTTCTGATTTTGTTGG 30 AGTCTATGATGTACCTTCTGATTTTGTCGG 28 f 3628 3657 AGATTGCAAA CGGGCGCGGG
>OMZ 125-7 TCCGCTGAGAAAGCTTATTAAAGGTCAAGT 30 CCCGCTGAGGAAACTTATCAAAGGTCAGGT 28 f 12518 12547 AAGCGGATAG CGGCAAGATG
>OMZ 125-8 GCTAGACGGGTTTAATAAGCACGGTTTAG 29 GCTAGATGGCTTCAACAAGAAGGGTCTCG 21 f 10508 10537 CGCTATCTGC GCGGATTAAT
>OMZ 125-9 TCCCAACTCATGACTAGTAACTTTCGCATA 30 TCCCAATTCGTGACTAGTAATCTTTGCATA 25 r 2287 2258 GATTAATCAA AGGTTTCACG
>OMZ 125-10 TCCGCTGAGAAAGCTTATTAAAGGTCAAGT 30 CCCGCTGAGGAAACTTATCAAAGGTCAGGT 25 f 12518 12547 AAGCGGATAG CGGCAAGATG
>OMZ 125-11 GCTAGACGGGTTTAATAAGCACGGTTTAG 29 GCTAGATGGCTTCAACAAGAAGGGTCTCG 21 f 10508 10537 CGCTATCTGC GCGGATTAAT
>OMZ 125-12 CTAACAATTGATGACGACCCGATTTTAAAAA 31 ATAACGATTGATGATGACCCAATTTTGAAAA 26 f 2513 2543 AGAAGGTACA AAGCTTTAGT
>OMZ 125-13 ATCGAGCAAGTCAATAGCATTTCCGCTAAT 30 GTCTAGTAGGTCAATAGCGTTTCCACTAAT 24 r 21127 21098 GTCGTGCGCT CGGAATGCCT
>OMZ 125-14 CAATTCGTCAAATTCTCCACCAAGAAGTGC 30 TAATTCGTCAAATTCTCCACCTAGAAGCGC 27 r 30908 30879 GTAAATTTTA TGGATTAGCT
>OMZ 125-15 ACTGCAGATCAACATTTGTAAACGGAATCT 30
>OMZ 125-16 ATTCGCAGTGACTCTATGGAAATGGATACT 30
>OMZ 125-17 AAGTGTTCTTTGCATAAAATCGGGCAGTTC 30
>OM98x-25
^ forward (f) or reverse (r) strand
>OMZ 125-19 CAGCACGCGCCAAGAAAGTCAAAAATGACA 30 CCGCACGCGCTAAGAAAATCAAGAATGACA 26 f 3483 3512 ACTGCCAAAA CAGGCGCTAA
>OMZ 125-20 ACCCTACAAATTCATTGGTTCAAAGCCTGA 30 GCCTTATAAATTTATCGGTTCAAAACCTGA 24 f 14323 14352 ATTTCGTAAC CGGAACTTAC
>OMZ 125-21 AAAGGACATGCTGATACTGTGGCACCTGTT 30
>OMZ 125-22 CATTGAGTCAACTGGCGGGTTTTATCTTAA 30 CATTGAGTCAACTGGTGGCTTTTACCTCAA 26 f 18393 18422 CAGATGGATC CGGGAAAAAT
>OMZ 125-23 GATAAAGATGAATACAAAGACCCAAACACT 30 GATAAAGAGGAATACAAAGACCCGAATACT 27 f 1805 1834 TGCACAAGAT TGGATAAAGT
>OMZ 125-24 GATAAAGATGAATACAAAGACCCAAACACT 30 GATAAAGAGGAATACAAAGACCCGAATACT 27 f 1805 1834 TGCACAAGAT TGGATAAAGT
>OMZ 125-25 TATCTTTTGGCGGAATGAAATCTATTGTAT 30
>OMZ 125-26 AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
>MT4653-1 CGCTCTTGCACTTGTTCGGCGTTTGATTGC 30 CGTTCCTGCACTTGCTCGGCATTCGATTGT 24 r 3702 3673 TCTGTCATAA TGGTCCCCGC
>MT4653-2 TATTATGTTGAAAAATAATAACTGATGTAA 30
>MT4653-3 ATGCTTCTGGTACTGGTTTCTTCCCAAACT 30 ATGCTTCAGGAACTGGTTTCTTCAACAATT 24 f 11530 11559 CCTGCGAAAT TCAGGCGCCC
>MT4653-4 GTTCTGCAAGTGCTGAATCATAAGCTTTCT 30 GTTCTGCGAGTGCTGAGTCATAAGCCTTCT 27 r 4806 4835 ACTTGTTCAC TAGCTTCTAA
>MT4653-5 AAAAGAGTCATTGATATTAAGTGTAATGAA 30 AAAAAAGTTATCGACATGAAGTGTGATGAG 23 f 22380 22409 GGATGACTTT TGGCTAGGCA
>MT4653-6 AGCGTTTTTCCATCAATTGACGGTGCTAGA 30 TCAATATTCCCGTCAATCGACGGAGCTAGA 21 f 20559 20588 CCCCGTTTGG TGGTGGCAAT
>MT4653-7 CTTTGAATGCTTTATCAATGTTCTGAAAGG 30 CTTTGAATGCTTTATCTATGTTTTGAAAGG 28 f 524 533 AAGAAAAAAG GGTGAAGAGA
>MT4653-8 TTTCAAAATGCGCCAGAATCAGTTGATGGA 30
>MT4653-9 AATGTATGCACCGCGTTTCTTGACCAAGTA 30 GATGTATGCACCGCGTTTTCTGACCAAATA 26 f 570 599 GAGAATTGGC TGGACAAGAG
>MT4653-10 CGCTTGAAGGCGAGAATTGAATTCTTGATAG 31
>MT4653-11 AACATTATCGCTAATGGAATTTCAAATATT 30
>MT4653-12 CAATGAAACAAAAGAGAGATTAACTGCTCT 30
>MT4653-13 TTTAGTTTGCGATTATGAGGACTCCGCAAG 30 TTTAGTCTGTGACTATGAAGACTCTGCGAG 25 f 20330 20359 ACATTAAATA CGGTGATAAG
>MT4653-14 TGCAGGACAAGAGGTAATGTATATATCGCG 30 AGCTGGTCAAGAAGTTATGTATATCTCGCA 23 f 16857 16886 GCATGTATTC AGGCATGATA
>MT4653-15 AAAATTGTTTTAATAAAGTTATTCTTAGCA 30
>MT4653-16 TTTAAGGAATACATTTGTTGGTGTATTTGC 30
>OM98x-1 TCCCCCTCCTTACATAATGTCGCTAGCTGA 30
>OM98x-2 GCTAAGAAATCAAGTAGTAATAAGTAGGGC 30
>OM98x-3 GCAGACGAGACTAACAAACAGCGTATACAG 30 GCAGACGAAACGAACAAACAGCGTATACAG 28 f 16516 16545 CTTAGATTTA CAGATTGCAG
>OM98x-4 AAAATCTGCTGAAACGCGCTATGAAGGTCT 30
>OM98x-5 TTTATTTGCTCTTGCGGTTTTTACCGAGCC 30
>OM98x-6 ATCAGAAAATGAAATTAAAACAATTAATCT 30
>OM98x-7 TTATTGAGTTTGAACGGTCGCGATGTGTTG 30
>OM98x-8 TGATTATCGAAAGATACGGACAAAATGAGA 30
>OM98x-9 TGAAGATTCTAACATTATAGATGAAATTTT 30
>OM98x-10 CCTTCAAAGGTTGTTGACCATCTTGCAAGA 30
>OM98x-11 CAACATCTTCTAAAAATTCCACTTGCGTTA 30
>OM98x-12 TTCGTTTGTTGCCAGTCGTTTGGCAAACCT 30 GTCCTTTGTTGCCAGTCGTTTAGCTAATTT 24 f 12167 12196 CGCGAGTGTG AGGCGTTAAC
>OM98x-13 TTGACAACAATGATGTTGCATTCCAGATTT 30 TTGGCAATAACGATGTCGCTTTCCAAATTT 24 f 19228 19257 CAGACGCTAG GGGGCAGTGA
>OM98x-14 CAAAAGCACGAATGGTTGGTAGATAAACTTT 31
>OM98x-15 TTCGAAAGTTCCTGCAGTATCCAAAGTTGT 30
>OM98x-16 TATTCTTGTTAATACGTTCATTCCATGAGT 30
>OM98x-17 ATCTTGGTTTGCAAGGAAACTGAAAAACAT 30 ATCTTGATTTGTAAGGAAACCGAAAAACAT 27 f 6493 6532 AAAAATGAAA ATATTTGACG
>OM98x-18 TTCGAAAGTTCCTGCAGTATCCAAAGTTGT 30
>OM98x-19 TATTCTTGTTAATACGTTCATTCCATGAGT 30
>OM98x-20 ATCTTGGTTTGCAAGGAAACTGAAAAACAT 30 ATCTTGATTTGTAAGGAAACCGAAAAACAT 27 f 6493 6532 AAAAATGAAA ATATTTGACG
>OM98x-21 TGACGGTGTCGTCGAGTTTTACACTCGCAA 30 TGATGGTGTCGTCGAGTTTTACACTCGCAA 29 f 15615 15644 GGAAAAATTC GGGCTCTAAC
>OM98x-22 TTTCTTTTTATCTTTCTTACATATATATAG 30
>OM98x-23 GATTAATTCAAGTAGTGAGTCATCATTTTT 30
>OM98x-24 CAAAAGCTTTGTCATCCATAATGGATTGAA 30
AATAGAATCAAATTCTCCTAAGTCAGTTAA 30
* number of identical bp
Supplementary Table S3
spacer sequence bp M102 sequence id* s^ from bp to bp 5' to spacer 3' to spacer
>UA159-1 TGAAATCAATCGCATAGTATATGAAATGAGTTTT 34 TGAAATCAATCGCATCGTGTACGCTATGAGTTTT 29 f 27343 27376 TTTCAAGTTC GGAGAAGCTT
>OMZ 7-1 TGCATTTGTTAGTTGATTATCTCGACCTGTCCCA 34
>OMZ 7-2 AATTTGAAATGTCTATCCAATCAGAAGATTTATCA 35
>OMZ 7-3 TACAGTGCGACTGACTGCAGTAATAAACACTAA 33 CACAGTGCGATTGACTGCTACTATTAATACTAA 25 f 17112 17144 ACAACACTTC TGCAGGCGTT
>OMZ 7-4 AGAGCTCGAAAAGAGCATAACTAACCCAACAACAA 35 AGAGCTTGAAAAGAGCATAACTAATCCAACAACAA 33 f 15930 15964 TAACCATCTC TCACAGTTGT
>OMZ 7-5 ACTGAAAAAGAATTACCAAGCAGTAATCATTGA 33
>OMZ 7-6 AAGATGGCTGGAATATGAAGGAGAGGTAGAAAG 33
>OMZ 7-7 TTCAAAAAATCCTGAAATAAACACTTCTGGTTTTT 35
>OMZ 26-1 AGCATTAACTACTCGGTTTTGGAAAAAAGTTGT 33 CGCGTTTGCGACGCGGTTTTGAAAAAAAGTAGT 25 r 19389 19366 ACCGCCGTTC AAAAGTCAGC
>OMZ 26-2 ATATGAAGTTAAACAAAAAGTCTTTAAGGCAGAAA 35
>OMZ 26-3 TGACTAATTATATTAGCGCAAGCGATGACGGACT 34 TGACTGATTATATTAGCGCAAGTGATAATGGACT 30 f 16757 16790 TTTAATTTTC AACCATTGCA
>OMZ 26-4 AACAGATAATATGGATGTATCACGATTAGATAAG 34
>OMZ 26-5 TTTCAACTCTGTATCAAATCCAAAAAGCATAGTTG 35 AAACTTTTCC TTAAAGATTT
>OMZ 26-6 TGAAATCAATCGCATAGTATATGAAATGAGTTTT 34 TGAAATCAATCGCATCGTGTACGCTATGAGTTTT 29 f 27343 27376 TTTCAAGTTC GGAGAAGCTT
>OMZ 27-1 ATCGGTAAGAAGGTCGTTTCTGGCATTGGCACAGCA 36 ATCGGTAAGAAGGTCATCACTGGGATTGGTACAGCC 30 f 10068 10103 AGTTTATTTT GTCAAAGGAT
>OMZ 27-2 AAAAATAAAGACCCGGTAAATATCTGGGAAGAG 33 AAGAATAAAGACCCAGTAAATATCTGGGAAAAC 30 f 2861 2893 TGATATCTTT GACAAGACCC
>OMZ 27-3 TATAGAGCGTTTGACAGGGACTATTGTCCCAAGCA 35 TATAGAGCGCTTGACAGGAACCATCGTTCCAAAAA 28 f 24654 24688 AAGACGGTGC AGTGCAACAT
>OMZ 27-4 ATATCTATCAATCAATCTTAGACGACACAGATCAAA 36 ATATCTATCAATCAATCTTAGATGATACAGACCAAA 33 f 5247 5282 CAATTAGTGC AACTTCTATA
>OMZ 27-5 CCAAACAACACGACCACCAACATAATCAAAACCA 34 CCAAACAATACGACCACCAATGAAATCAAAACCA 30 r 19154 19121 TATACTTTTC GAATTAAATT
>OMZ 27-6 AATTTAAAGTTTAGTTTGATTATTTCTTTTGTGAG 35
>OMZ 27-7 TGGTACGTTAAAGCGCACCCAACCACCAAACCAA 34 CGGAACATTGAAGCGCACCCAACCGCCAAACCAG 28 r 14509 14477 CTGAAAATTC TAGAAGCCTA
>OMZ 27-8 TATAGAAGCAAACGTTAATTATGATGATACTTCAC 35
>OMZ 27-9 TCAACAGCAAAGGTTTTAAAGCAGCTGAAGTAAA 34
>OMZ 27-10 TATATATATTATACCGTATATTCAAATATACGTCA 35
>OMZ 27-11 TGATTTCAATATCTCTTTTAAATCTCCATGAAT 33
>OMZ 27-12 AATTTAAAGTTTAGTTTGATTATTTCTTTTGTGAG 35
>OMZ 27-13 TTGGATAGGTCACACCGTTAATCCAGTCAGTGAG 34
>OMZ 27-14 TTTCGTCCGAATTGGTTATTAATTGCCAGATTA 33
>OMZ 27-15 ATTTAAGACAATTGCAGACCAACAAGCAAATCTC 34
>OMZ 27-16 TTATCTGGAAAGATAGAATATTGTGTCCCTGATT 34
>OMZ 27-17 ACGGTCTATTTGCGATATGCTAAGCGTATGTAAC 34 GCGGTCTATTTGCGATATGCTAAGCGTATATAAC 32 r 21399 21366 TTTAGTTTTC CTAACATGTA
>OMZ 27-18 AGTTCAAAAGGAACATTCATATGTACATCCAACAC 35
>OMZ 27-19 TGTTAAAGTCTCTGAATAGTCATATATGTAAAAC 34 TGTCAAAGTTTCTGAGTAGTCATATATGTAAAAC 31 r 15114 15081 TTTTAATTTC TTTTGATACT
>OMZ 27-20 AGTTCGCTTTCTTTCAGTGCTTCTATGCGCTTGT 34 AATTCACTTTCTTTAATTGCTTCTATGCGTTTGT 29 r 26023 25990 CCTTTCTTTC AATCGCGAAC
>OMZ 27-21 AAAGATTGTCGACCACACAGTGCCAGTCGAAATT 34 GAAGATAGTTGACCACACGGTACCCGTTGAGATT 26 f 306 339 AACCCAATTC GCCCCAGAAG
>OMZ 27-22 CAGTCAGGCTTGTAAAAAAACCAAGAGCTCGAACA 35
>OMZ 27-23 TGAAGTCTGCTGGTATTCTTTTCAAGGGTCTTGTA 35 TGGAGCCTGCTAGTGTTCTTTTCTAAGGTCTTATA 28 r 11167 11133 TGTGGTCTTC CCATTTCCCG
>OMZ 27-24 AAAAAAGCTGTGTCATTTTGCTTCATCAGCATAGA 35 AAAAAAGCTGTATCGCTTTGCCTCATCAGCATAAC 29 r 24028 23994 AATCTTTTTT TTTTGTACCA
>OMZ 27-25 TTCGCCGTCCATAGTATCGCCATGAGTAGCAGT 33 CTCGCCGTCCATAGTGTCTCCGTGAACGCCGGT 25 r 12374 12342 AGTTATATTC GACAAAACTA
>OMZ 27-26 AGAGCTCCGCTAACAAAACTGCCGATAGACTTGCC 35
>OMZ 27-27 TTTCTTGTTTTCTCGCCCTATTCCGCGCGGGTCT 34
>OMZ 27-28 AGAGCTCCGCTAACAAAACTGCCGATAGACTTGCC 35
>OMZ 27-29 TTTATATTCTCTTTGCAGAGTAGCAAGACCTGATT 35 TTTATACTCTCTTTGCAGAGTAGCAAGGCCCGACT 31 r 8531 8497 GGTTTTGCTC TTTGATAGTC
>OMZ 27-30 AATTATCGTTAAGCGCTTTTCAGCATTAGCTACTC 35 GATTATTGTCAACCGCCGTTCCGCGTTTGCGACGC 25 r 19419 19385 TTTCTTCCTC GGTTTTGAAA
>OMZ 27-31 AAGAAATTCAGGTGGATAAAGAACTTAATGACTA 34
>OMZ 27-32 TGTATGGAATACATTGACATACCAATGATACTCAT 35
>OMZ 27-33 CTATAGATATATACTCATCATTTGCATCAATTACTC 36
>OMZ 27-34 TTCATTTTACATATTTATTATACCACGCATTGCG 34
>OMZ 30-36 TCATGCTCTCTTCATCAGCTTTGCACTCTTTTAA 34
>OMZ 27-35 TTATAGAGAACAGTCAAAGCCACTCCCACAGTGG 34
>OMZ 27-36 AATAATAGTTTCTTCTCTTGACCAATTATCATAAA 35
>OMZ 27-37 ATCTATTTCGACCAAAACACAAAAACGCTTGACCT 35 ATCTATTTTGATAAAGACACAAAAACATTAGATTT 27 f 14750 14784 CTCTAGCTTT GAGTTTCAGC
>OMZ 27-38 AACCAGACTTGGGAAGAATCCCGTCCCTGAAGCGT 35 AACTAAGCTTGGAAAGAAGCCAGTTCCTGAAGCAT 27 r 11798 11764 TAATTGCCTC AAGGCATAGC
>OMZ 27-39 AATTTGCGCTCGCTCCTCTCAAGGTGATTGGCGG 34
>OMZ 27-40 AATTTGCGCTCGCTCCTCTCAAGGTGATTGGCGCG 35 AAGTTGCATTTGCTCCTCTCAAAATAATCGGCGCT 25 f 10438 10472 AAAACACTAC TTAGTTGTCC
>OMZ 27-41 TTTAGAAACCTTACCGCCATTTACATAGCCGTAT 34 TTGCGAGACTATACCGCCGTTTGCATATCCGTAC 25 r 12980 12947 ATAGACCTTC GCCGCAACCC
>OMZ 27-42 ATAAAAATCAGTCTCCATAAAATCGTTGACCGACC 35
>OMZ 27-43 ACGTCTTTCCAATACACGACCAATAGATTCTAAA 34
>OMZ 27-44 ATTGCCATGGTTTGAAGCTGTTCAAGATTTTAAA 34
>OMZ 27-45 ATATATCTAAGGATTTGAAGGAAGTTGCTAAACA 34
>OMZ 27-46 ATATTTTTCGGGTATGAAAGCTTTATGCATATAAT 35
>OMZ 27-47 ACGACATCAAGGCGGAGATGTCATTTCACTTGTTG 35
>OMZ 27-48 CACTATGGTCTAGAACATGGTATTCCTTCAGTAGC 35
>OMZ 27-49 TTTCAACTCTGTATCAAATCCAAAAAGCATAGTTG 35
>OMZ 27-50 TGAAATCAATCGCATAGTATATGAAATGAGTTTT 34 TGAAATCAATCGCATCGTGTACGCTATGAGTTTT 29 f 27343 27376 TTTCAAGTTC GGAGAAGCTT
>OMZ 30-1 AGTCAATCCCTCAATCATTTGCCTGTTCGTTTCCA 35
>OMZ 30-2 TAACGGCGGTGATGTTTTTGCTGCAAGTGAAATT 34
>OMZ 30-3 ACCAAGAACAAAAAAAGTTAATCGAAATTATGGA 34
>OMZ 30-4 AAATATTGGGAATAAAATAAAAGACGTCGCTACT 34
>OMZ 30-5 AGATGAAGTTAAACAAGAAGTCTTTAAGGCAGAAA 35
>OMZ 30-6 TTGGGATTTGTGTAATATGCCAAAAATTCCTCGT 34
>OMZ 30-7 AATCTGTTCAACATTTGATTGTTGGTCCGAACGT 34 CACTTGCTCGGCATTCGATTGTTGGTCCCCGCGC 23 r 3694 3661 TAACGTTCCTG CCGCCGACAA
>OMZ 30-8 GAATGGTTGTTAAGCCATTATCTGTATCGATAAC 34
>OMZ 30-9 AGGAATATTGGGCCGTTTATGTCATCAAAACAAAA 35
>OMZ 30-10 TAAGCAAGTAAGAAGGCAGACGGCACAAGCAGTT 34
>OMZ 30-11 TACCTTGTGGCACAAAGCTTTGTCCATTTGGCAA 34
>OMZ 30-12 AAACAAAAAAAAGATTAGAAAAAACCTTTAAAG 33
>OMZ 30-13 AAATATAGTAACTCTCTTATCGATAGCGATACTTT 35
>OMZ 30-14 TTTAACAGGAGCCGTTTGTCTTACGTATTCCGTT 34
>OMZ 30-15 ATTAATTGCGAATCATACAGATGAAATTGGGCAA 34
>OMZ 30-16 TATTGGTGATAGTGCAGAACAAGCAAACAAGAC 33
>OMZ 30-17 AACGGAGCCTTGTTGCTCCCACGGAACGAAGCTAA 35 AATAGAGCCCTGCTGTTCCCAGGGGATAAAACTGA 24 r 2203 2169 TTTTAGCTTC ATTGCGACAA
>OMZ 30-18 ATCAAATTATACCTTTAATTAAATTTTGTCGCTT 34 ATCAAATCATACCCTTAATCAAATTTTGTCTCCT 29 f 13329 13296 AATGTATTTC GCTGTACTTG
>OMZ 30-19 TTTTGTTTGTGCAGCATCAAGTGCTGCTTCAGAA 34
>OMZ 30-20 AAAAGGTGTTTCGGTTCCAACTAAGGCAGTAGCT 34
>OMZ 30-21 TTTACGGCGTAGAAACACTAAAAAATACAAGGAAT 35 TATATGGTGTGGAAACACTTAAGAACTCACGCAAT 25 f 14280 14314 GGAAAGTTGT TTCGTAACGC
>OMZ 30-22 CTCATAATTTGGTTGTGCATGCTATTAATACAGT 34
>OMZ 30-23 CGGTAATAAGCTTGCTGATACAGCTGGAAAAGTC 34
>OMZ 30-24 GACGATAGACGTTATGGCTCTGCACGAGTTGGTG 34
>OMZ 30-25 CGCTTTTAGTTTAGCTAAAGAGCTGAAATATCCT 34
>OMZ 30-26 TTGATCAGTATCGACACCGCGACCTTCAGCAGCCA 35 TTGGTCAGTATCCACACCACGACCTTCCGCGGCTA 29 r 21000 21034 TGCCATAAAC AACGTGTGTA
>OMZ 30-27 TTAGAAGACCTATGACAGGTACATTAACTATTG 33
>OMZ 30-28 AAAAAGAAACGTGCTGATCGTAAGCATAGCTATC 34
>OMZ 30-29 AATAGCACCATTAAATGATGATGCGTTACATAAAG 35
>OMZ 30-30 TTGCAAAGAATGGTGAGAATGCTCGCAAACGACAAA 36
>OMZ 30-31 AAGTTCTGAGATGGTCAAAGACCAAATCCCGCCGC 35 AAGCTCTGAGATGGTTAGAGACCAAATCCCGCCGC 32 r 15936 15902 TGCTCTTTTC TAGAAAACAC
>OMZ 30-32 ACTGGCATAGCTAAAAGTATAGCAAATGTGTTTA 34 ACTGGCATAGCTAAGAGTATAGCCAGCGTTTTCA 28 f 9921 9954 GAGTGTATTC AGACCTTCAG
>OMZ 30-33 ATTTTCGAAGTTAGCATTAAGCGCACGTGTACCT 34
>OMZ 30-34 AAGAGTTGTCACTATTGTTTTGTATGGATCTAT 33
>OMZ 30-35 ACTATCCCTAAATTACAAGATGGAAAGTTAGTTG 34 ACTATTCCAAAATTAAAAGACGGAAAATTAGTTG 29 f 14983 15016 TTTTGACTTT ATGGTATAGA
>OM98x-31 ATAACCATAGTCCAACCATTCATCAACAAATTT 33
>OMZ 30-37 AAGATCACAACCACGTTTATAATGGTTACAACTAC 35
>OMZ 30-38 AAATGATGTTGGTGAATTTTATGAATGGTTTGGAA 35
>OMZ 30-39 AAATTCGAAACGAGTATTACAGGGAAAAAAAGAA 34
>OMZ 30-40 ATGGGATAATGCTATACCAATTACAAGTTTAAAG 34
>OMZ 30-41 AAGAACTCATTAAATTCCTTGAAACTATATTTGA 34
>OMZ 30-42 TTCAAAAAATCCTGAAATAAACACTTCTGGTTTTT 35
>OMZ 67-1 AATTATGAAAGCTCAGTATGGACAACTTGATAA 33
>OMZ 67-2 TTCAAAAAATCCTGAAATAAACACTTCTGGTTTTT 35
>OMZ 960-1 AAAATAATTGGGATAGCAATGCCGTCGCTGGTCAC 35 AAAACAACTGGGACAGTAATGCAGCGGCAGGTCAC 27 f 12751 12785 CCAAACGTGC CCATCTATTG
>OMZ 960-2 GAAAGAAACTTTTGGAAAGTCAGCGATAGCACAA 34
>OMZ 960-3 AACGCGAGTCAAACGGGGACCCTAATGTCCAAAAT 35 AGCGAGAAAGTAACGGAGACCCAAACGTGCAAAAC 25 f 12721 12755 TCAACTATTC AACTGGGACA
>OMZ 960-4 TTCACGAGTTTCGGCGTCATCTCTAAGCTTATCAA 35 TTCACGAGTTTTTGCGTCGTCTCTAAGTTTATCAA 31 r 6862 6828 TGAGTACTTC GCCTTACGTC
>OMZ 960-5 TAAGCACAAGGAAGCTTTGCAAGCCGTCGGTAA 33 TAAACACAAAGAAGCTTTGCAAGCCGTCGGCAA 30 f 10016 10048 ACAGAACATC GGTGCTAGCA
>OMZ 960-6 AAGAGGGAACAAGACGAAACATTAAAAGCTATTGA 35 AAAAAGGAACAAGATGAAACACTAAAAGCTATCGA 25 f 1718 1752
>OMZ 960-7 AATAACGCAGCTAAGAATGTTGCAATCAACACGCT 35 AATAGCGCAGCTAAAAATGTTGCAATCAACACGCT 33 f 14021 14055 GACTGCGTTT TCCAAATGAA
>OMZ 960-8 TTGACAATCTTGAACTTCAGTGTTAGACCAATGGT 35
>OMZ 960-9 ATATTATGTTAAATCAATGAAACATGGTATTGA 33
>OMZ 960-10 TGATTGTTTGCGCTGTCACTTGATAGTTCTTGT 33 TGATTGTTTGTGCCGTCACTTGATAATCTTTGT 28 r 25239 25207 TTGTCATTTC ATTTTTTAAC
>OMZ 960-11 AAGATGGCTGGAATATGAAGGAGAGGTAGAAAG 33
>OMZ 960-12 TAGAGGAGAAGCAGAAAAATACGTCCAAGAATAC 34
>OMZ 960-13 TTCAAAAAATCCTGAAATAAACACTTCTGGTTTTT 35
>OM98x-1 GTGCTGAAACATGCAACGTTGGAAGACTTAGAA 33 GTACTGAAGCACGCGACGCTAGAAGACTTGGAA 26 f 23863 23895 TCGCAGTTTT GAACTTCAAG
>OM98x-2 AACTGGCGCCGTAGTTGCTTCTGCTTGCTTAGCT 34
>OM98x-3 AACATTTGTTTTTGTATGAGTCTCGAGAAAATCAA 35
>OM98x-4 CTTAGCTTGCTTGCTATTCATCCCCATAATGCGT 34
>OM98x-5 AAAGAGTGTGTCTCTTTTGTCGCTAGTCGGTTAG 34 CGCGAGTGTGTGTCCTTTGTTGCCAGTCGTTTAG 26 f 12156 12189 CTACTTCTTC CTAATTTAGG
>OM98x-6 TATCACAAAAGTGACTACACCAACACCTGAAAA 33
>OM98x-7 AATACTGGCTTTGATTTTGGCGGCGGTCGCGTAGT 35 AATTCTGGTTTTGATTTCATTGGTGGTCGTATTGT 25 f 19116 19150 TCCAAAATTT TTGGGAAAAG
>OM98x-8 TACTTGATAGTTAATGCCATCACGCTTGCTTTT 33 TGCTTGATAATTGATGCCGTCTCGTTTGCTTTT 27 r 2242 2210 TCACGTCTTC AGCTTCAATA
>OM98x-9 TATGCTTGTATTTAGCGACTGTACCATCGTATAG 34
>OM98x-10 TTTTGGATTTACACAATCAAAGATAAACTTTAAA 34
>OM98x-11 TCCACTAAGTTTGCTAGTTATCTTGCTATGTGGAC 35 GATAGACGCTTTGCAAGTTATCTCGCTATGTGGAC 25 f 6755 6789 GGTCGGCTTT TAATTGGGGA
>OM98x-12 AAACTAAAAAAATGTTGGAAGACATTCTGGAAA 33
>OM98x-13 TTAGTGATTTGTTTTGTAATTGCAAAAAGTCCAA 34 TTAGTGATTTGTTTTGTAATTGCGAAAAGTCCGT 31 r 19207 19174 CACTGTGTTC GTAGTCATCG
>OM98x-14 TTGTTATTGTCATTTTTATATTCCATTTCCATAA 34 TTGCTATTATCGTTTCTGTATTCCATTTCCATGA 29 r 16976 16943 TACTGCATTT AATTTCCAAT
>OM98x-15 TTTCTGAGACCCGCCAAAAGCTTTTGAGACTAA 33 TTTTTGCGACCCGCCAAAAGCTTTCGAAACTAG 28 r 10769 10737 TCTTGGCTTC CTTTTGCATG
>OM98x-16 AAATCGGCTTGCATCACTTATCCGTTCTACGCCG 34 AAAGCGGCTTGCGTCGCTTATCAGCTCTATACCA 25 r 15051 15018 TCATAGCTTC TCAACTAATT
>OM98x-17 ATCGAATGCAATTGGTTATTATCATTTTGCACGAT 35 TAGTGATTGCATTGGATTTTACCATTTCGCACGAT 24 f 20219 20253 AAGTTGCAAC TTGGGGGCTC
>OM98x-18 CATCAGAAACTGAAATTGCATTAATTACTGATGAA 35
>OM98x-19 AAAATCAAGCGTTAATCCGCTTAACGGTACAAA 33 AAAACCAAGCGTTAATCCGTTTAACTGTTCAGA 28 f 19490 19522 CATGATATTC TGGATGAATT
>OM98x-20 ATCAGTCAGCAGTAGCAACTTTTGGAAAATCGC 33
>OM98x-21 TCTATACGTCCCTCTATAGCTATCTTTTAAGCTGT 35
>OM98x-22 TCCACTCTGAAGGTCCAGCTGTAATAAGTGGTGT 34
>OM98x-23 AAGAAAGGTTTTAAGAAATTTGCTGAAGCAGTTG 34 AAGAAAGGTATTAAGAAATTTTTTGAAGGCTCTA 27 f 7775 7808 CGACATTTTC AGAATTTTGG
>OM98x-24 TATATTCTCATCTTTTACTTTTTGCTCTTTTCCA 34
>OM98x-25 TATTTTTGTGATGGATACAAGTGTCGCTTATGGT 34
>OM98x-26 TTTAGTGAATTACTCAATAAATATACAAGCGGCAA 35
>OM98x-27 TTCTTTTGTTTCTGGTTTGATGATACCAGCTGCTG 35
>OM98x-28 AATTATCGTTAAGCGTTTTTCAGCATTAGCGACC 34 GATTATTGTCAACCGCCGTTCCGCGTTTGCGACG 23 r 19419 19386 TTTCTTCCTC CGGTTTTGAA
>OM98x-29 AAAAATATTGTTGTAACTGCGCAACATCTTCCCA 34
>OM98x-30 CAACAAGTATAGAACGTTGGACGAAAGACTATAA 34
>OMZ 175-1 TGAAATCAATCGCATAGTATATGAAATGAGTTTT 34 TGAAATCAATCGCATCGTGTACGCTATGAGTTTT 29 f 27343 27376 TTTCAAGTTC GGAGAAGCTT
^ forward (f) or reverse (r) strand
>OM98x-32 AGAAATATAAGCTTTGATGATAGCTTTCCCTAGTT 35
>OM98x-33 CGTTAGGACGAGGACTTTTTCTAACGCCGAGGTT 34
* number of identical bp
Supplementary Table S4: CRISPR1 repeats
strain general repeat last repeat
UA159 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 381 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 7 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 20 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 25 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 64 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 67 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 186 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 380 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 382 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
OMZ 1040 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 1079 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
AT10 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
L18 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
LML7 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
MT4863 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAT GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
OMZ 125 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAC
MT4653 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCTGTGTTAGTTACTGATTTACTAAAAT
OM98x GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT
Supplementary Table S5: CRISPR2 repeats
strain general repeat last repeat
OMZ 7 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGTTTTTT
OMZ 26 GTCGCACCCTTCACGAGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
OMZ 27 GTCGCACCCTTCACGAGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
OMZ 30 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
OMZ 67 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGTTTTTT
OMZ 918 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
OMZ 960 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGTTTTTT
OMZ 175 GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
OM98x GTCGCACCCTTCACGGGTGCGTGGATTGAAAT GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT
 Supplementary Table S6: Similarity of S. mutans CRISPR spacers 
CRISPR1 
spacer identity with accession number 
OMZ 1040-15 28/30 S. thermophilus phage 7201 (large subunit terminase) AF145054                
L18-9 27/30 S. pyogenes hypothetical protein, phage associated AE004092 
OMZ 125-5 30/30 S. mutans SMU.820 (hypothetical protein) AE014133 
OMZ25-17 28/30 S. agalactiae gbs0997, plasmid pNEM316-1 AL766848 
At10-1 29/30 S. mutans SMU.1705 AE014133 
OMZ 20-33 
OMZ 25-18 
OMZ 64-12 
OMZ 380-8 
OMZ 382-31 
OMZ 1079-37 
OMZ 125-26 
OM98x-24 
29/30 S. agalactiae gbs0362, gbs0693, gbs1015 (plasmid pNEM316-
1) 
AL766848 
 
CRISPR2 
spacer identity with putative function accession number 
OMZ 67-1 32/33 S. pyogenes putative DNA methyltransferase - phage-
associated 
AE014074 
OMZ 960-9 33/33 S. mutans putative transposon protein TnSmu1 SMU.201c AE014133 
OMZ 30-1 32/33 S. agalactiae gbs0384, gbs0714, gbs0995 (on genomic islands 
III, VII, VIII), completely identical amino acid sequences. 
AL766848 
OMZ 27-46 35/35 S. mutans SMU.219 AE014133 
OMZ 27-48 35/35 S. mutans SMU.191 AE014133 
OMZ 27-49 OMZ 
26-5 
31/35 S. mutans hypothetical protein SMU.216c, transposon-
associated TnSmu1  
AE014133 
 
Supplementary Figure S1 
 
UA159           TCGTTTCCCCTATCGGATCATTTATGGCATCGTTTGTTTTTCATACCTAGGTGCCTCACC 60 
OMZ 960         TCGTTTCCCCTATCGGATCATTTATGGCATCGTTTGTTTTTCATACCTAGGTGCCTCACC 60 
OM98x           TCGTTTCCCCTATCGGATCATTGATGGCATCGTTTGTTTTTCATACCTAGGTGCCTCACC 60 
S. equi         GCGGTTTCCGTTTCGTATCATTGATGGGGTGGTGTGTTTTTCTTACCTGGGTGCTTCGCC 60 
S. pyogenes     ACGGTTTCCGTTTCGGATTATTGACGGTATTGTCTGTTTTTCTTATTTGGGTGTGTCGCC 60 
                 ** ** ** * *** ** *** * **  * ** ******** **  * ****  ** ** 
 
UA159           ATCTTTGATTGAACTTTGTGCCAAAAATCAAATTAACCTTTCCTTTCATACGCCTCAGGG 120 
OMZ 960         ATCTTTGATTGAACTTTGTGCCAAAAATCAAATTAACCTTTCCTTTCATACGCCTCAGGG 120 
OM98x           ATCTTTGATTGAACTTTGTGCCAAAAATCAAATTAACCTTTCCTTTCATACGCCTCAGGG 120 
S. equi         TGCCTTGATTAAGCTCTGTACGGAGAATCAGATTAATTTGTCCTTTCATACGCCTCAGGG 120 
S. pyogenes     TGCTTTGGTGAAGTTATGTACGGAGAATCAGATTAATTTATCGTTTCATACACCACAAGG 120 
                  * *** *  *  * *** *  * ***** *****  * ** ******** ** ** ** 
 
UA159           ACGATTTTGTGGCCGTTTCGTTGGGCCGGCAAATGGCAAT--CCTTTTACGACGTCAGCA 178 
OMZ 960         ACGATTTTGTGGCCGTTTCGTTGGGCCGGCAAATGGCAATGTCCTTTTACGACGTCAGCA 180 
OM98x           ACGATTTTGTGGCCGTTTCGTTGGGCCGGCAAATGGCAATGTCCTTTTACGACGTCAGCA 180 
S. equi         CCGTTTTTGTGGTCGTTATGTTGGTGCGACAAATGGTAATGTGCTGTTGCGACGAGAGCA 180 
S. pyogenes     GCGTTTTTGTGGTCGCTATATTGGTTCAACCAATGGGAATGTGTTGTTGCGTAGAGAACA 180 
                 ** ******** ** *   ****  *  * ***** ***    * ** **  *  * ** 
 
UA159           GTATAGGCTAGCTGATAATGACCTTTCTCTGGCGTATGCCAAACGGTTTATCCTGGCAAA 238 
OMZ 960         GTATAGGCTAGCTGATAATGACCTTTCTCTGGCGTATGCCAAACGGTTTATCCTGGCAAA 240 
OM98x           GTATAGGCTAGCTGATAATGACCTTTCTCTGGCGTATGCCAAACGGTTTATCCTGGCAAA 240 
S. equi         CTATCGTTTAGCAGATCGCGATGAGTCCTTGGAGTATGCCAAGCGGTTTATTTTAGCAAA 240 
S. pyogenes     TTATCGTTTATCTGATCGTGAGGAATCTTTGGAATACGCAAAGCGGTTTATTTTGGCTAA 240 
                 *** *  ** * ***   **    **  ***  ** ** ** ********  * ** ** 
 
UA159           GATTTCAAATGCCAGAAAGTATCTATTACGGTTTCGGCGTGACCATCGAGCCAAAATAAA 298 
OMZ 960         GATTTCAAATGCCAGAAAGTATCTATTACGGTTTCGGCGTGACCATCGAGCCAAAATAAA 300 
OM98x           GATTTCAAATGCCAGAAAGTATCTATTACGGTTTCGGCGTGACCATCGAGCCAAAATAAA 300 
S. equi         AATATCAAATGCTAGGAAATACTTGCTTCACTTTAGGCGTGACCATCGAGATCAGATTGA 300 
S. pyogenes     AATTTCCAATTCAAGGAAATACTTGCTACGCTTTAAACGAGATCATCGTCAACAGATTGA 300 
                 ** ** *** * ** ** **  *  * *  ***   ** ** *****     * **  * 
 
UA159           TCAACAACTTTTTGAGGAAGTCAATACTGAGTTGACTTTTGCTCTGGAAATGGTGGCTAC 358 
OMZ 960         TCAACAACTTTTTGAGGAAGTCAATACTGAGTTGACTTTTGCTCTGGAAATGGTGGCTAC 360 
OM98x           TCAACAACTTTTTGAGGAAGTCAATACTGAGTTGACTTTTGCTCTGGAAATGGTGGCTAC 360 
S. equi         TGGCAAGCTTTTTGAAGAGGTCAATGGTGAGCTGATCTGGGCACTTGAGATGGTGCAGGC 360 
S. pyogenes     TACCAAGCTTTTTGAGGCTGTTAATGACGAATTGATATGGGCTTTAGAGATGGTTCAGGC 360 
                *    * ******** *  ** ***   **  ***  *  **  * ** *****     * 
 
UA159           TGCAAGAGATAAGGATACTTTACTTGGTATTGAAGGTCAAGCTGCTAACCACTATTTCCG 418 
OMZ 960         TGCAAGAGATAAGGATACTTTACTTGGTATTGAAGGTCAAGCTGCTAACCACTATTTCCG 420 
OM98x           TGCAAGAGATAAGGATACTTTACTTGGTATTGAAGGTCAAGCTGCTAACCACTATTTCCG 420 
S. equi         AACAGATAATAAGGATTCTCTTCGCGGCATTGAAGGTCAAGCTGCCAACCAGTACTTCCG 420 
S. pyogenes     AGCAGATAATAAAGACTCTTTAAGAGGGATTGAAGGCCAAGCTGCTAATCAGTATTTTCG 420 
                  **    **** **  ** *    ** ******** ******** ** ** ** ** ** 
 
UA159           TGCTTTTAATGATTTAGTCTTGACAGATAAGTAGACATTTCAATTTAAGGGACGGACACG 478 
OMZ 960         TGCTTTTAATGATTTAGTCTTGACAGATAAGCAGACATTTCAATTTAAGGGACGGACACG 480 
OM98x           TGCTTTTAATGATTTAGTCTTGACAGATAAGCAGACATTTCAATTTAAGGGACGGACACG 480 
S. equi         TATTTTCAATGATTTGGTGTTAACGGATAAGAAGGCCTTTACCTTTGGTGGTCGCAGTAA 480 
S. pyogenes     CATATTTAATGACCTGGTGTTGACGGACAAAAAAACGTTTTACTTCCAAGGTCGGAGTAA 480 
                    ** *****  * ** ** ** ** **  *  * ***   **    ** ** *     
 
UA159           ACGGCCGCCGCAAGATTGTGTTAATGCACTTTTATCCTTTGGTTACAGTATGTTGACTTA 538 
OMZ 960         ACGGCCGCCGCAAGATTATGTTAATGCACTTTTATCCTTTGGTTACAGTATGTTGACTTA 540 
OM98x           ACGGCCGCCGCAAGATTGTGTTAATGCACTTTTATCCTTTGGTTACAGTATGTTGACTTA 540 
S. equi         GAGACCTCCCTTGGATCGTGTGAATGCCCTTTTATCTTTTGGCTACAGTTTGCTGACCTT 540 
S. pyogenes     ACGACCACCCTTAGATTGTGTTAATGCCCTCTTGTCTTTTGGTTACAGTTTACTGACCTT 540 
                  * ** **    ***  *** ***** ** ** ** ***** ****** *  **** *  
 
UA159           TGAGTGTCAGTCTGCCTTAGAGGCGGTTGGATTAGACAGTTATGTCGGATTTTACCATAC 598 
OMZ 960         TGAGTGTCAGTCTGCCTTAGAGGCGGTTGGATTAGACAGTTATGTCGGATTTTACCATAC 600 
OM98x           TGAGTGTCAGTCTGCCTTAGAGGCGGTTGGATTAGACAGTTATGTCGGATTTTACCATAC 600 
S. equi         TGAATGTCAGTCGGCCTTAGAGGCGGTCAGCTTGGATAGCTATGTTGGCTTTTTTCATAC 600 
S. pyogenes     TGAATGTCAATCTGCCTTGGAAGCTGTCGGATTAGACAGTTACGTTGGTTTCTTTCACAC 600 
                *** ***** ** ***** ** ** **  * ** ** ** ** ** ** ** *  ** ** 
 
UA159           AGATAGACCTGGTCGTGCCAGCTTAGCTTTGGATTTAGTGGAAGAATTTCGTTCTTATAT 658 
OMZ 960         AGATAGACCTGGTCGTGCCAGCTTAGCTTTGGATTTAGTGGAAGAATTTCGTTCTTATAT 660 
OM98x           AGATAGACCTGGTCGTGCCAGCTTAGCTTTGGATTTAGTGGAAGAATTTCGTTCTTATAT 660 
S. equi         GGATAGGCCGGGTCGCGCTAGTCTTGCCTTGGATTTGGTAGAGGAATTTCGTTCCTATAT 660 
S. pyogenes     GGATCGTCCTGGGCGTGCTAGTTTAGCGCTTGATTTAGTTGAAGAGTTCCGCTCATATAT 660 
                 *** * ** ** ** ** **  * **  * ***** ** ** ** ** ** ** ***** 
 
UA159           TGTTGATAGATTTGTTTTTTCGTTGATAAATAAAGGACAATTAAGCAAAAAGCACTTTGA 718 
OMZ 960         TGTTGATAGATTTGTTTTTTCGTTGATAAATAAAGGACAATTAAGCAAAAAGCACTTTGA 720 
OM98x           TGTTGATAGATTTGTTTTTTCGTTGATAAATAAAGGACAATTAAGCAAAAAGCACTTTGA 720 
S. equi         TATTGATCGTTTTGTGTTTTCATTGATTAATAAAGGACAGCTGACAAAGAAGCATTTTGA 720 
S. pyogenes     TGTAGATCGTTTTGTCTTTTCATTAATTAATAAAGGACAACTTCAGAAAAAACACTTTGA 720 
                * * *** * ***** ***** ** ** ***********  *    ** ** ** ***** 
 
UA159           CATTAAGGAAAATGGCAGTGTTATTTTGACTGAAAAAGGACGTGCTATTTTTATTGAAGC 778 
OMZ 960         CATTAAGGAAAATGGCAGTGTTATTTTGACTGAAAAAGGACGTGCTATTTTTATTGAAGC 780 
OM98x           CATTAAGGAAAATGGCAGTGTTATTTTGACTGAAAAAGGACGTGCTATTTTTATTGAAGC 780 
S. equi         TGTTAAGGAGAGTGGCAGTATTTTGCTAACAGAAAAGGGACGTGTGACATTTATTGAGCT 780 
S. pyogenes     GGTTAAAGAAAATGGTAGTATTTTATTGACGGAAAATGGCAGAGCTATTTTTATTGATTT 780 
                  **** ** * *** *** ** *  * ** ***** **  * *  *  ********    
 
UA159           GTGGCAAAAGCGCAAGCATACGGAGGTTGAACACCCTTTCACCAAGGAAAAAGTCAAGTT 838 
OMZ 960         GTGGCAAAAGCGCAAGCATACGGAGGTTGAACACCCTTTCACCAAGGAAAAAGTCAAGTT 840 
OM98x           GTGGCAAAAGCGCAAGCATACGGAGGTTGAACACCCTTTCACCAAGGAAAAAGTCAAGTT 840 
S. equi         GTGGCAAAAGCGTAAGCACATGGAGGTAGAGCACCCGTTTACAAAAGAAAAGGTCAAGCT 840 
S. pyogenes     GTGGCAGAAGCGTAAGCATACTGAGGTAGAACATCCTTTTACAAAAGAGAAAGTAAAACT 840 
                ****** ***** ***** *  ***** ** ** ** ** ** ** ** ** ** **  * 
 
UA159           AATGTTGTTACCTTATGTACA 859 
OMZ 960         AATGTTGTTACCTTATGTACA 861 
OM98x           AATGTTGTTACCTTATGTACA 861 
S. equi         AATGCTCCTGCCTTATGTGCA 861 
S. pyogenes     TATGTTATTACCCTATGTACA 861 
                 *** *  * ** ***** ** 
 
